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Abstract 
Salmonella enterica serovar Typhimurium is a facultative intracellular pathogen, 
capable of causing disease in a variety of animal hosts. Both invasion of the host 
intestinal epithelial cells, and survival and replication in host macrophages are required 
for the successful establishment of the typhoid-like infection in mice. Material in this 
thesis describes regulation of Salmonella virulence genes involved in both invasion and 
the systemic stages of infection.  
Salmonella uses the Salmonella Pathogenicity Island I (SPI1) Type Three 
Secretion System (T3SS) to invade intestinal epithelia in the distal ileum of the host small 
intestine. HilA, a master regulator of the system, determines the level of SPI1 T3SS in the 
cell. Three AraC-like regulators, HilD, HilC, and RtsA, directly activate hilA expression, 
as well as each other and themselves, forming a complex feed-forward regulatory loop to 
control SPI1 expression. The production of the SPI1 T3SS system is tightly controlled, 
with many regulators and environmental conditions known to affect hilA expression. We 
provide a classification of these various regulatory signals based on their point of 
integration into the SPI1 regulatory circuit showing that the SPI1 system is controlled at 
multiple levels. The majority of the SPI1 regulatory input integrates into the system via 
HilD. Regulatory signals of Class I, II, and V affect hilA expression via HilD by acting at 
the level of HilD protein, controlling hilD expression post-transcriptionally, or affecting 
HilD autoactivation, respectively. The regulatory signals in Class III control hilA 
independently of HilD, HilC, or RtsA, while those in Class IV affect all promoters in the 
SPI1 regulatory circuit.  
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The flagellar protein FliZ is a Class I regulator of SPI1 that activates hilA 
expression by affecting HilD protein activity. Thus, FliZ serves as a link between 
flagellar regulon and SPI1. We provide evidence that the FliZ-dependent regulatory input 
into SPI1 is limited, despite the fact that the SPI1 and flagellar genes are co-regulated 
under a variety of conditions and FliZ was shown to be an important regulator of SPI1 in 
the mouse model of infection. In the small intestine of the host, bacteria have to respond 
to multiple environmental cues. Additional data suggest that the availability of inorganic 
phosphate can serve as a potential clue to intestinal localization and SPI1 induction in 
Salmonella, a phenomenon that was not previously appreciated. 
In the systemic stage of infection, bacteria replicating in host macrophages must 
survive the phagocytic respiratory burst that produces superoxide. Salmonella 
Typhimurium strain 14028 produces two periplasmic superoxide dismutases, SodCI and 
SodCII, but only SodCI contributes to virulence. Although we have shown that this is 
primarily due to differences in the two proteins, evidence suggested that the two genes are 
differentially  regulated. Part of this thesis describes sodCI and sodCII regulation in vitro 
and in vivo. In vitro, sodCII is controlled by the RpoS sigma factor, similarly to 
the Escherichia coli ortholog, sodC. In contrast, sodCI is regulated by the PhoPQ two-
component regulatory system, which is known to control a number of virulence genes 
required for survival in macrophages. Expression of sodCI is induced 10-15 fold when 
bacteria replicate in murine tissue culture macrophages, or in mice. This induction in  
macrophages is controlled by the PhoPQ system, allowing for the timely induction of 
sodCI within the host to combat phagocytic superoxide. 
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Chapter 1: Introduction 
1.1 Overview of Salmonella  
Salmonella is a facultative intracellular pathogen capable of causing disease in a 
variety of host organisms. The symptoms range from mild self-limiting gastroenteritis to 
systemic infection such as human typhoid fever. Typhoid fever caused by Salmonella 
Typhi still remains a serious public health problem in developing countries with around 
22 million cases of disease per year reported worldwide (169). Salmonella enterica 
serovar Typhimurium and Enteriditis are in turn responsible for food borne disease with 
about 1.4 million cases reported per year in US alone (148). S. typhimurium infection of 
mice and mouse-derived tissue culture cell lines is an established model for human 
disease (146,169). In BALB/c mice S. typhimurium causes a systemic infection similar to 
that of the human typhoid fever caused by S. typhi. The ease of genetic manipulation and 
availability of developed animal model makes S. typhimurium a good choice for studying 
interactions between this intracellular pathogen and its mammalian host. 
1.2 Infection route and progression 
Salmonella usually enters the host via the oral route through ingestion of 
contaminated food or water (155). Bacteria that survived the acid conditions of the 
stomach then colonize the small intestine where invasion of the most distal Peyer’s Patch 
is preferred (38,70). S. typhimurium invades intestinal epithelial cells using a Type Three 
Secretion System (T3SS) encoded by Salmonella Pathogenicity Island I (SPI1). SPI1 
T3SS includes more than 30 proteins that form a needle-like complex capable of injecting 
effector proteins directly into the cytosol of host cells. Effector proteins cause  
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cytoskeleton rearrangements inside the host cell that facilitate engulfment of bacteria 
(27,104,228). After replication in the Peyer’s patch tissue, bacteria disseminate to spleen, 
liver and bone marrow during the systemic phase of infection (27). Macrophages are 
considered the primary site of Salmonella replication during infection, and the ability of 
bacteria to survive in macrophages is critical for establishment of systemic disease 
(26,31,186,192). Fields et.al (61) have shown that Salmonella mutants that cannot survive 
in macrophages are avirulent. 
Normally, phagocytosed bacteria are killed by macrophages when an array of 
antimicrobial substances is delivered to the resulting phagosomes.  Phagosomes fuse with 
lysosomes containing hydrolases and antimicrobial peptides. The NADHP-dependent 
oxidase (Phox), that produces superoxide, is also assembled on the phagosomal 
membrane. In addition, nitric oxide is produced using inducible NO-synthase (iNOS) and 
other reactive nitrogen species (RNS) and reactive oxygen species (ROS) are generated 
(152,211). However, Salmonella is able to survive and replicate within macrophages by 
utilizing multiple virulence factors to prevent the induction and/or delivery of 
antimicrobial compounds to the phagosome, creating a unique compartment called the 
Salmonella Containing Vacuole (SCV), and by protecting itself from those effectors that 
were delivered. A number of these virulence factors are encoded and/or injected into the 
macrophage cytoplasm by SPI2, and SPI2 T3SS is required for Salmonella replication 
within macrophages (30,72,87,133,219,224). Eventually, bacteria increase in numbers 
and disseminate throughout the body leading to septicemia and death of the host. 
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1.3 Virulence 
To establish a successful infection, Salmonella utilizes multiple virulence factors 
expressed at different stages of the disease process. A number of these factors are 
associated with Salmonella Pathogenicity Islands (SPIs) within the Salmonella 
chromosome. SPI genomic regions have altered GC content compared to the rest of the 
chromosome, suggesting that they have been acquired by horizontal gene transfer. SPI1 
and SPI2 Type Three Secretion Systems (T3SS) are required for invasion of the intestinal 
epithelium and survival within macrophages, respectively, enabling Salmonella to 
manipulate host response to the invading bacteria by injecting corresponding effector 
proteins into the host cells (84,199,200). In addition, SPI3 and SPI4 have been implicated 
in survival within macrophages, and SPI5 encodes effector proteins for both SPI1 and 
SPI2 (12,19,116). Both SPI1 and SPI2 are tightly regulated virulence factors. Numerous 
regulators have been shown to affect SPI1; a detailed list of regulators is shown in Table 
1.1.   Regulation of SPI2 is mediated by a number of regulatory mechanisms including 
PhoP/Q, EnvZ/OmpR, and SsrA/B.  A recently published study has shown that the 
nucleoid protein Hns represses SPI2, and SsrB activates SPI2 by knocking Hns from the 
DNA (229).  There is an overlap in the regulatory circuits of these two systems, for 
example, PhoP/PhoQ activates SPI2 while it represses SPI1.  Meanwhile, EnvZ/OmpR 
activates and Hns represses expression of both systems.  
The two-component regulatory system PhoP/PhoQ is known to be  required for 
virulence (153).  This system regulates expression of many genes and acts as an activator 
of expression for some genes, termed pags (PhoP activated genes), and as a repressor of 
others, termed prgs (PhoP repressed genes; (76).   The PhoPQ system activates 
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expression of the SPI2 T3SS and represses SPI1. It regulates several important cellular 
functions including adaptation to low Mg2+ conditions, regulation of virulence genes 
during infection, including those acquired by horizontal gene transfer, and modification 
of bacterial cell envelope (76). 
Some other virulence factors are encoded on prophages that are integrated into 
the Salmonella chromosome. Prophage Gifsy-1 harbors grvB (gogB) which encodes a 
translocated effector protein (34). Gifsy-2 contributes to virulence through sodCI, which 
encodes Cu/Zn periplasmic superoxide dismutase involved in protection against 
oxidative stress, and gtgE, encoding a protein of unknown function (42,59,62,63,89).   
The spvRABCD genes, encoded on the Salmonella virulence plasmid, are 
required for systemic infection (79) with SpvB functioning as a mono-ADP-ribosyl 
transferase involved in actin depolymerization (129). The transcriptional regulator SlyA 
has been implicated in resistance to oxidative stress, macrophage survival and virulence 
in the mouse model (23,233). The alternative sigma factor RpoE was shown to be 
important for virulence (94,216).  Some auxotrophic mutations have also been shown to 
attenuate macrophage survival and virulence in the animal model (61), suggesting that 
SCVs are limiting for some nutrients.  
1.4 SPI1 T3SS 
Overview 
The ability to invade intestinal epithelial cells is a critical step in establishing 
Salmonella infection. Invasion is mediated by a Type Three Secretion System (T3SS) 
encoded on a Salmonella Pathogenicity Island 1 (SPI1), a 40 kb island of Salmonella 
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specific DNA. SPI1 T3SS forms a needle-like complex to allow direct injection of 
effectors into the cytosol of host cells (114,119,120). These effectors cause physiological 
changes inside host cells that include actin rearrangements and engulfment of bacteria 
(246).  
The SPI1 locus encodes genes for the assembly of a functional secretion apparatus, 
a number of secreted effectors and their chaperons, and several regulatory proteins 
(Fig.1.1). 
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Figure 1.1 Salmonella Pathogenicity Island 1.  Bold arrows below the gene names 
represent operons transcribed together.  The sitABCD operon is not included on this 
figure as it is not involved in the invasion process (101).  See Lostroh and Lee (137), 
from which the figure was adapted, for references regarding the functional assignment of 
genes. 
 
Structural genes and some effectors are encoded in prg/org, inv/spa and sip/sic 
operons (SPI 1 encoded effectors include SipA, SipB, SipC, SipD, AvrA and SptP), while 
some of the secreted effectors are encoded elsewhere on the chromosome (137). These 
include SopA, SopB, SopD, SopE, SopE2, SspH1 and SlrP.  SipB, SipC and SipD 
proteins form a pore in the host cell membrane through which the effector proteins are 
secreted (198). SipA is an actin-binding protein that promotes engulfment of the bacteria 
by lowering the threshold for the polymerization of actin (85,88,247,248). SopE and 
SopE2 are functionally redundant GTP-exchange factors where each of them is able to 
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activate Cdc42 and Rac to promote actin rearrangement, which leads to membrane 
ruffling and engulfment of the bacterium (10,65,66,246). The GTPase activation protein 
SptP induces actin depolymerization, helping the host cell to return to a normal state after 
invasion (69). 
Salmonella requires production of the SPI1 T3SS only at a particular stage of 
infection; therefore the regulation of this system is tightly controlled (52,115). The level 
of SPI1 gene expression is dependent on the level of the transcriptional master regulator 
HilA (8). HilA directly activates transcription of genes in the inv/spa and prg/org 
operons, which leads to the production of the secreted effectors and the functional 
secretion apparatus (Fig. 1.2) (1,8,126,137). In the laboratory, expression of hilA is 
activated in “SPI1 inducing conditions” (high osmolarity and low oxygen), which are 
thought to resemble the conditions in the small intestine (9,126). 
Feed-forward loop model of SPI1 regulation 
Three AraC-like regulators, HilC, HilD and RtsA, directly induce hilA 
expression (50,171,197). HilC and HilD are encoded on SPI1, while RtsA is encoded on 
a 15 kb Salmonella specific insert located near the gene for tRNAPheU. RtsA is encoded 
in an operon with RtsB, which negatively regulates expression of flhDC, and therefore 
downregulates the entire flagellar regulon (50). Each regulator can independently bind to 
overlapping sites in the hilA promoter region; the DNA recognition sequence for each of 
the regulators differs slightly (171-173). HilC, HilD and RtsA each activate expression 
of hilC, hilD and rtsA genes forming a feed-forward loop to control hilA expression (Fig. 
1.2) (48).  
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Figure 1.2 A working model for SPI1 Regulation.  Blue lines indicate transcriptional 
regulation.  Red lines indicate post-transcriptional regulation.  Green lines represent post-
translational regulation.  Activation is noted by lines with arrows at the ends.  Repression 
is noted as lines with blunt ends.  Solid lines represent direct regulation.  Short-dashed 
lines represent regulation that is not known to be direct or indirect.  For clarity, the genes 
encoding SPI1 regulators are not shown.   
 
HilC, HilD and RtsA can also induce expression of the inv/spa (but not the 
prg/org) operon (37,45,50,136). However, HilA is a better inducer of the inv/spa and is 
required for the induction of prg/org gene expression. Thus, HilA is necessary for the 
production of the functional Type Three Secretion apparatus.  
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The whole system acts as a switch, where inducing signals have to reach the 
threshold for HilD autoactivation, which then leads to the increase in expression of the 
other regulators to turn the system on. HilD has a predominant role in activating SPI1, 
with HilC and RtsA acting as amplifiers of the signal, but all three regulators are required 
for full induction of hilA in vitro, as well as for producing successful invasion in vivo (48).  
1.5 Regulation of virulence during invasion 
Various regulatory proteins encoded outside of SPI1 have been shown to affect 
hilA expression (Table 1.1). More information on the known SPI1 regulators is provided 
in this chapter.  
Table 1.1 A List of regulatory factors controlling expression of SPI1 with references 
supporting the proposed mechanism. 
Regulator Mechanism of action/comments References 
HilA 
Direct activation of prg/org and 
inv/spa operons (8,37,45,135,136) 
HilD 
Direct activation of hilA, hilD, hilC, 
and rtsA (48,195); 
HilC 
Direct activation of hilA, hilD, hilC, 
and rtsA (47,48,103,195); 
RtsA 
Direct activation of hilA, hilD, hilC, 
and rtsA (48,50); 
HilE 
Repression of hilA by binding to and 
preventing HilD function 
(14);Ellermeier JR (unpublished) 
FliZ 
Activation of hilA via post-
translational regulation of HilD 
(29,100,132,139,221) 
EnvZ/OmpR Activation of hilA via HilD (48,138);Ellermeier JR 
(unpublished) 
9 
 
Table 1.1 (cont.) 
Regulator Mechanism of action/comments References 
FadD 
Activation of hilA via an unknown 
mechanism 
(139);Ellermeier JR (unpublished) 
SirA 
Activation of hilA via activation of 
csrBC to block CsrA repression of 
hilD 
(2,48,103,125,215,221);Ellermeier 
JR (unpublished) 
Dam 
Activation of hilA via post-
transcriptional regulation of hilD (134)  
Ack Pta 
Activation of hilA via an unknown 
mechanism by formate 
(93) 
YfgL 
Activation of hilA via an unknown 
mechanism 
(3,58) 
Fnr 
Repression of hilA via an unknown 
mechanism 
(221);Ellermeier JR (unpublished) 
PhoPQ 
(PhoQ24) 
Direct repression of hilA (9,13,17,175,250);Ellermeier JR 
(unpublished) 
Hns 
Direct repression of hilA, hilC, hilD 
and rtsA (172,173,197) 
Hha 
Direct repression of hilA, hilC, hilD 
and rtsA (55,172,173,221) 
Fis 
Activation of hilA; exact mechanism 
unclear 
(110,196,236) 
HU Activation of hilA (196) 
RfaH 
Activation of hilA via unknown 
mechanism 
(159) 
Fur 
Activation of hilA via unknown 
regulation of HilD 
(53) 
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Table 1.1 (cont.) 
Regulator Mechanism of action/comments References 
TdcA Activation of hilA through FliZ (113) 
FlhDC 
Activation of hilA via activation of 
fliZ (29,132) 
DsbA 
Activation of hilA via activation of 
FliZ, and repression of RcsCDB 
(51,132) 
RcsCDB 
Repression of hilA via repression of 
FliZ and an unknown regulation of 
HilD 
(132) 
Lon 
Repression of hilA via degradation of 
HilD, HilC, and FliZ 
(20,29,213,214) 
ClpXP Repression via FliZ (107) 
FimZY 
Repression of hilA via activation of 
hilE (15) 
Mlc 
Repression of hilA via activation of 
hilE 
(131) 
CpxA 
Activation of hilA via unknown 
mechanism, apparently independent 
of CpxR 
(160) 
Lrp 
Overproduction of Lrp represses hilA 
via unknown mechanism 
(7) 
PmrM 
Activation of hilA via unknown 
mechanism 
(143,158,221) 
ApaH/YgdP 
Repression of invasion via unknown 
mechanism 
(99) 
PhoBR Repression of hilA via PhoBR (139) 
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Table 1.1 (cont.) 
Regulator Mechanism of action/comments References 
Dimethyl 
sulfide/ 
DMSO 
Repression of hilA via unknown 
mechanism 
(4) 
Temperature 
Activation of hilA when shifted from 
25-37C 
(174) 
Butyrate 
Repression of hilA via unknown 
mechanism 
(73) 
ppGpp 
Activation of hilA via an unknown 
mechanism 
(177,204,217);Ellermeier JR 
(unpublished) 
Bile Repression of hilA via SirA (180,181) 
Formate Activation of hilA ( see Ack Pta) (93) 
Propanediol 
Repression of hilA via unknown 
mechanism 
(162) 
 
HilE 
HilE is a known negative regulator of SPI1. Data from the bacterial two-hybrid 
system suggested that HilE directly binds to HilD protein to prevent its action (14). In E. 
coli, HilE had an effect on hilA expression only in the presence of HilD. Unpublished 
data (Chubiz JE) confirmed the direct interaction of HilE and HilD by co-
immunoprecipitation. HilE was suggested to serve as a point of integration of the 
regulatory signals affecting SPI1. FimZY, which regulates type I fimbriae genes, were 
presumed to control hilE transcription (15). Mlc was also suggested to negatively 
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regulate hilE expression (131). There were conflicting data on the regulation of SPI1 by 
the two-component regulatory system PhoPQ (for the review of the PhoPQ system, see 
section 1.6). Overexpression of PhoPQ results in a decrease of hilA expression. It was 
suggested that PhoP activated hilE expression, resulting in repression of SPI1 (13).  Data 
from Ellermeier (unpublished) showed that PhoPQ regulation of hilA was independent of 
HilE. 
EnvZ/OmpR 
EnvZ/OmpR is a two-component regulatory system involved in the control of 
porin gene expression (ompC, ompF), and in the regulation of virulence gene expression 
(48,60,138). EnvZ was shown to activate hilC transcription, while hilD transcription was 
not affected (138), suggesting that EnvZ controls hilC expression. Further work by 
Ellermeier suggested that EnvZ works at the level of HilD ((48); Ellermeier, 
unpublished). 
BarA/SirA 
Two-component regulatory system BarA/SirA controls expression of a number of 
genes involved in carbohydrate metabolism, motility, biofilm formation, and invasion 
(1,103,124,138,184,187). The exact signal sensed by BarA is not known, although bile 
was suggested to affect SPI1 gene expression via SirA. In E. coli, the SirA/BarA 
homologs UvrY/BarA regulate expression of target genes in association with CsrA, csrB, 
and csrC. CsrA is a 61 amino acid protein, which directly binds to, and affects stability of 
mRNA transcripts (187). Two RNAs, csrB and csrC, antagonize the CsrA activity by 
binding multiple CsrA molecules. Transcription of both RNAs is controlled by UvrY. 
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The csrABC system has been implicated in SPI1 regulation, with CsrA protein binding to 
hilD mRNA to affect stability, or prevent translation. Thus, SirA induction of csrBC 
indirectly activates hilD expression post-transcriptionally, by antagonizing the action of 
CsrA. Some published data suggested that SirA could also directly bind to the promoters 
of hilA and hilC. However, recent data confirms that SirA controls hilD post-
transcriptionally (Ellermeier, unpublished).  
Fur 
 Fur plays an important role in regulation of gene expression in response to iron 
(106).  When bound to Fe2+, Fur binds to promoter regions, and directly represses genes 
under Fur control. Fur has been suggested to play a role in gene regulation when 
Salmonella resides in the small intestine of the host. Intestinal environment is thought to 
be rich in Fe2+, which leads to activation of Fur, resulting in repression of genes involved 
in an uptake of iron (and other metals). When Salmonella resides in a small intestine, Fur 
represses the sitABCD genes, which encode manganese transport system. It was 
suggested that this system is induced during invasion of intestinal epithelia, when iron is 
presumably sequestered by the host (97,101). Fur positively regulates hilA expression, by 
affectin HilD post-translationally via an unknown intermediate. This regulation was 
shown to be dependent on both the HilD protein and the hilD promoter (53). However, 
the molecular mechanism of Fur regulation of hilA remains to be elucidated. 
Nucleoid proteins 
Nucleoid proteins were recently shown to have an important role in regulation of 
horizontally acquired genes. Hns negatively controls foreign DNA by binding to the 
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chromosomal regions with low GC content to turn off gene expression (166). Another 
nucleoid protein, Hha was also shown to silence many virulence genes by binding to the 
DNA and repressing transcription in compex with Hns (11,141). SPI1 genes, located 
within the Salmonella pathogenicity island, were likely horizontally acquired. Thus, 
regulation of SPI1 gene expression by Hns/Hha would be expected. Studies by 
Olekhnovich et.al (172,173) showed that Hns and Hha silencing plays an important role 
in SPI1 regulation. Hns/Hha were shown to repress transcription of SPI1 genes, with 
SPI1 regulators HilA, HilD, HilC, and RtsA counteracting this repression (172,173,196). 
HilD, HilC, and RtsA were not required for induction of hilA in the absence of Hns/Hha. 
Hns/Hha have also been suggested to play a role in osmoregulation of SPI1, since hilA 
and rtsA expression was no longer controlled by osmolarity (and oxygen availability) in 
the absence of Hns and Hha (172,173).  Additionally, nucleoid proteins Fis and HU were 
shown to affect SPI1 expression. Loss of Fis or HU resulted in down-regulation of hilA 
(110,196,236). 
Flagellar regulon 
Bacterial flagellum is a complex structure that allows bacterial cells to propel 
themselves through liquid (swim) or to move across solid surfaces (swarm) (140). It 
consists of three structural components: the basal body, the hook and a long helical 
filament. The basal body is embedded in the bacterial cell membrane and serves to 
anchor the flagellum. The hook connects the flagellar filament, which functions as a 
propeller, to the basal body allowing flexible attachment to the bacterial cell.  
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Flagella regulon consists of more than 60 genes separated into three classes based 
on their transcriptional hierarchy (67). Class I is composed of master regulon flhDC, 
which encodes FlhD4C4, the heterohexameric transcriptional activator of class II genes. 
Various regulatory signals are integrated at that level, thus determining the motility status 
of the bacteria    (244). Class II operon encodes alternative sigma factor FliA, anti-sigma 
factor FlgM and proteins required for the assembly of the hook-basal body of the 
flagellum. Assembly of the flagellum allows for the export of FlgM leading to the release 
of FliA, which in turn activates Class III genes (108,170). 
FliZ, encoded in the operon with FliA, is an enhancer of Class II flagellar gene 
expression and is only found among Enterobacteriaceae (96,121). The regulatory role of 
FliZ was studied in several organisms. In Zenorabdus nematophila, FliZ directly 
activates transcription of the Class II genes (123), while in S. typhimurium the regulation 
of FlhD4C4 appears to be posttranslational (190). In E. coli FliZ can also function as an 
RpoS inhibitor (176). Most importantly, in Salmonella FliZ had been shown to activate 
SPI1 gene expression suggesting that FliZ can be an important link between SPI1 and 
motility (46,100,139). Recent study suggested that FliZ could affect SPI1 expression 
through HilD (107,132). Chapter 6 of this thesis contains experimental data that provide 
insight into the role of FliZ in SPI1 regulation. 
ClpXP and Lon proteases were implicated in control of SPI1 expression. Lon 
protease was shown to degrade HilC and HilD, affecting hilA expression. Presumably, 
the action of Lon protease allows to down-regulate the SPI1 system after invasion 
(20,213,214). Chubiz et al. (29) have recently provided evidence that Lon affects SPI1 
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gene expression via FliZ. ClpXP protease was also suggested to function via FliZ to 
repress SPI1 (107). 
Other regulators that affect SPI1 
 Recently published data showed that Dam, a DNA methylase, positively 
regulates SPI1 expression. Dam was suggested to act post-transcriptionally at the level of 
hilD, since the hilD mRNA levels were reported to be affected in the dam null backround, 
while hilD transcription was not significantly affected (134). The sensor kinase CpxA, 
involved in the periplasmic stress response signaling, was shown to activate hilA at low 
pH independently of its response regulator CpxR (161).  Expression of Salmonella 
invasion genes was downregulated in the absence of YfgL, an outer membrane 
lipoprotein (flagellar and SPI2 genes were similarly downregulated in this background). 
In E. coli, YfgL was shown to be involved in assembly of the outer membrane β-barrel 
proteins in complex with YaeT, YfiO, and NlpB (188,241). Not surprisingly, the yfgL 
mutation resulted in significant attenuation of Salmonella virulence in mice (58). The 
authors showed that constitutive expression of HilA restored secretion of the SPI1 
effector SipA in the absence of YfgL. This result suggests that the effect of the yfgL 
mutation on SPI1 gene expression was not due to the inability to assemble T3SS in 
Salmonella membrane. Thus, the reason for the YfgL requirement for proper expression 
of SPI1 genes is not clear. DNA-binding protein FNR regulates expression of genes in 
response to changes in oxygen concentration, and can serve as a positive or a negative 
regulator. It can function by itself of together with another protein, ArcA. Previously, 
FNR was suggested to activate expression of SPI1 genes (64). However, recently 
published (221) and unpublished data (Ellermeier JE) suggested that FNR represses SPI1. 
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Small signaling molecule, ppGpp, mediates stringent response during starvation. 
The production of ppGpp is controlled by the combined action of RelA and SpoT, with 
SpoT being able to both synthesize and degrade this small molecule. Loss of RelA and 
SpoT is known to result in a severe virulence defect due to dramatic reduction in 
expression of the hilA, hilD, and hilC genes (177,204), implicating ppGpp in the 
regulation of Salmonella invasion genes. The effect of ppGpp was shown to be 
independent of the PhoPQ, HilE, and Hha (177). No clear explanation of the ppGpp 
mediated regulation of SPI1 was provided in literature, where the suggestions of the exact 
mechanism have been conflicting. One source suggested that ppGpp regulated hilA by 
acting via RtsA, while other data suggested that it could act at the level of hilA. Taken 
together with unpublished data by Ellermeier that showed ppGpp-dependent regulation of 
hilC, rtsA, and possibly hilD, it looks that ppGpp can act by either affecting transcription 
of all SPI1 genes, or act at the level of hilA.  Further studies will be required to determine 
the exact mechanism of the ppGpp regulation.  
Another regulator of SPI1 gene expression, RfaH, is a homolog of E. coli NusG 
transcriptional antiterminator, which serves to overcome the intrinsic terminator signals 
during transcription of long operons. RfaH is involved in regulation of LPS production, 
with genes for the LPS core and O-antigen biosynthesis clustered in long operons. Both 
SPI1 and flagellar gene expression was shown to be reduced in rfaH mutant, but the 
mechanism of the regulation by RfaH was not addressed (159). Previously published data 
suggested that hilA is negatively controlled by the PhoR/PhoB two-component regulatory 
system, which controls a large number of genes involved in response to environmental Pi 
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limitation (139).  Phosphate regulation of hilA is addressed in detail in Chapter 7 of this 
thesis. 
Environmental conditions that affect SPI1 
 In the course of infection Salmonella needs to respond to a multitude of signals 
within the host to appropriately regulate virulence gene expression. Not surprisingly, 
numerous environmental conditions have been shown to affect SPI1 expression. The 
presence of bile affects SPI1 negatively, supposedly to prevent the production of the SPI1 
T3SS in the proximal part of the small intestine where bile enters the gastrointestinal tract 
of the host. The exact mechanism of bile sensing has not been elucidated, although it was 
suggested that bile works at or above the BarA/SirA system (180). In addition, the 
dimethyl sulfide (DMS) and dimethyl sulfoxide (DMSO) were suggested to play a role in 
repression of SPI1. The authors showed that the presence of DMS/DMSO inhibited 
expression of the SPI1 genes hilA and invF, suggesting that these compounds regulate 
Salmonella invasion gene expression in the digestive tract of the host (4). The mechanism 
of this inhibition is not clear at this moment. The 1,2-propanediol, a product of rhamnose 
and fucose fermentation, was also implicated in the repression of SPI1 (163).  
 Short chain fatty acids also have a role in SPI1 regulation. Butyrate (as well as 
propionate) was shown to downregulate expression of SPI1 genes. The fact that butyrate 
concentration is higher in the cecum than in the distal ileum of the host, suggests that 
butyrate serves to turn off the production of the SPI1 T3SS outside of the site of 
Salmonella invasion (125). Formate, on the other hand, was shown to be an inducing 
signal for SPI1 expression, with concentration of formate higher in the distal ileum (93). 
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Deletion of the ack pta genes resulted in downregulation of SPI1, while addition of 
formate to growth medium alleviated the effect of loss of Ack and Pta. Acetate, found in 
a high concentration in the distal ileum, was similarly implicated in activation of invasion 
genes (125). The temperature shift from the 250C to the 370C has been shown to induce 
SPI1 and flagellar genes in Salmonella. Hns was suggested to play a role in this 
temperature response (174).  
Our studies show that, in every case where it has been explicitly tested, signals 
feed into the SPI1 regulatory circuit through HilD (48,53,132). Therefore, HilD might 
serve as a point of integration of various signals into SPI1 regulatory circuit. Studies of 
this system in the last decade have uncovered multiple regulators and environmental 
conditions affecting SPI1 T3SS in vitro and in vivo. However, in many cases it is not 
known where these signals feed into SPI1 regulatory system and Chapter 6 of this thesis 
addresses some of these questions. 
1.6 Regulation of virulence in the systemic stage of infection 
 
Alternative sigma factors  
The ability to survive conditions within the host requires appropriate regulation of 
multiple virulence factors. Alternative sigma factors that alter promoter preferences of 
RNA polymerase and thus gene expression have been implicated in governing resistance 
to various environmental stresses (185). Sigma factor RpoS is important for bacterial 
survival under multiple stress conditions including starvation and low pH and also for 
Salmonella virulence (57,168,235). A number of enzymes involved in defense to 
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oxidative stress are regulated by RpoS and E. coli sodC is a member of this regulon (75).  
Serovar Typhimurium sodCII was also shown to be controlled by RpoS (56). However, 
loss of SodCII does not result in a virulence defect, since SodCII protein was shown to be 
degraded in host macrophages (112).     
The RpoE regulon is known to be involved in response to periplasmic stress in 
E.coli and Salmonella (183,189). While alternative sigma factor RpoE plays a role during 
nutrient deprivation, and is important during survival and replication inside macrophages, 
resistance to oxidative stress and Salmonella virulence in vivo (94,216).  
SlyA 
 Transcriptional regulator SlyA controls a large stress response regulon involved 
in resistance to oxidative stress, macrophage survival, and virulence 
(23,165,167,201,233). SlyA regulated genes were also shown to overlap with RpoS and 
RpoH stress response regulons (205,207). 
Two-component regulatory systems 
Salmonella encounters many diverse conditions through the progression of 
disease and proper regulation of virulence genes is essential for bacterial adaptation to a 
particular niche. Bacteria utilize two-component signal-transduction systems to ensure 
proper sensing and response to environmental stimuli. Such systems consist of an integral 
membrane sensor kinase protein and cytoplasmic response regulator protein. Sensor 
kinase autophosphorylation in response to various environmental changes leads to 
phosphorylation of response regulator which in turn activates or represses expression of 
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target genes. A number of two-component regulatory systems implicated in Salmonella 
virulence are discussed below. 
PhoP/ PhoQ   
PhoPQ is a two-component regulatory system that directly and indirectly controls 
expression of ~ 3% of the genes in Salmonella enterica serovar Typhimurium including 
those involved in survival inside macrophages (76,249). PhoQ, the sensor kinase, 
undergoes autophosphorylation in response to various stimuli including low magnesium 
concentrations (74), low pH (16,145) and antimicrobial peptides (5,6) which causes 
phosphorylation of the response regulator PhoP. PhoP then binds to the promoters of 
target genes resulting in activation or repression. Micromolar concentrations of Mg2+ 
serve as an inducing signal for the system in vitro while millimolar concentrations are 
repressing (16,74,77,153,243). Published literature suggests that Mg2+ concentration 
serves as a clue of Salmonella subcellular localization within the host where low and high 
concentrations of magnesium correspond to the phagosome location and extracellular 
location of bacteria, respectively (76). The fact that low pH and antimicrobial peptides, 
an important part of the macrophage antimicrobial defences, seem to be more important 
for the activation of the PhoPQ system than divalent cations (179) further confirms the 
critical role this system plays in bacterial adaptation to intracellular environment inside 
macrophages. 
Null mutations of either phoP or phoQ were shown to cause a virulence defect 
(~5 logs increase in LD50 in IP infection of mice). The constitutive phoQ24 mutation 
also confers a  virulence defect that suggests the importance of proper regulation of 
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PhoPQ target genes during infection (153,154). The phoQ24 allele commonly used to 
study PhoPQ regulation is a single base pair mutation (Thr to Ile) at position 48 in the 
periplasmic domain of the PhoQ sensor kinase (80,81). This mutation leads to 
constitutive activation or repression of the PhoPQ regulated genes. 
PhoPQ is known to regulate several important functions including adaptation to 
low Mg2+ conditions, regulation of virulence genes during infection including those 
acquired by horizontal gene transfer, and modification of bacterial cell envelope.  PhoPQ 
directly activates expression of two genes encoding Mg2+ transporters, mgtA and mgtB, 
and mgtC which encodes an inner membrane protein facilitating growth in low Mg2+ 
concentrations (76). Direct PhoP interaction with the promoter regions of target genes is 
typically characterized by the presence of the PhoP binding site which consists of a direct 
repeat T/GGTTTA overlapping the -35 promoter sequence in a significant subset of 
PhoPQ regulated genes (127,157,203,250). However, not all directly regulated genes 
have the canonical PhoP box. (250) have described a number of variations of target gene 
promoter structures including PhoP binding sites in opposite orientation or further 
upstream of the promoter region. A subset of genes in the PhoPQ regulon is controlled 
indirectly through other two-component regulatory systems including PmrAB, SsrAB and 
RstAB. 
PmrA/ PmrB  
The PmrAB two-component regulatory system is post-transcriptionally regulated 
by PhoPQ via PmrD (117), while it also responds to mildly acidic pH and high iron 
concentrations independently of PhoPQ (240). This system controls S. typhimurium 
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resistance to antimicrobial peptides via modifications of the lipopolysacharide (LPS), 
which results in more positively charged LPS, blocking the action of positively charged 
antimicrobial peptides (82,117).   
SsrA/ SsrB  
The SsrAB two-component regulatory system is essential for the induction of the 
SPI2 T3SS and responds to conditions such as low osmolarity and low pH, which the 
bacteria encounter inside the SCV. The PhoPQ system was shown to regulate expression 
of ssrAB by binding to the promoter region of ssrB (18). 
RstA/ RstB  
PhoPQ is also known to positively regulate the two-component regulatory system 
RstAB (157,242). In Salmonella, the RstA response regulator was shown to directly 
activate the feoB gene, which encodes the Fe2+ transporter (102). The sensor kinase, RstB, 
was suggested to affect PhoQ sensor kinase protein to enhance transcription of the PhoP-
activated genes (164).  
1.7 Superoxide dismutases and their role in virulence during systemic stage of 
infection 
 
The ability of Salmonella to survive in macrophages during the systemic stage of 
infection is critical for the successful progression of the disease. Inside macrophages, 
bacteria are subjected to an array of antimicrobial substances including superoxide. 
Therefore, Salmonella must protect itself against phagocytic superoxide in order to 
survive and replicate in the host.  
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Overview  
Superoxide dismutases (SODs) are metalloenzymes that require a transition metal 
in the active site of the enzyme for the dismutation reaction of superoxide into hydrogen 
peroxide and molecular oxygen:  
O2 + O2·-+ 2H+ = O2 + H2O2 
Based on the transition metal in the active site, SODs are divided into three groups: 
manganese (Mn-SOD), iron (Fe-SOD), and copper-zinc (Cu/Zn SOD). Bacterial Mn-
SOD is referred to as SodA, and Fe-SOD is referred to as SodB. Cu/Zn superoxide 
dismutases are referred to as SodCs.  
Mechanism of superoxide damage  
S. typhimurium and E. coli have two cytoplasmic superoxide dismutases, SodA 
and SodB, involved in protection against endogenously produced superoxide, which 
results from inadvertent transfer of an electron to oxygen from flavoproteins, especially 
NADH-dehydrogenase II (150). Published data describing the phenotypes of E. coli sodA 
sodB double mutants provides explanation of superoxide toxicity (211). Superoxide 
present in cytoplasm can directly inactivate a set of dehydratase enzymes containing 
exposed [4Fe-4S] clusters, e.g., aconitase and fumarase.  This blocks several metabolic 
pathways and also results in the release of iron from damaged clusters. The released iron 
can then catalyze the formation of hydroxyl (OH•) radical via the Fenton reaction (152). 
In this case, hydrogen peroxide formed as a result of superoxide dismutation reacts with 
the free iron to form OH• radical. Association of positively charged iron with the 
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negatively charged phosphodiester backbone of DNA promotes direct damage to DNA 
by hydroxyl radical (98).  
1.8 Salmonella Typhimurium Cu/Zn SODs  
The periplasmic location of Cu/Zn bacterial SODs suggests that these enzymes 
play a role in protection of the bacteria from exogenous sources of oxidative stress. 
Mutants lacking sodC, unlike sodA sodB mutants, were shown to have no growth defect 
in laboratory media. A number of bacteria that have periplasmic SODs are intracellular 
pathogens, suggesting that these enzymes could potentially scavenge superoxide radicals 
produced during the oxidative burst of macrophages, and thus provide an effective 
virulence factor to the pathogen. A possible explanation of the presence of periplasmic 
SODs in some free-living bacteria is based on presumption that periplasmic SODs offer 
protection from free radical generating agents in the environment, such as phenolic 
compounds or oxygen released by photosynthetic bacteria.                                                        
S. typhimurium 14028 has two periplasmic Cu/Zn SODs, SodCI and SodCII. 
SodCI is encoded on the functional lambdoid bacteriophage Gifsy-2 (Fig. 1.3). The sodCI 
gene is embedded within but transcribed in the opposite orientation to the late phage 
operon (56,62).  SodCII is encoded on the chromosome and is the ortholog of 
Escherichia coli SodC. The Gifsy-2 phage is preferentially found among most virulent 
serovars of Salmonella (56,90) , with Gifsy-2 lysogens being more virulent than non-
lysogens (62,89).  The virulence contribution of Gifsy-2 phage is independent of phage 
function as the two major virulence factors encoded by Gifsy-2, SodCI and GtgE, are 
expressed by the lysogen independently of the phage induction or DNA replication (89). 
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1.9 Role of periplasmic SODs in protection against oxidative stress during infection 
Reactive oxygen species are known to be important for the control of Salmonella 
infection. The human genetic disorder called Chronic Granulomatous Disease (CGD) is 
characterized by mutations in one of the subunits of NADPH-dependent oxidase (Phox). 
Thus, the affected individuals are unable to produce superoxide and other ROS, resulting 
in increased susceptibility to a variety of infections including Salmonella bacteremia 
(237).   
Only SodCI contributes to S.typhimurium virulence and is responsible for 
detoxification of phagocytic superoxide produced during infection. SodCII does not 
contribute to virulence even when SodCI is absent. Both complete deletions of the sodCI 
gene or point mutations that eliminate SodCI enzymatic activity result in 7-15 fold 
attenuation of virulence in mouse IP (intraperitoneal) competition assays (36,118). The 
virulence phenotype of the sodCI mutation depends on phagocytic superoxide 
production; in phox-/- knockout mice lacking NADPH-dependent oxidase, the sodCI 
mutant strain was not attenuated compared to the wild type (wt) strain (36). Published 
experiments performed in tissue culture macrophages have also supported this 
conclusion. The fact that a sodCI sodCII strain competes evenly with the wt strain in an 
Figure 1.3 sodCI location within functional Gifsy-2 prophage sequence.  
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in vitro competition assay further confirms that the sodCI mutant phenotype is not due 
to endogenous superoxide production. 
There was also a suggestion that production of powerful oxidant peroxinitrite, 
product of the reaction between superoxide and nitric oxide, might explain the observed 
virulence defect of sodCI mutation. However, there was no difference in attenuation of 
virulence when sodCI mutant was competed against wild type strain in C57BL/6 or 
congenic iNOS deficient mice. That result confirms that phagocytic superoxide alone is 
responsible for damage sustained by Salmonella sodCI mutants during infection and is in 
agreement with the published data (147,223). They showed that infected macrophages 
did not produce ROS and RNS species simultaneously. ROS were produced early in 
infection for the first few hours after internalization of bacteria, while RNS production 
was evident at later time points. These data suggest that superoxide and nitric oxide act 
separately to limit bacterial survival and replication inside macrophages, and that 
peroxynitrite does not play a critical role in limiting Salmonella infection (147,223).  
Superoxide is a charged molecule and cannot cross membranes at neutral pH. 
However, when residing inside macrophages bacteria are exposed to acidic conditions of 
the phagosome (pH 4.5-5.0). At low pH superoxide could become protonated, cross the 
membrane and enter the bacterial cytoplasm. It was previously suggested that in such 
cases phagocytic superoxide would kill Salmonella by the same mechanism of direct 
DNA damage described for endogenous superoxide (24,211,212). However, recent data 
have shown that sodCI acts independently of cytoplasmic SODs and bacterial DNA 
repair systems during infection in BALB/c mice and thus does not protect the 
cytoplasmic compartment (36). So the observed virulence defect of the sodCI mutant 
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must be due to damage of an extracytoplasmic target(s) of superoxide. None of the 
known classes of enzymes directly damaged by superoxide are found in the periplasm of 
S. typhimurium suggesting that sodCI is protecting an unknown periplasmic target. 
Chapter 4 of this thesis describes the use of phylogenomic mapping analysis to find 
potential targets of phagocytic superoxide, while Chapter 3 provides analysis of 
transcriptional regulation of sodCI and sodCII in vivo and in vitro. 
The establishment of a successful Salmonella infection in the host is a complex 
process that requires coordinate regulation of multiple virulence factors at various stages 
of the process. This thesis will focus on different aspects of virulence gene regulation 
during two distinct stages of the infection: invasion of epithelial cells and survival in 
macrophages.  
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Chapter 2: Materials and methods 
2.1 Bacterial strains and growth conditions  
All Salmonella strains used in this study are isogenic derivatives of Salmonella 
enterica serovar Typhimurium 14028 (American Type Culture Collection) and were 
constructed using P22 HT105/1 int-201 (P22)-mediated transduction (142).  Luria-
Bertani (LB) medium and modified N-minimal medium (78) were used for growth of 
bacteria.  Bacterial strains were grown at 37oC except for the strains containing 
temperature sensitive plasmids pCP20, pKD46 and pINT-ts (CRIM) (41,83) which were 
grown at 30oC.  Antibiotics were used at the following concentrations:  100 µg/mL 
ampicillin (Ap); 20 µg/mL chloramphenicol (Cm); 12.5 µg/mL gentamycin; 50 µg/mL 
kanamycin (Km); 25 µg/mL tetracycline (Tc); 50 µg/mL apramycin.  The β-galactosidase 
chromogenic indicator 5-bromo-4-chloro-3-indolyl β-D-galactopyranoside was used at a 
concentration of 80 µg/mL.  Enzymes were purchased from Invitrogen or New England 
Biolabs and used according to the manufacturer’s recommendations.  Primers were 
purchased from IDT Inc. 
Deletion of various genes and concomitant insertion of an antibiotic resistance 
cassette was carried out using Lambda Red-mediated recombination (41,245) as 
described in (49). The end-points of each deletion or insertion are indicated in Table 2.1. 
The appropriate insertion of the antibiotic resistance marker was checked by P22 linkage 
to known markers and/or PCR analysis. In each case, the constructs resulting from this 
procedure were moved into a clean wild-type background (14028) by P22 transduction. 
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In some cases, antibiotic resistance cassettes were removed using the temperature 
sensitive plasmid pCP20 carrying the FLP recombinase (28). 
 2.2 Construction of the transcriptional/translational lac fusions  
           Transcriptional or translational lac fusion constructs were generated from insertion 
mutations using the FLP/FRT mediated site-specific recombination method, as described 
by Ellermeier et al. (49). The fusion joints are indicated in Table 2.1.  
To construct the transcriptional hilA-lac fusion (132), the promoter region of hilA 
(hilA promoter 5’ primer, GTAAGGTACCGTCCAGATGACACTATC; hilA promoter 
3’ primer, TGACGAATTCTTCTGAGCGTAGCAGGG) was cloned 5’ to a promoterless 
lacZ gene in pDX1, an apramycin resistant plasmid derived from pAH125 (83,132).  All 
constructs were confirmed by DNA sequence analysis. The resulting fusion plasmid was 
integrated into the serovar Typhimurium chromosome at the Lambda attachment site 
using λInt produced from CRIM helper plasmid pINT-ts (83).  Each integrant was tested 
by PCR to ensure that only a single copy of the plasmid was present (83). 
The sodCI and sodCII transcriptional lac fusions were generated using the pCE70 
plasmid (149). To prevent the possible amplification of the fusion construct in the 
chromosome due to phage induction, with the resulting artifactual increase in lac activity, 
the sodCI fusion was made such that the Gifsy-2 phage sequences downstream of sodCI 
were deleted through the attachment site (see (89)). To ensure that the strains were not 
attenuated in vivo, the fusions were positioned immediately downstream of the sodCI and 
sodCII coding region. The resulting fusion strains competed evenly with the wild type 
strain in I.P. competition assays performed in BALB/c mice (data not shown; see (89)). 
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 2.3 The β-galactosidase assays in vitro  
β-galactosidase assays were performed using a microtiter plate assay as 
previously described (202) on strains grown under the indicated conditions. β-
galactosidase activity units are defined as (μmol of ONP formed min-1) x 106/ (OD600 x 
ml of cell suspension) and are reported as mean ± standard deviation where n = 4.  For 
log phase cultures, bacteria were grown overnight in LB, diluted 1/100 in the indicated 
medium and upon reaching OD600 of 0.2, diluted 1/4 and grown to OD600 of 0.2-0.3. 
Cultures grown in standard SPI1 inducing conditions were initially inoculated into LB 
(0.5% NaCl), grown for 8-12 hours, then subcultured 1/100 and grown statically for 18-
22 hours in 3 ml LB with 1% NaCl (high salt LB, HSLB) in a 13 x 100 mm tubes. LB, or 
LB without NaCl (NSLB) were used where indicated. In some experiments, the modified 
N-minimal medium, or the modified MOPS medium were used as indicated.  
2.4 The β-galactosidase assays in bacteria recovered from infected macrophages   
RAW 264.7 macrophages (American Type Culture Collection) were maintained 
in RPMI-1640 medium supplemented with 10% fetal bovine serum and 1% L-glutamine 
(BioWhittaker).  Macrophages were seeded into 6-well plates at 1-5x106 cells/well.  
Bacteria were grown overnight in modified N-minimal medium pH 5.6 supplemented 
with 10 µM magnesium chloride.  Bacterial cells were washed with sterile phosphate 
buffered saline (PBS) and opsonized in 50% mouse serum for 20 min at 37oC.  Bacteria 
were then diluted in RPMI medium and used to infect macrophages at a Multiplicity of 
Infection (MOI) of 20.  After a 40 min incubation period, the wells were washed twice 
with PBS and then RPMI medium containing 12.5 µg/mL gentamycin to kill extracellular 
bacteria was added to the wells.  After 20 min of additional incubation, the wells were 
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washed once with PBS.  RPMI medium supplemented with 12.5 µg/mL gentamycin was 
added to the wells, and this was designated time zero.  After 16 hrs, the wells were 
washed twice with PBS and macrophages were lysed with 1% Triton X-100.  The 
released bacteria were washed with PBS and dilutions of each sample were plated on LB 
agar to determine the number of bacteria.  β-galactosidase activity was assayed using the 
chemiluminescent substrate Lumigal 530 according to manufacturer’s instructions 
(Lumigen Inc.).  The β-galactosidase activity of each sample was calculated per CFU 
(Colony Forming Unit) of bacteria in a sample.  The in vitro β-galactosidase activity of 
bacteria grown in RPMI media (16 hrs of growth) was measured using the same assay. 
2.5 The β-galactosidase assays in bacteria recovered from infected mouse splenic 
tissue  
BALB/c mice were infected intraperitoneally with 104 cells of the sodCI+-lac+ or 
sodCII+-lac+ fusion strain.  After 4 days of infection, mice were sacrificed and the spleens 
were homogenized to release the bacteria.  Bacterial cells were extracted from splenic 
tissue as described previously (202). The isolated bacteria were resuspended in PBS and 
dilutions of each sample were plated on LB agar to determine the number of viable 
bacteria in a sample.  β-galactosidase activity was assayed using the chemiluminescent 
substrate Lumigal 530 according to manufacturer’s instructions (Lumigen Inc.).  The β-
galactosidase activity of each sample was calculated per CFU of bacteria in a sample.  
The in vitro β-galactosidase activity of bacteria in the inoculum grown in LB medium (16 
h of growth) was measured using the same assay.    
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2.6 Primer extension analysis 
Bacterial cells were grown in LB to OD600 ~1.0 and total RNA was isolated 
according to manufacturer’s instructions (Qiagen RNEasy Mini). Omniscript Reverse 
Transcriptase (Qiagen Inc.) was used to reverse transcribe the sodCI using extension 
primer sodCIext3 (CCAGCTACCAGCGACAATATTGTG). The primer was 
radioactively labeled with [γ-32P] ATP using Optikinase (USB Corporation). A DNA 
fragment of 400-bp corresponding to the sequence immediately upstream of sodCI 
coding region was amplified by PCR using Platinum Pfx DNA polymerase (Invitrogen 
Inc.). The resulting PCR product was used to generate a sequence ladder with the same 
primer that was used for the extension reaction. The extension product was resolved on 
an 8% polyacrylamide-7 M urea gel alongside the sequence ladders. The Sequenase 2.0 
kit used for the sequencing reactions, polyacrylamide gel mix, and GTG running buffer 
were purchased from the USB Corporation.  
2.7 Deletion analysis of the sodCI promoter  
The sodCI promoter was analyzed by amplifying and cloning portions of the 
promoter region 5’ to a promoterless lacZ gene in pDX1, an apramycin resistant plasmid 
derived from pAH125 (83,132).  All constructs were confirmed by DNA sequence 
analysis.  The resulting fusion plasmids were integrated into the serovar Typhimurium 
chromosome at the Lambda attachment site using λInt produced from CRIM helper 
plasmid pINT-ts (83).  Each integrant was tested by PCR to ensure that only a single 
copy of the plasmid was present (83).   
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2.8 Competition assays in mice  
BALB/c mice (BALB/cAnNHsd) were purchased from Harlan Sprague Dawley, 
Inc. Bacterial strains were grown overnight (16 h) in LB medium. Cultures of the two 
strains of interest were mixed 1:1 and the mixture was washed, and diluted in sterile 
0.15M saline. For competition assays, female mice were inoculated intraperitoneally (I.P.) 
in groups of 5 to 10 with the mixture of two bacterial strains (approximately 500 total 
bacteria). Inocula were plated on LB and then replica plated onto the appropriate 
selective media to determine the total number and the percentage of the two strains used 
for the infection. Mice were sacrificed after 4 to 5 days of infection and spleens were 
harvested. Serial dilutions of homogenized spleens were plated on LB agar, and resulting 
colonies were replica plated onto selective medium to determine the relative percentage 
of each strain recovered. The competitive index (CI) was calculated as follows: (percent 
strain A recovered/ percent strain B recovered)/ (percent strain A inoculated/ percent 
strain B inoculated). The CI of each set of assays was analyzed statistically using the 
Student’s t-test. In most cases, the strains were rebuild by P22 transduction, and the 
mouse I.P. competition assay was repeated to ensure that the virulence phenotypes were 
the result of the designated mutations. All animal work was reviewed and approved by 
the University of Illinois IACUC and performed under protocols 04137 and 07070.   
2.9 Competition assays in RAW 264.7 macrophages  
RAW 264.7 macrophages (American Type Culture Collection) were maintained 
in DMEM medium supplemented with 10% fetal bovine serum and 1% L-glutamine 
(BioWhittaker). Macrophages were seeded into 6-well plates at 1-5x106 cells/well. For 
competition assays the inoculum consisted of equal mix of two bacterial strains. The 
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actual CFU and relative percentage of each strain was determined by plating the 
inoculum on LB agar. Bacterial cells were washed with sterile phosphate buffered saline 
(PBS) and opsonized in 50% mouse serum for 20 min at 37oC. Bacteria were then diluted 
in DMEM medium and used to infect macrophages at a Multiplicity of Infection (MOI) 
of 5- 10.  After a 15 min incubation period, the wells were washed three times with PBS 
and then DMEM medium containing 25 µg/mL gentamycin to kill extracellular bacteria 
was added to the wells, and this was designated time zero. After 2 hrs, the wells were 
washed twice with PBS and macrophages were lysed with 1% Triton X-100. Serial 
dilutions of each sample were plated on LB agar to determine the number of bacteria, and 
resulting colonies were replica plated onto selective medium to determine the relative 
percentage of each strain recovered. The competitive index (CI) was calculated as 
described above. The Student’s t-test was used for statistical analyses.  
2.10 RNA isolation  
Bacterial RNA isolation from infected RAW 264.7 macrophages following 2h of 
infection was based on the protocol described previously (54). RAW 264.7 macrophages 
(American Type Culture Collection) were maintained in DMEM medium supplemented 
with 10% fetal bovine serum and 1% L-glutamine (BioWhittaker). Macrophages were 
seeded into 6-well plates at 5x106 cells/well. Bacterial cells were washed with sterile 
phosphate buffered saline (PBS) and opsonized in 50% mouse serum for 20 min at 37oC. 
Bacteria were then diluted in DMEM medium and used to infect macrophages at a 
Multiplicity of Infection (MOI) of 10.  After a 15 min incubation period, the wells were 
washed three times with PBS and then DMEM medium containing 25 µg/mL gentamycin 
to kill extracellular bacteria was added to the wells, and this was designated time zero. 
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After 2 hours of incubation macrophages were lysed for 30 minutes on ice with Lysis 
buffer (1% phenol, 19% ethanol and 1% SDS in RNAse-free water). The lysates were 
collected in 50 mL conical tubes and centrifuged for 20 minutes (+4 C) at 4000 rpm to 
pellet bacteria. The bacterial pellet was washed twice with lysis buffer and stored at -80C. 
Bacterial RNA isolation was performed using Ribopure Bacterial RNA Kit (Ambion Inc.). 
Resulting total RNA was treated with DNAseI (Ambion Inc.). 
Total RAW 264.7 macrophage RNA for microarray analysis was isolated using 
the Trizol reagent (Invitrogen Inc.), followed by on-column purification of the aqueous 
phase using Ribopure RNA Kit (Ambion Inc.). Resulting RNA was treated with DNAseI 
using Kit (Ambion Inc.).     
2.11 Bacterial strains and plasmids used in this thesis 
 
Table 2.1 Bacterial strains and plasmids used in this thesis. 
Name Genotype a Deletion 
endpoints b 
 Source or 
reference c 
14028 Wild-type    ATCC d 
JS538 Φ(sodCI+-lac+)2917 1098178- 
1130040 
  
JS531 Φ(sodCII+-lac+)110 1516586- 
1516598 
  
bJS539 ΔrpoS1191::Tet 3065506- 
3066484 
  
JS540 Φ(sodCI+-lac+)2917 ΔrpoS1191::tet     
JS541 Φ(sodCII+-lac+)110 ΔrpoS1191::tet     
JS542 phoQ24   (154) 
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Table 2.1 (cont.) 
Name Genotype a Deletion 
endpoints b 
 Source or 
reference c 
JS543 Φ(sodCI+-lac+)2917 phoQ24     
JS544 Φ(sodCII+-lac+)110 phoQ24     
JS545 phoP102::Tn10d-Cm   (154) 
JS546 Φ(sodCI+-lac+)2917 phoP102::Tn10d-
Cm 
    
JS547 Φ(sodCII+-lac+)110 phoP102::Tn10d-
Cm 
    
JS548 ΔpmrA621::Cm 4533696- 
4534407 
  
JS549 Φ(sodCI+-lac+)2917 ΔpmrA621::Cm     
JS550 Φ(sodCI+-lac+)2917 phoQ24 
ΔpmrA621::Cm 
    
JSG1050  pmrI::MudJ    Gunn JS 
JS551 pmrI::MudJ ΔpmrA621::Cm     
JS552 ΔrstA1::Cm 1551266- 
1552007 
  
JS553 Φ(sodCI+-lac+)2917 ΔrstA1::Cm     
JS560 Φ(sodCI+-lac+)2917 phoQ24 
ΔrstA1::Cm 
    
JS554 ΔssrB101::Cm 1476102- 
1476851 
  
JS555 Φ(sodCI+-lac+)2917 ΔssrB101::Cm     
JS561 Φ(sodCI+-lac+)2917 phoQ24  
ΔssrB101::Cm 
    
KG838  ∆ptr  3149666-
3152534 
 
KG839  ∆ptr ∆sodCI::Kn     
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Table 2.1 (cont.) 
Name Genotype a Deletion 
endpoints b 
 Source or 
reference c 
KG740  ∆pmrA::Cm ∆sodCI::Kn     
KG939  ∆ampG::Cm  498525-
500072 
  
KG940  ∆ampG::Cm ∆sodCI::Kn     
KG750 ∆pyrD::Cm   1146964-
1147997 
  
KG751 ∆pyrD::Cm ∆sodCI::Kn     
KG748 ∆pepN::Cm   1144133-
1146761 
  
KG749 ∆pepN::Cm ∆sodCI::Kn     
KG768  ∆dcp::Cm 1589683-
1591729  
  
KG769  ∆dcp::Cm ∆sodCI::Kn     
KG750  ∆asmA::Cm   2204982-
2206853 
  
KG751  ∆asmA::Cm ∆sodCI::Kn    
KG774 ∆STM2176::Cm  2272960-
2273624  
  
KG775  ∆STM2176::Cm ∆sodCI::Kn     
KG772 ∆yibF::Cm   3874178-
3874796 
  
KG773  ∆yibF::Cm ∆sodCI::Kn     
KG867  ∆ybbN::Cm  564015-
564871 
  
KG868  ∆ybbN::Cm ∆sodCI::Kn     
KG903  ∆trkA::Cm   3579771-
3581196 
  
KG904  ∆trkA::Cm ∆sodCI::Kn     
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Table 2.1 (cont.) 
Name Genotype a Deletion 
endpoints b 
 Source or 
reference c 
KG904  ∆trkA::Cm ∆sodCI::Kn     
KG905  ∆sixA::Cm   2497411-
2497897 
  
KG906 ∆sixA::Cm ∆sodCI::Kn     
KG878  ∆yfiH::Cm   2804819-
2805548 
  
KG879  ∆yfiH::Cm ∆sodCI::Kn     
KG1006 ∆glnE::Cm   3364015-
3366884 
  
KG1011 ∆glnE::Cm ∆sodCI::Kn     
KG1005 ∆nagZ::Cm  1292605-
1293635  
  
KG1010 ∆nagZ::Cm ∆sodCI::Kn     
KG1002 ∆yfbS::Cm  2443992-
2445822  
  
KG1007 ∆yfbS::Cm ∆sodCI::Kn     
KG1003 ∆pSLT046::Cm   37503-38268   
KG1008 ∆pSLT046::Cm ∆sodCI::Kn     
KG972 ∆sodCI::Kn 1130087-
1130549 
 
JS454 ∆sodCII103::Cm    (118) 
KG973  ∆sodCI::Kn ∆sodCII103::Cm   
JS564 ∆hilD138::Kn    (53) 
JS253 ∆hilD114::Cm    (50) 
JS749 attλ::pDX1::hilA’-lacZ   (132) 
JS951 ∆hilD138::Kn attλ::pDX1::hilA’-lacZ   (29) 
JS576 ∆hilD114::Cm attλ::pDX1::hilA’-lacZ   (53) 
JS953 tetRA-rtsA attλ::pDX1::hilA’-lacZ   (29) 
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Table 2.1 (cont.) 
Name Genotype a Deletion 
endpoints b 
 Source or 
reference c 
JS955 ∆hilD138::Kn tetRA-rtsA 
attλ::pDX1::hilA’-lacZ 
   (29) 
JS488 Φ(hilD’-lac+)114     
JS892 Φ(hilD’-‘lacZ)hyb139   (29) 
JRE573 ∆hilE115::Cm     
KG1051 ∆hilE115::Cm  attλ::pDX1::hilA’-lacZ     
KG1073 ∆hilE115::Cm ∆hilD138::Kn 
attλ::pDX1::hilA’-lacZ 
    
KG1052 ∆hilE115::Cm tetRA-rtsA 
attλ::pDX1::hilA’-lacZ 
    
KG1074 ∆hilE115::Cm ∆hilD138::Kn tetRA-
rtsA attλ::pDX1::hilA’-lacZ 
    
KG1372 Φ(hilD’-lac+)114 ∆hilE115::Cm     
KG1339 Φ(hilD’-‘lacZ)hyb139 ∆hilE115::Cm     
JS941 ∆fliZ8042::Cm    (29) 
JS950 ∆fliZ8042::Cm  attλ::pDX1::hilA’-lacZ    (29) 
JS952 ∆fliZ8042::Cm ∆hilD138::Kn 
attλ::pDX1::hilA’-lacZ 
   (29) 
JS954 ∆fliZ8042::Cm tetRA-rtsA 
attλ::pDX1::hilA’-lacZ 
   (29) 
JS956 ∆fliZ8042::Cm ∆hilD138::Kn tetRA-
rtsA attλ::pDX1::hilA’-lacZ 
   (29) 
KG1375  Φ(hilD’-lac+)114 ∆fliZ8042::Cm     
KG1342 Φ(hilD’-‘lacZ)hyb139 ∆fliZ8042::Cm     
KG1220  ∆envZ::Cm    Ahmer lab 
 
KG1057 ∆envZ::Cm  attλ::pDX1::hilA’-lacZ     
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Table 2.1 (cont.) 
Name Genotype a Deletion 
endpoints b 
 Source or 
reference c 
KG1104  ∆envZ::Cm ∆hilD138::Kn 
attλ::pDX1::hilA’-lacZ 
    
KG1058  ∆envZ::Cm tetRA-rtsA 
attλ::pDX1::hilA’-lacZ 
    
KG1105  ∆envZ::Cm ∆hilD138::Kn tetRA-rtsA 
attλ::pDX1::hilA’-lacZ 
    
KG1368  Φ(hilD’-lac+)114∆envZ::Cm     
KG1335  Φ(hilD’-‘lacZ)hyb139 ∆envZ::Cm     
JRE3038  ∆fadD::Kn     
KG1061  ∆fadD::Kn  attλ::pDX1::hilA’-lacZ     
KG1079  ∆fadD::Kn ∆hilD114::Cm 
attλ::pDX1::hilA’-lacZ 
    
KG1062  ∆fadD::Kn tetRA-rtsA 
attλ::pDX1::hilA’-lacZ 
    
KG1080  ∆fadD::Kn ∆hilD114::Cm tetRA-rtsA 
attλ::pDX1::hilA’-lacZ 
    
KG1336  Φ(hilD’-lac+)114 ∆fadD::     
KG1369  Φ(hilD’-‘lacZ)hyb139 ∆fadD::     
CDE1051  ∆sirA::Cm (sirA3::Cm)   BA746  
KG1065  ∆sirA::Cm  attλ::pDX1::hilA’-lacZ     
KG1102  ∆sirA::Cm ∆hilD138::Kn 
attλ::pDX1::hilA’-lacZ 
    
KG1066  ∆sirA::Cm tetRA-rtsA 
attλ::pDX1::hilA’-lacZ 
    
KG1103  ∆sirA::Cm ∆hilD138::Kn tetRA-rtsA 
attλ::pDX1::hilA’-lacZ 
    
KG1376  Φ(hilD’-lac+)114 ∆sirA::Cm     
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Table 2.1 (cont.) 
Name Genotype a Deletion 
endpoints b 
 Source or 
reference c 
KG1343  Φ(hilD’-‘lacZ)hyb139 ∆sirA::Cm     
KG1136  ∆dam::Cm 3638689-
3639527 
  
KG1137  ∆dam::Cm  attλ::pDX1::hilA’-lacZ     
KG1139  ∆dam::Cm ∆hilD138::Kn 
attλ::pDX1::hilA’-lacZ 
    
KG1142  ∆dam::Cm tetRA-rtsA 
attλ::pDX1::hilA’-lacZ 
    
KG1143  ∆dam::Cm ∆hilD138::Kn tetRA-rtsA 
attλ::pDX1::hilA’-lacZ 
    
KG1370  Φ(hilD’-lac+)114 ∆dam::Cm     
KG1337  Φ(hilD’-‘lacZ)hyb139 ∆dam::Cm     
KG1231  ∆ack pta::Cm 2447938-
2451363 
  
KG1406  ∆ack pta::Cm  attλ::pDX1::hilA’-lacZ     
KG11410  ∆ack pta::Cm ∆hilD138::Kn 
attλ::pDX1::hilA’-lacZ 
    
KG1268  ∆ack pta::Cm tetRA-rtsA 
attλ::pDX1::hilA’-lacZ 
    
KG1269  ∆ack pta::Cm ∆hilD138::Kn tetRA-rtsA 
attλ::pDX1::hilA’-lacZ 
    
KG1409  Φ(hilD’-lac+)114 ∆ack pta::Cm     
KG1411  Φ(hilD’-‘lacZ)hyb139 ∆ack pta::Cm     
KG1223  ∆yfgL::Cm 2653048-
2654226 
  
KG1158  ∆yfgL::Cm  attλ::pDX1::hilA’-lacZ     
KG1160  ∆yfgL::Cm ∆hilD138::Kn 
attλ::pDX1::hilA’-lacZ 
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Table 2.1 (cont.) 
Name Genotype a Deletion 
endpoints b 
 Source or 
reference c 
KG1166  ∆yfgL::Cm tetRA-rtsA 
attλ::pDX1::hilA’-lacZ 
    
KG1167  ∆yfgL::Cm ∆hilD138::Kn tetRA-rtsA 
attλ::pDX1::hilA’-lacZ 
    
KG1371  Φ(hilD’-lac+)114 ∆yfgL::Cm     
KG1338  Φ(hilD’-‘lacZ)hyb139 ∆yfgL::Cm     
KG1219  ∆fnr::Cm  1754380-
1755116 
  
 
KG1201  ∆fnr::Cm  attλ::pDX1::hilA’-lacZ     
KG1202  ∆fnr::Cm ∆hilD138::Kn 
attλ::pDX1::hilA’-lacZ 
    
KG1180  ∆fnr::Cm tetRA-rtsA attλ::pDX1::hilA’-
lacZ 
    
KG1181  ∆fnr::Cm ∆hilD138::Kn tetRA-rtsA 
attλ::pDX1::hilA’-lacZ 
    
KG1367  Φ(hilD’-lac+)114 ∆fnr::Cm     
KG1346  Φ(hilD’-‘lacZ)hyb139 ∆fnr::Cm     
JRE3238  phoQ24 ∆ycfD::Kn     
JRE3274  phoQ24 ∆ycfD::Kn  attλ::pDX1::hilA’-
lacZ 
    
JRE3105  phoQ24 ∆ycfD::Kn ∆hilD114::Cm 
attλ::pDX1::hilA’-lacZ 
    
JRE3371  phoQ24 ∆ycfD::Kn tetRA-rtsA 
attλ::pDX1::hilA’-lacZ 
    
JRE3372  phoQ24 ∆ycfD::Kn ∆hilD114::Cm 
tetRA-rtsA attλ::pDX1::hilA’-lacZ 
    
KG1441  Φ(hilD’-lac+)114 phoQ24 ∆ycfD     
KG1442  Φ(hilD’-‘lacZ)hyb139 phoQ24 ∆ycfD     
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Table 2.1 (cont.) 
Name Genotype a Deletion 
endpoints b 
 Source or 
reference c 
KG1475  ∆hha::Cm 528131-
528349 
  
KG1532  ∆hha::Cm  attλ::pDX1::hilA’-lacZ     
KG1533  ∆hha::Cm ∆hilD138::Kn 
attλ::pDX1::hilA’-lacZ 
    
KG1539  ∆hha::Cm tetRA-rtsA 
attλ::pDX1::hilA’-lacZ 
    
KG1540  ∆hha::Cm ∆hilD138::Kn tetRA-rtsA 
attλ::pDX1::hilA’-lacZ 
    
KG1538  Φ(hilD’-lac+)114 ∆hha::Cm     
KG1537  Φ(hilD’-‘lacZ)hyb139 ∆hha::Cm     
KG1217  ∆fis::Cm     
KG1071  ∆fis::Cm  attλ::pDX1::hilA’-lacZ     
KG1108  ∆fis::Cm ∆hilD138::Kn 
attλ::pDX1::hilA’-lacZ 
    
KG1072  ∆fis::Cm tetRA-rtsA attλ::pDX1::hilA’-
lacZ 
    
KG1109 ∆fis::Cm ∆hilD138::Kn tetRA-rtsA 
attλ::pDX1::hilA’-lacZ 
    
KG1365  Φ(hilD’-lac+)114 ∆fis::Cm     
KG1332  Φ(hilD’-‘lacZ)hyb139 ∆fis::Cm     
KG1476  ∆hupA::Cm 4386709-
4386981 
  
KG1477  ∆hupB::Cm 508105-
508378 
  
KG1518  ∆hupA:: ∆hupB::Cm  
attλ::pDX1::hilA’-lacZ 
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Table 2.1 (cont.) 
Name Genotype a Deletion 
endpoints b 
 Source or 
reference c 
KG1553  ∆hupA:: ∆hupB::Cm ∆hilD138::Kn 
attλ::pDX1::hilA’-lacZ 
    
KG1517  ∆hupA:: ∆hupB::Cm tetRA-rtsA 
attλ::pDX1::hilA’-lacZ 
    
KG1552  ∆hupA:: ∆hupB::Cm ∆hilD138::Kn 
tetRA-rtsA attλ::pDX1::hilA’-lacZ 
    
KG1570  Φ(hilD’-lac+)114 ∆hupA:: ∆hupB::Cm     
KG1569  Φ(hilD’-‘lacZ)hyb139 ∆hupA:: 
∆hupB::Cm 
    
KG1229  ∆rfaH::Cm 4182923-
4183411 
  
KG1448  ∆rfaH::Cm  attλ::pDX1::hilA’-lacZ     
KG149  ∆rfaH::Cm ∆hilD138::Kn 
attλ::pDX1::hilA’-lacZ 
    
KG1450  ∆rfaH::Cm tetRA-rtsA 
attλ::pDX1::hilA’-lacZ 
    
KG1451  ∆rfaH::Cm ∆hilD138::Kn tetRA-rtsA 
attλ::pDX1::hilA’-lacZ 
    
KG1416  Φ(hilD’-lac+)114 ∆rfaH::Cm     
KG1418  Φ(hilD’-‘lacZ)hyb139 ∆rfaH::Cm     
JRE957  ∆relA::Kn     
KG1511  ∆relA ∆spoT::Cm  attλ::pDX1::hilA’-
lacZ 
    
KG1564  ∆relA ∆spoT::Cm ∆hilD138::Kn 
attλ::pDX1::hilA’-lacZ 
    
KG1531 ∆relA ∆spoT::Cm tetRA-rtsA 
attλ::pDX1::hilA’-lacZ 
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Table 2.1 (cont.) 
Name Genotype a Deletion 
endpoints b 
 Source or 
reference c 
KG1563  ∆relA:: ∆spoT::Cm ∆hilD138::Kn 
tetRA-rtsA attλ::pDX1::hilA’-lacZ 
    
KG1522  Φ(hilD’-lac+)114 ∆relA:: ∆spoT::Cm     
KG1521  Φ(hilD’-‘lacZ)hyb139 ∆relA 
∆spoT::Cm 
    
KG1218 ∆fur41::Cm    (53) 
KG1059  ∆fur41::Cm  attλ::pDX1::hilA’-lacZ     
KG1077  ∆fur41::Cm ∆hilD138::Kn 
attλ::pDX1::hilA’-lacZ 
    
KG1060  ∆fur41::Cm tetRA-rtsA 
attλ::pDX1::hilA’-lacZ 
    
KG1078  ∆fur41::Cm ∆hilD138::Kn tetRA-rtsA 
attλ::pDX1::hilA’-lacZ 
    
KG1366  Φ(hilD’-lac+)114 ∆fur41::Cm     
KG1333  Φ(hilD’-‘lacZ)hyb139 ∆fur41::Cm     
KG1021 attλ::pDX1::hilA’-lacZ hilD138::     
KG1020  attλ::pDX1::hilA’-lacZ ∆fliZ8042::     
KG1025  attλ::pDX1::hilA’-lacZ ∆flhDC:: tetRA-
fliZ 
    
JR422  attλ::pDX1::hilA’-lacZ hilD138:: 
∆hilE115::Cm 
    
JR401  attλ::pDX1::hilA’-lacZ ∆fliZ8042:: 
∆hilE115::Cm 
    
JR446  attλ::pDX1::hilA’-lacZ ∆flhDC:: tetRA-
fliZ ∆hilE115::Cm 
    
JR425  attλ::pDX1::hilA’-lacZ hilD138:: 
∆envZ::Cm 
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Table 2.1 (cont.) 
Name Genotype a Deletion 
endpoints b 
 Source or 
reference c 
JR404  attλ::pDX1::hilA’-lacZ ∆fliZ8042:: 
∆envZ::Cm 
    
JR449  attλ::pDX1::hilA’-lacZ ∆flhDC:: tetRA-
fliZ ∆envZ::Cm 
    
JR426  attλ::pDX1::hilA’-lacZ hilD138:: 
∆fadD::Kn 
    
JR406  attλ::pDX1::hilA’-lacZ ∆fliZ8042:: 
∆fadD::Kn 
    
JR453  attλ::pDX1::hilA’-lacZ ∆flhDC:: tetRA-
fliZ ∆fadD::Kn 
    
JR424  attλ::pDX1::hilA’-lacZ hilD138:: 
∆sirA::Cm 
    
JR403  attλ::pDX1::hilA’-lacZ ∆fliZ8042:: 
∆sirA::Cm 
    
JR448  attλ::pDX1::hilA’-lacZ ∆flhDC:: tetRA-
fliZ ∆sirA::Cm 
    
KG1139  attλ::pDX1::hilA’-lacZ hilD138:: 
∆dam::Cm 
    
KG1138  attλ::pDX1::hilA’-lacZ ∆fliZ8042:: 
∆dam::Cm 
    
KG1141  attλ::pDX1::hilA’-lacZ ∆flhDC:: tetRA-
fliZ ∆dam::Cm 
    
KG1408  attλ::pDX1::hilA’-lacZ hilD138:: ∆ack 
pta::Cm 
    
KG1407  attλ::pDX1::hilA’-lacZ ∆fliZ8042:: 
∆ack pta::Cm 
    
KG1412  attλ::pDX1::hilA’-lacZ ∆flhDC:: tetRA-
fliZ ∆ack pta::Cm 
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Table 2.1 (cont.) 
Name Genotype a Deletion 
endpoints b 
 Source or 
reference c 
KG1160  attλ::pDX1::hilA’-lacZ hilD138:: 
∆yfgL::Cm 
    
KG1159  attλ::pDX1::hilA’-lacZ ∆fliZ8042:: 
∆yfgL::Cm 
    
KG1162  attλ::pDX1::hilA’-lacZ ∆flhDC:: tetRA-
fliZ ∆yfgL::Cm 
    
KG1535  attλ::pDX1::hilA’-lacZ hilD138:: 
∆hha::Cm 
    
KG1534  attλ::pDX1::hilA’-lacZ ∆fliZ8042:: 
∆hha::Cm 
    
KG1536  attλ::pDX1::hilA’-lacZ ∆flhDC:: tetRA-
fliZ ∆hha::Cm 
    
JR462  attλ::pDX1::hilA’-lacZ hilD138:: 
∆fis::Cm 
    
JR459  attλ::pDX1::hilA’-lacZ ∆fliZ8042: 
∆fis::Cm: 
    
JR452  attλ::pDX1::hilA’-lacZ ∆flhDC:: tetRA-
fliZ ∆fis::Cm 
    
KG1550  attλ::pDX1::hilA’-lacZ hilD138:: 
∆hupA:: ∆hupB::Cm 
    
KG1549  attλ::pDX1::hilA’-lacZ ∆fliZ8042:: 
∆hupA:: ∆hupB::Cm 
    
KG1551  attλ::pDX1::hilA’-lacZ ∆flhDC:: tetRA-
fliZ ∆hupA:: ∆hupB::Cm 
    
KG1415  attλ::pDX1::hilA’-lacZ hilD138:: 
∆rfaH::Cm 
    
KG1414  attλ::pDX1::hilA’-lacZ ∆fliZ8042:: 
∆rfaH::Cm 
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Table 2.1 (cont.) 
Name Genotype a Deletion 
endpoints b 
 Source or 
reference c 
KG1419  attλ::pDX1::hilA’-lacZ ∆flhDC:: tetRA-
fliZ ∆rfaH::Cm 
    
 KG1524 attλ::pDX1::hilA’-lacZ hilD138:: 
∆relA::Kn ∆spoT::Cm 
    
KG1523  attλ::pDX1::hilA’-lacZ ∆fliZ8042:: 
∆relA::Kn ∆spoT::Cm 
    
KG1525  attλ::pDX1::hilA’-lacZ ∆flhDC:: tetRA-
fliZ ∆relA::Kn ∆spoT::Cm 
    
JR423  attλ::pDX1::hilA’-lacZ hilD138:: 
∆fur41::Cm 
    
JR402  attλ::pDX1::hilA’-lacZ ∆fliZ8042:: 
∆fur41::Cm 
    
JR447  attλ::pDX1::hilA’-lacZ ∆flhDC:: tetRA-
fliZ ∆fur41::Cm 
    
JRE3155 ∆flhDC::Cm  JRE thesis 
KG1454 attλ::pDX1::hilA’-lacZ ∆flhDC::Cm   
KG1456 attλ::pDX1::hilA’-lacZ hilD138:: 
∆flhDC::Cm 
  
KG1455  attλ::pDX1::hilA’-lacZ ∆fliZ8042:: 
∆flhDC::Cm 
  
KG1608 ∆tdcA::Cm  
 
 
KG1601 attλ::pDX1::hilA’-lacZ ∆tdcA::Cm   
KG1604 attλ::pDX1::hilA’-lacZ hilD138:: 
∆tdcA::Cm 
  
KG1603  attλ::pDX1::hilA’-lacZ ∆fliZ8042:: 
∆tdcA::Cm 
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Table 2.1 (cont.) 
Name Genotype a Deletion 
endpoints b 
 Source or 
reference c 
KG1605  attλ::pDX1::hilA’-lacZ ∆flhDC:: tetRA-
fliZ ∆tdcA::Cm 
  
JS631 attλ::pDX1::hilA’-lacZ Δhfq::Kn  (53) 
KG1232 ΔphoBR::Cm 450794-
452850 
 
KG1233 ΔphoU::Cm 4060000-
4060725 
 
KG1234 Δpst-phoU::Cm 4060000-
4064625 
 
KG1261  Φ(apeE+-tnpR-lac+)     
KG1262  Φ(apeE+-tnpR-lac+) ΔphoBR::Cm     
KG1263  Φ(apeE+-tnpR-lac+) ΔphoU::Cm     
KG1264 Φ(apeE+-tnpR-lac+) Δpst-phoU::Cm   
KG1248 attλ::pDX1::hilA’-lacZ ΔphoBR::Cm   
KG1249 attλ::pDX1::hilA’-lacZ ΔphoU::Cm   
KG1250 attλ::pDX1::hilA’-lacZ Δpst-phoU::Cm   
CDE1080 pCE61integrated  (149) 
KG1555 CDE1080 Φ(apeE+-tnpR-lac+)   
    
    
  Plasmids     
pDX1 lacZ tL3 attP oriR6K aacIV tmgB     (132) 
pKG101 pDX1 sodCI fragment E 1130675- 
1130745 
  
pKG102 pDX1 sodCI fragment D 1130635- 
1130745 
  
pKG103 pDX1 sodCI fragment A 1130589- 
1130745 
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Table 2.1 (cont.) 
Name Genotype a Deletion 
endpoints b 
 Source or 
reference c 
pKG104 pDX1 sodCI fragment C 1130635- 
1130689 
  
pKG105 pDX1 sodCI fragment B 1130589- 
1130689 
  
pKG112 pDX1 sodCI fragment F mutant 
fragment C 
(see Fig. 3.8) 
  
pKG113 pDX1 sodCI fragment G mutant 
fragment C 
(see Fig. 3.8) 
  
pKG114 pDX1 sodCI fragment H mutant 
fragment C 
(see Fig. 3.8) 
  
pCP46 bla PBAD gam bet exo pSC101 oriTS   (41) 
pCP20 bla cat cI857 λPR flp pSC101 oriTS   (28) 
pCE70 oriR6K FRT-tnpRwt-lacZY aph (Kanr)   (149) 
pCE61 ColE1 ori res1-tetAR-res1  (149) 
pINT-ts Intλ   (83) 
pSC2-phoP reppMB1 ApR T7 6His-phoP   (109) 
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Chapter 3: Salmonella enterica serovar Typhimurium 
periplasmic superoxide dismutase, SodCI, is a member of the 
PhoPQ regulon and is induced in macrophages 
3.1 Introduction 
 Salmonella Salmonella enterica serovar Typhimurium are enteric pathogenic 
bacteria capable of infecting and causing disease in humans and animals.  As an 
intracellular pathogen, serovar Typhimurium encounters a variety of host defense 
mechanisms and must adapt to different conditions within the host organism.  An 
important aspect of serovar Typhimurium pathogenesis is survival within host 
macrophages (61), which is partly dependent on the ability of the bacterium to protect 
itself from the phagocytic respiratory burst that generates reactive oxygen species such as 
superoxide (42,59). 
 Serovar Typhimurium strain 14028 produces two periplasmic Cu/Zn superoxide 
dismutases, SodCI and SodCII.  SodCI is encoded on the functional lambdoid 
bacteriophage Gifsy-2, embedded within but transcribed in the opposite orientation to the 
late phage operon (56,62,89).  SodCII is encoded on the chromosome and is the ortholog 
of Escherichia coli SodC.  Strains containing a sodCI null mutation are attenuated in 
mouse time-to-death assays (42,59).  In intraperitoneal (I.P.) competition assays against 
the isogenic wild type strain, sodCI mutants show 7 to 10-fold attenuation (90,118).  In 
contrast, sodCII null mutations in strain 14028 do not confer a virulence phenotype, even 
in the absence of SodCI (118,220).   
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 Krishnakumar et al. (118) provided evidence that both SodCI and SodCII are 
expressed during infection and inherent differences in the two proteins primarily explain 
the differential role in virulence.  However, data also suggest that the two genes are 
differentially regulated.  Uzzau et al. (220) showed that epitope tagged SodCI 
accumulated to significantly higher levels than epitope tagged SodCII in bacteria 
recovered from macrophages and animals.  Eriksson et al. (54) noted transcriptional 
induction of sodCI but not sodCII in microarray analysis of serovar Typhimurium grown 
in tissue culture macrophages.  We noted that producing SodCII under the control of the 
sodCI promoter not only failed to complement a sodCI virulence defect, but actually 
attenuated the bacterium further.  One explanation for this phenomenon was that the non-
functional SodCII was being overproduced (118).  
A number of enzymes involved in defense to oxidative stress are RpoS regulated 
and E. coli sodC is a member of this regulon (75).  Serovar Typhimurium sodCII was 
also shown to be controlled by RpoS (56).  For sodCI, stationary phase regulation had 
been reported, but it was apparently independent of RpoS (56).   
PhoPQ is a two-component regulatory system that is critical for serovar 
Typhimurium adaptation to intracellular growth (76).  It consists of a sensor kinase, 
PhoQ, which phosphorylates PhoP, the response regulator.  PhoP then binds to the 
promoters of target genes resulting in activation or repression (74,77,153,243).  In vitro, 
the system is activated by low cation concentrations (74) and low pH (16).  However, 
more recent evidence suggests that low pH (145) and direct detection of antimicrobial 
peptides produced by macrophages (5,6) are the critical signals in the Salmonella 
containing vacuole responsible for inducing PhoP phosphorylation.  Several PhoPQ-
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regulated genes encode regulatory proteins that directly or indirectly control expression 
of a subset of the PhoPQ regulon.  The PmrAB two-component regulatory system 
controls genes responsible for LPS modification and resistance to certain antimicrobial 
peptides (82,117).  This system is induced by PhoPQ via PmrD (117).  PmrAB can also 
be activated independently of PhoPQ by high iron conditions or by mildly acidic pH 
(240).  PhoPQ is also known to regulate rstAB, encoding a two-component system of 
unknown function (157,242); ssrAB, the two-component system that controls expression 
of the Salmonella Pathogenicity Island 2 (SPI2) type three secretion system (18); and 
slyA, which controls a large stress response regulon (165,167,201). 
In this study we show that sodCI and sodCII are differentially regulated.  The 
sodCI gene is regulated by the PhoPQ two-component regulatory system in vitro and in 
vivo.  In contrast, sodCII is under the control of RpoS.  Both systems are induced in 
bacteria recovered from tissue culture macrophages or the spleens of infected mice, with 
sodCI expressed at a higher level compared to sodCII.  
3.2 Results 
The sodCI and sodCII genes are transcriptionally induced in stationary phase 
Previous studies (118,220) have shown that SodCI, but not SodCII, contributes to 
serovar Typhimurium strain 14028 virulence in mice.  These studies also suggested that 
sodCI is expressed at a higher level than sodCII in vivo, although our results (118) 
indicated that sodCII is expressed during infection.  Both enzymes are produced in 
laboratory culture (118,220) and induced in the stationary phase of growth (56,118).  We 
used single-copy chromosomal transcriptional lac fusions to sodCI and sodCII to study 
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the expression of both genes in vitro and in vivo.  We constructed our fusions by inserting 
promoterless lacZY genes (49)  just downstream of the sodCI or sodCII stop codons.  In 
the case of sodCI, this insertion is associated with a deletion of all Gifsy-2 phage genes 
downstream of sodCI through attL, including int, the immunity region and the genes 
encoding the putative replication proteins (Fig. 3.1). This ensured that phage induction 
did not artifactually increase lac activity.  Thus, both fusion constructs produced SodCI 
or SodCII equivalently to wild type (data not shown).  Moreover, the strain containing the 
sodCI+-lac+ fusion and associated deletion of the Gifsy-2 phage genes was fully virulent 
(data not shown), which is consistent with our previous data showing that the phage 
genes are not required for virulence and that SodCI is produced from the lysogenic phage 
(89).   
To analyze expression, we first determined the β-galactosidase activity produced 
from the sodCI-lac and sodCII-lac fusion strains in different stages of growth in LB 
medium.  Figure 3.2 shows that sodCI and sodCII genes are induced 3.75 and 5.3 fold in 
stationary phase, respectively.   
Genes that are induced in stationary phase are often under the control of RpoS 
(86).  Indeed, E.coli sodC (the sodCII ortholog) is known to be regulated by RpoS (75).  
Introduction of an rpoS deletion mutation into the fusion bearing strains resulted in 
decreased expression of sodCII.  In contrast, sodCI expression was unaffected by loss of 
RpoS.  These data are in agreement with the previous results of Fang et al. (56).  The 
enzymatic activity of SodCI and SodCII in wt and rpoS backgrounds in vitro correlated 
with the lac fusion results (data not shown).  These results show that sodCII is regulated 
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by RpoS in vitro.  In contrast, sodCI expression in vitro is apparently under the control of 
some other regulator.   
Expression of sodCI is controlled by PhoPQ in vitro  
Microarray analysis suggested that sodCI was a member of the PhoPQ two-
component regulon (165).  To examine whether sodCI was under the control of PhoPQ in 
vitro, we monitored the expression of the sodCI-lac fusion in modified N-minimal 
medium, pH 5.6, supplemented with 10 mM or 10 µM MgCl2; divalent cations serve as a 
signal for the PhoPQ system in vitro (6,74,194).  As shown in Figure 3.3, sodCI was 
induced 2-fold in low Mg2+ conditions (10 µM).  Introduction of a phoP null mutation 
abolished this induction.  Introduction of the phoQ24 allele (111,154,226) resulted in 
high level constitutive expression of sodCI.  The expression of the sodCII-lac fusion was 
analyzed under the same conditions.  In contrast to sodCI, expression of the sodCII was 
not significantly affected by either the concentration of magnesium or introduction of the 
phoP or phoQ24 mutations (Figure 3.3).  These results indicate that sodCI is regulated by 
the PhoPQ two-component regulatory system in vitro while sodCII is not. 
 
Transcription of sodCI is induced 10-15 fold in tissue culture macrophages and in 
mice  
Both sodCI and sodCII are expressed in the host (118), but several previous 
studies suggested that sodCI is expressed at a higher level than sodCII (54,118,220).  In 
order to study the in vivo expression of both genes, the strains bearing sodCI+- and 
sodCII+- transcriptional lac fusions were used to infect RAW 264.7 macrophages.  The β-
galactosidase activity of bacteria isolated from macrophages was compared to that of 
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bacteria grown in laboratory culture.  As seen in Figure 3.4 A, expression of sodCI was 
10-fold induced in macrophages while sodCII expression was induced 4 fold.  To study 
the expression levels of both genes during infection, BALB/c mice were infected with 
sodCI+- or sodCII+-fusion strains and bacteria were isolated from the spleen after 4 days 
of infection.  The β-galactosidase activity of the bacteria isolated from mice and those 
grown in laboratory media are shown in Figure 3.4 B.  Strikingly similar to our 
macrophage expression data, sodCI was induced 15 fold in BALB/c mice compared to 
the laboratory culture, while sodCII was induced 3.5 fold.  This correlation between the 
tissue culture macrophage and mouse data is consistent with the concept that the majority 
of bacteria are found within macrophages in the host (130).  These data also suggest that 
our macrophage experiments are relevant to study the in vivo regulation of sodCI and 
sodCII.  
PhoPQ regulates sodCI in vivo  
To test if PhoPQ is responsible for sodCI induction in vivo, RAW 264.7 
macrophages were infected with strains harboring the sodCI- or sodCII- transcriptional 
fusions in wt, phoP or phoQ24 backgrounds.  As above, expression of sodCI was induced 
15 fold in macrophages (Figure 3.5 A).  This induction was completely dependent on 
PhoP; introduction of the phoP null mutation abolished sodCI expression in macrophages.  
Expression of sodCI was elevated 3 fold in tissue culture medium in the phoQ24 
background compared to the wild type and expression was induced an additional 22 fold 
in the macrophages.  This is likely due to the effect of lowering pH on the activation of 
the PhoQ24 protein; a similar effect was seen in vitro when comparing growth media at 
pH 7.4 versus pH 5.6 (data not shown).  The sodCII fusion was induced 2-3 fold in 
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macrophages and this induction was not affected in the presence of the phoP null or 
phoQ24 mutations (Figure 3.5 A).   
These experiments are potentially complicated by the reduced viability of the 
phoP and phoQ mutants in macrophages (61,153,154).  Indeed, we recover 
approximately 3-10 fold less phoP or phoQ24 mutant compared to wild type cells after 
16 hours of incubation.  However, the fact that the specific activity of the sodCII fusion 
was unaffected in the pho mutants shows that any survival defect was irrelevant to these 
measurements.  These results show that PhoPQ regulates sodCI expression in vivo, but 
does not affect sodCII expression, which correlates well with our in vitro data. 
In vitro, sodCII is primarily under the control of RpoS.  We therefore tested the 
effect of an rpoS null mutation on sodCII and sodCI expression in macrophages.  As 
above, sodCII was induced almost 4 fold in bacteria recovered from macrophages 
compared to those propagated in tissue culture medium (Figure 3.5 B).  Loss of RpoS 
abrogated sodCII induction.  In contrast, sodCI expression was unaffected.  Although not 
significant in this experiment, there might be residual RpoS-independent induction of 
sodCII, which again would be consistent with our in vitro data.   
PhoPQ regulation of sodCI is apparently direct  
PhoPQ is known to activate a number of regulatory systems: PmrAB, SlyA, 
SsrAB, and RstAB (18,117,157,165,167,201,242).  It is possible that sodCI is not directly 
regulated by PhoP, but rather indirectly via one of these systems.  In order to test this 
hypothesis, we inactivated these systems in both the wild type and phoQ24 backgrounds 
and assayed the resulting β-galactosidase activity from the sodCI-lac fusion.  Navarre et 
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al. (165) previously concluded that sodCI was not under the control of SlyA.  Our data 
show that expression of sodCI is unaffected by deletion of pmrA, ssrB, or rstA in either 
the wild type or phoQ24 background (Figure 3.6).  These results are consistent with the 
hypothesis that PhoP directly activates sodCI expression. 
Analysis of the sodCI promoter region  
To precisely map the sodCI promoter, we used primer extension analysis (Figure 
3.7). The results revealed that the transcription start site of sodCI is 61 bp upstream of the 
ATG start codon.  To find the promoter region that is necessary for PhoP activation, we 
cloned various fragments of the sodCI promoter 5’ to a promoterless lacZ gene in pDX1, 
an apramycin resistant plasmid derived from pAH125 ((83); Lin and Slauch, 2007). 
These constructs were integrated into the chromosome at the Lambda attachment site in 
both wild type and phoQ24 backgrounds.  The results in Figure 3.8 indicate that the 
smallest fragment that was cloned, corresponding to -42 to +12 of the sodCI promoter 
(fragment C), conferred regulation in response the phoQ24 allele.  The fragment 
corresponding to -98 to -29 was not significantly regulated and serves as a negative 
control.   
 Analysis of a series of PhoP-regulated promoters suggests a consensus sequence 
for PhoP binding: two (G/T)GTTTA(A/T) direct repeats separated by 4 
bps(128,157,203,250).  In a significant subset of PhoP activated promoters this binding 
site overlaps the -35 promoter sequence (250).  A similar sequence is noted at the 
appropriate location in the sodCI promoter from -42 to -25 (Figure 3.9). To test the 
relevance of this sequence, we altered specific base pairs in the context of the -42 to +12 
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fragment.  Any change to this consensus sequence significantly affected activation in the 
phoQ24 background.  The most striking example is fragment H (Figure 3.9), in which 
three base pair changes, corresponding to sites shown to be critical for PhoP activation of 
the mgtA promoter in E. coli  (243) completely abrogated the transcriptional activation in 
the phoQ24 background.  These results show that the -42 to +12 fragment contains all of 
the sequence required for PhoP activation and suggest that the identified consensus PhoP-
binding site is critical for this activation.  
The data above identify a putative PhoP binding site.  Together with the fact that 
known PhoP–regulated transcriptional activators are apparently not involved in sodCI 
regulation, these results suggest that PhoP acts directly at the sodCI promoter.  However, 
our attempts to gelshift sodCI promoter fragments using purified His-tagged PhoP under 
a variety of conditions were inconclusive (not shown).  Zwir et al. (250) recently 
combined bioinformatics and gene expression analysis to identify members of the PhoP 
regulon.  They used chromatin immunoprecipitation assays to confirm PhoP binding to 
designated sites.  Dr. Groisman was kind enough to test if PhoP was crosslinked to the 
sodCI promoter in his assay.  Using primers that amplify a 276 bp fragment centered on 
the putative PhoP site, the results (not shown) suggested that PhoP did not bind to this 
region under the in vitro inducing conditions.  Thus, while our genetic data strongly argue 
that PhoP directly activates sodCI transcription, we have been unable to confirm direct 
binding using in vitro molecular techniques.  There are two possible explanations for 
these inconclusive results.  Perhaps there is an additional unidentified regulator that is 
controlled by PhoP and directly acts at the sodCI promoter.  If so, then this regulator 
apparently binds to a site that is strikingly similar to that recognized by PhoP.  
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Alternatively, PhoP binding to the non-consensus sodCI site is weak and is only realized 
under the in vivo induced conditions.  Indeed, induction of sodCI in vivo is far greater 
than what is achievable in vitro under any condition that we tested (Figures 3 and 4).  At 
the moment, we favor the latter interpretation.   
3.3 Discussion 
Salmonella enterica serovar Typhimurium strain 14028 produces two periplasmic 
superoxide dismutases, SodCI and SodCII.  Although both proteins are produced during 
infection (118), only SodCI contributes to virulence.  Although this inequality in roles is 
mostly due to some difference in the two proteins, several lines of evidence suggested 
that the two genes were differentially regulated in the host (54,118,165,220).  Here we 
show that sodCI, encoded on the Gifsy-2 bacteriophage, is a member of the PhoPQ 
regulon.  As such, it is transcriptionally induced in the Salmonella containing vacuole of 
the macrophage, ideally expressed to combat phagocytic superoxide known to be 
important in controlling Salmonella infection (42,147,222,223).  The PhoPQ regulon 
includes a large number of genes whose products contribute to macrophage survival by 
conferring, for example, resistance to antimicrobial peptides and low pH (76,250).  PhoP 
also contributes to activation of the SPI-2 type three secretion system required for 
establishment of the so-called Salmonella containing vacuole (SCV) in which the bacteria 
replicate (18). We now add resistance to phagocytic superoxide to the PhoP repertoire of 
intracellular survival functions, further emphasizing the central importance of this 
regulon.   
 In vitro, the PhoPQ system is induced in media with a low concentration of 
divalent cations including Mg and Ca (76) and the regulon includes Mg transporters 
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apparently required to adapt to the low Mg environment.  However, recent data suggest 
that Mg may not be the dominant signal that activates the system in the macrophage.  
Rather, low pH seems critical (145).  Also, it has been shown that PhoQ can respond to 
sub-lethal concentrations of antimicrobial peptides, a signal that is also likely to be 
important in vivo (5,6).  The PhoPQ regulon, partially via the PmrAB system, is 
responsible for resistance to these peptide antibiotics.  Our data are consistent with these 
observations.  In N-minimal medium, even at pH 5.6, lowering the Mg concentration 
induced sodCI only 2- 3 fold.  In contrast, the gene was induced approximately 15 fold in 
macrophages and in the animal.  Induction was even more dramatic in the strain 
producing the PhoQ24 protein, which does not respond to Mg at pH 5.6 (Figure 2).   
 All of the known PhoP regulon members involved in virulence were apparently 
acquired by horizontal gene transfer (76,250).  SodCI is expressed from the lysogenic 
Gifsy-2 phage.  The phage encodes a number of potential virulence factors including SseI, 
which is under the transcriptional control of SsrAB (239)  and is secreted by the SPI2 
Type Three Secretion System (151), and GtgE, a putative cytoplasmic protein of 
unknown function with no known homologs.  (See (89), for a more complete analysis of 
Gifsy-2).  Mutations in only sodCI and gtgE confer a phenotype in the mouse model of 
infection, together accounting for essentially all of the approximately 150-fold decrease 
in virulence seen in a strain cured of Gifsy-2 phage (89).  We know that both sodCI and 
gtgE are expressed from the lysogen and that phage induction is not required, because 
strains containing deletions of Gifsy-2 that block excision, immunity, late gene 
transcription and replication, but which leave sodCI and gtgE intact, are fully virulent 
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(89).  Indeed, studies here were performed with strains deleted for all phage genes 
downstream of sodCI, analogous to the deletion mentioned above.   
 In the phage, the sodCI open reading frame and downstream ailT gene are 
inserted between the open reading frames for the minor tail proteins M and L.  In Lambda, 
the stop codon for M overlaps the start codon for L, as is common for genes in the late 
operon.  Presumably, sodCI evolved to be regulated by PhoPQ after it was acquired by 
the Gifsy-2 phage.  Indeed, the start codon for the Gifsy-2 L gene is at position -30 in the 
sodCI promoter and much of the putative PhoP binding site is within the L open reading 
frame (Figure 8).  Interestingly, eight of the first nine amino acids of Gifsy-2 L 
(corresponding to 23 of the first 27 nucleotides) are identical to those of Lambda L and a 
subset of other lambdoid phage L proteins.  This conservation of amino acids is certainly 
not the rule among the lambdoid phages and many of the genes in the late operon show 
no direct homology to Lambda, although the overall layout of genes and, presumably, 
function are conserved.  Thus, this conservation suggests that the N-terminus of L is 
important.  One of the base pairs that differs from Lambda, leading to an amino acid 
change from Arg to Pro in the sequence, corresponds to the first conserved G in the 
upstream PhoP half site.  Although the overall PhoP binding site differs from consensus, 
this must be viewed in the context of the L open reading frame.  For example, the (G/T)G 
in the downstream PhoP half site in the sodCI promoter is not conserved, but these 
nucleotides correspond to the ATG start codon for L (Figure 8).  Thus, the phage 
presumably evolved to regulate the acquired sodCI gene via PhoP while maintaining the 
amino acid sequence critical for L function.   
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Given these constraints, sodCI has apparently evolved an imperfect PhoP binding 
site.  Indeed, although a few members of the PhoPQ regulon, such as phoPQ, mgtA and 
slyB, possess consensus or near consensus binding sites, many members of the regulon do 
not (127,250).  Binding has also been observed at imperfect sites in the pmrD and pcgL 
promoters (127).  In other cases, however, binding has not been shown in vitro, although 
partial sites are apparent.  We have been unable to prove direct binding of PhoP to the 
sodCI promoter in vitro.  Given the strong induction in vivo versus that obtainable in vitro, 
it is possible that PhoP, appropriately activated in the phagosome and itself increased in 
production, is capable of binding these imperfect sites and directly activating expression 
of this entire repertoire of genes, important for survival in this hostile environment.  
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3.4 Figures  
 
Construction of lacZY Transcriptional Fusions
FRT
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Figure 3.1 lac fusion immediately downstream of the sodCI coding sequence, 
the Gifsy-2 phage sequence downstream of sodCI deleted.
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Figure 3.2 β-galactosidase activity of sodCI- and sodCII-lac fusion strains. (A) Cells 
were assayed in log phase or stationary phase of growth. (B) The effect of ΔrpoS::Tet 
mutation on sodCI and sodCII expression in stationary phase of growth. β-galactosidase 
activity units are defined as (µmol of ONP formed min-1) x 106/ (OD600 x ml of cell 
suspension) and are reported as mean ± standard deviation where number of 
measurements, n = 4. 
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Figure 3.3 The effect of phoP::Tn10dCm and phoQ24 mutations on the expression of 
sodCI and sodCII in vitro.  Cultures were grown in N-min modified medium pH 5.6 
supplemented with 10 µM or 10 mM magnesium chloride (inducing and repressing 
conditions respectively), to OD600 of 0.3. β-galactosidase activity units are defined as 
(µmol of ONP formed min-1) x 106/ (OD600 x ml of cell suspension) and are reported as 
mean ± standard deviation where n = 4. 
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Figure 3.4 In vivo expression of sodCI and sodCII. (A) Expression of the sodCI-lac and 
sodCII-lac fusions in cells recovered from RAW macrophages or grown in RPMI 
medium. Expression of sodCI in macrophages was considered 100%. (B) Expression of 
the sodCI-lac and sodCII-lac fusions on cells isolated from BALB/c mice or grown in LB 
medium. Expression of sodCI in BALB/c mice was considered 100%. β-galactosidase 
activity was determined using a chemiluminescent assay. 
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Figure 3.5 The effect of regulatory mutations on sodCI and sodCII expression in vivo.  
Activity of sodCI- and sodCII-lac fusions in (A) phoP::Tn10dCm and phoQ24 
backgrounds or (B) an rpoS background.  After 16 hrs of incubation the β-galactosidase 
activity of the bacteria released from macrophages and those grown in RPMI were 
determined using the chemiluminescent assay. Expression of sodCI in a wt background in 
macrophages is considered 100%. 
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Figure 3.6 Expression of sodCI is unaffected by mutations in PhoP-dependent regulatory 
systems.  (A) The effect of a ΔpmrA::Cm mutation on the expression of sodCI.  The 
PmrA regulated gene, pmrI, is monitored as a control. (B) The effect of ΔrstA::Cm and 
ΔssrB::Cm mutations on the expression of sodCI.  All strains were grown in N-min 
modified medium pH 5.6 supplemented with 10 µM or 10 mM magnesium chloride 
(inducing and repressing conditions respectively), to OD600 of 0.3. β-galactosidase 
activity units are defined as (µmol of ONP formed min-1) x 106/ (OD600 x ml of cell 
suspension) and are reported as mean ± standard deviation where n = 4.   
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Figure 3.7 Mapping the transcription start site of sodCI by primer extension.  The 
phoQ24 mutant cells were grown in LB medium to OD600 ~1.0 for isolation of total 
RNA. The transcription start site on the corresponding sequence is underlined. 
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Figure 3.8 Deletion analysis of the sodCI promoter region. The serovar Typhimurium 
strains contained lac transcriptional fusions to the indicated fragments of the sodCI 
promoter region integrated at the λatt site in wt and phoQ24 strains. Cultures were grown 
in N-min modified medium pH 5.6 supplemented with 10 mM MgCl2 to OD600 of 0.3.  β-
galactosidase activity units are defined as (µmol of ONP formed min-1) x 106/ (OD600 x 
ml of cell suspension) and are reported as mean ± standard deviation where n = 4. 
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Figure 3.9 Analysis of the PhoP consensus sequence within the sodCI promoter. The 
sequence of Fragment C (Fig. 7) is shown.  The +1 base, -10 sequences and bases 
matching the PhoP consensus binding sequence are in bold.  The PhoP binding site 
consensus is shown above the sequence.  The underlined bases are those that have been 
shown to be critical in PhoP binding to the mgtA promoter in E. coli (243).  The N-
terminal amino acid sequence of Gifsy-2 L is indicated starting at -30; the first four of 
five amino acids in the L open reading frame are conserved with those of Lambda L.  The 
serovar Typhimurium strains contained lac transcriptional fusions to the indicated 
fragments of the sodCI promoter region integrated at the λatt site in wt and phoQ24 
backgrounds.  The base pairs that differ in fragments F-H are indicated.  Cultures were 
grown in N-min modified media pH 5.6 supplemented with 10 mM magnesium chloride 
to OD600 of 0.3. β-galactosidase activity units are defined as (µmol of ONP formed min-1) 
x 106/ (OD600 x ml of cell suspension) and are reported as mean ± standard deviation 
where n= 4. 
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Chapter 4: Phylogenomic mapping 
 
Systemic infection by S. typhimurium requires survival within host macrophages 
(61). Survival and propagation in the macrophage is dependent on the ability of the 
bacterium to protect itself from the respiratory burst that generates reactive oxygen 
species such as superoxide. Serovar Typhimurium strain 14028 produces two periplasmic 
Cu/Zn superoxide dismutases, SodCI and SodCII. SodCI is encoded on the functional 
lambdoid bacteriophage Gifsy-2.  The sodCI gene is embedded within but transcribed in 
the opposite orientation to the phage late operon (56,62). SodCII is encoded on the 
chromosome and is the ortholog of E.coli SodC. Strains containing a sodCI null mutation 
are attenuated in a mouse model. In I.P. competition assays against the isogenic wild type 
strain, these mutants show 7 to 10-fold attenuation (36,118). In contrast, sodCII mutants 
do not have a virulence phenotype in S. typhimurium 14028, even in the absence of 
SodCI (118). The molecular mechanism by which external superoxide kills or inhibits 
Salmonella is not known. Previous research in our lab has shown that SodCI protects an 
extracytoplasmic target during infection (36). However, none of the known classes of 
enzymes directly damaged by superoxide are found in the periplasm. Thus, SodCI is 
protecting an unknown periplasmic target. We attempted to elucidate the possible 
function of SodCI in Salmonella pathogenesis using the method of phylogenomic 
mapping.  
4.1 Application of the phylogenomic mapping method 
Phylogenomic mapping (206) allows for analysis of co-evolution of genes among 
more than 200 sequenced bacterial genomes. This method uses genome sequence 
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information for visualizing protein-protein interaction network. Genes that are found 
together throughout evolutionary history (that are co-inherited) are grouped together in 
functional modules (mountains). The co-inherited genes are presumed to be involved in 
the same biological process. Using the VxInsight software package, the Salmonella 
Typhimurium LT2 genome was visualized as a topographic map (Fig. 4.1), with sodCI 
located in Mountain 14 (Fig. 4.2). On this map, the clustering of genes with sodCI within 
the same mountain indicates possible functional interaction between them (shared 
function). It is important to note that gene encoding another periplasmic superoxide 
dismutase, sodCII, is clustered in the same mountain with sodCI. This fact supports the 
presumption that involvement in the same biological process would group such genes 
together. 
Vizualized in Fig. 4.3 are the genes in the immediate vicinity of sodCI in the 
Mountain 14. The genetic interactions between sodCI and these genes, predicted to be 
functionally related to sodCI, are then analyzed by I.P. competition assays in BALB/c 
mice. Competition assays in mice allow us not only to precisely address the virulence 
phenotypes of individual mutations, but to study the combined effect of the mutations of 
interest on Salmonella virulence. Three possible outcomes of this analysis are: (1) 
mutations of Mountain 14 genes show synthetic interaction with sodCI resulting in a 
more profound virulence defect, (2) mutations suppress the sodCI virulence phenotype, 
and (3) effect of mutations on virulence is independent of sodCI.  We would want to 
further characterize the first two groups of these mutations, which may help to identify 
the target of phagocytic superoxide and/or provide insight into how Salmonella protects 
itself against this damaging radical. 
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We have constructed the deletion mutations of a number of genes located near 
sodCI in Mountain 14. These null mutations were then tested for genetic interaction with 
sodCI using I.P. competiton assay in BALB/c mice. First, if we could find no information 
on the potential virulence defect of a mutation x from literature sources, the mutant strain 
x was competed against the wild type strain. Then the effect of the sodCI mutation was 
studied in the background of the null mutantion x, where mutant x sodCI double mutant 
strain was competed against mutant x single mutant strain. If the function of gene x is 
independent of sodCI, we would expect to see no change to the sodCI virulence 
phenotype. Synthetic interaction between sodCI and mutation x would result in a more 
severe virulence phenotype when x is deleted, suggesting that sodCI and gene x are 
involved in the same process (for example, protect the same target of phagocytic 
superoxide).  
A number of genes in Mountain 14 were shown to act independently of sodCI. 
The mouse I.P. Competition assay results for these mutations are shown in Table 4.1.  
Table 4.1 Genetic interactions of the null mutations of genes in mountain 14 with sodCI. 
Strain A Strain B Median CI 
Number of 
mice 
P 
sodCI wt 0.09 26 <0.0005 
ptr wt 0.69 2 NS 
ptr sodCI ptr 0.17 5 0.011 
pmrA sodCI pmrA 0.13 5 <0.0005 
ampG sodCI ampG 0.04 2 0.036 
cpxRA sodCI cpxRA 0.22 3 0.004 
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Table 4.1 (cont.) 
Strain A Strain B Median CI 
Number of 
mice 
P 
pyrD wt 0.09 1 NA 
pyrD sodCI pyrD 0.10 5 <0.0005 
pepN wt 1.51 1 NA 
pepN sodCI pepN 0.09 5 <0.0005 
dcp sodCI dcp 0.10 5 0.0014 
asmA wt 0.01 5 <0.0005 
asmA sodCI asmA 0.11 5 0.0028 
STM2176 wt 0.77 4 NS 
STM2176 sodCI STM2176 0.23 7 0.002 
yibF sodCI yibF 0.09 7 <0.0005 
nlpD wt 0.002 5 <0.0005 
ybbN wt 0.47 1 NA 
ybbN sodCI ybbN 0.15 4 0.0057 
trkA wt 0.06 2 0.0009 
trkA sodCI trkA 0.093 5 <0.0005 
sixA wt 0.004 1 NA 
sixA sodCI sixA 0.07 5 <0.0005 
yfiH wt 2.07 2 NS 
yfiH sodCI yfiH 0.13 5 <0.0005 
 
Initial data have suggested that yfbS and pSLT046 genes found in proximity to 
sodCI on the phylogenomic map have shown synthetic interaction with sodCI in IP 
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Competition Assays in BALB/c mice (Fig. 4.2). We have noticed that the yadH gene, 
which encodes carbonic anhydrase, is located in Mountain 14. However, deletion of the 
yadH is lethal in E. coli, and we were not able to delete this gene in Salmonella. The 
pSLT046, which encodes a periplasmic carbonic anhydrase, is located in Mountain 34, in 
the immediate vicinity of Mountain 14.   
 
 
However, we noted that there was a fair amount of variability in observed 
phenotypes between individual mice. In some cases, sodCI was synthetic with yfbS and 
pSLT046 while other samples showed that sodCI functioned independently of these genes. 
To try to resolve this instability all bacterial strains used were rebuild and experiments 
were repeated. The resulting data suggested that we no longer observed the synthetic 
interaction of yfbS and pSLT046 with sodCI (Table 4.3). 
<0.0005 5 0.039 pSLT046 pSLT046 sodCI 
<0.0005 5 0.027 pSLT046 pSLT046 sodCI 
P No. of mice Median CI Strain B Strain A 
  <0.0005 4 0.039 pSLT046 pSLT046 sodCI  
 
<0.0005 5 0.024 yfbS yfbS sodCI 
<0.0005 5 0.011 yfbS yfbS sodCI 
P No. of mice Median CI Strain B Strain A 
  <0.0005 5 0.009 yfbS yfbS sodCI  
Table 4.2 Genetic interactions of the yfbS and pSLT046 null mutations and sodCI. 
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The results across all groups of infected mice were then pooled. Figure 4.4 shows 
the results for each group of mice plotted separately, with the pool of competition assay 
results for each sodCI vs wt, yfbS sodCI vs yfbS, and pSLT046 sodCI vs pSLT046 
outlined. Statistical analysis (T-test; Log of Median CI was used for the statistical 
analysis) of the pooled groups had showed that the difference between the sodCI vs wt 
group and the yfbS sodCI vs yfbS (P=0.085), or the pSLT046 sodCI vs pSLT046 group 
(P=0.059) was not significant (P>0.05) with the observed variability among results from 
individual mice, and among different experiments for each group of strains.  
 
NS 9 0.89 wt yfbS 
<0.0005 8 0.096 wt DsodCI::Kan 
P No. of mice Median CI Strain B Strain A 
  <0.0005 9 0.06 yfbS yfbS sodCI 
<0.0005 10 0.18 wt pSLT046 
<0.0005 8 0.096 wt DsodCI::Kan 
P No. of mice Median CI Strain B Strain A 
  <0.0005 8 0.17 pSLT046   pSLT046 sodCI 
Table 4.3 Genetic interactions of the yfbS and pSLT046 null mutations and sodCI 
(rebuild strains). 
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4.2 Figures 
 
Figure 4.1 Salmonella Typhimurium LT2 genome visualized by VxInsight software. 
 
 
Figure 4.2 Salmonella Typhimurium sodCI is located in mountain 14. 
 
sodCI 
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Figure 4.3 Genes co-localized with sodCI in Mountain 14. 
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Figure 4.4 The pooled I.P. competition assay results addressing genetic interactions of 
yfbS and pSLT046 with sodCI. Each group represents a set of mice in an I.P. Competition 
Assay.   
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Chapter 5: RNA isolation for microarray analysis of 
Salmonella-host interactions 
 
Microarray analysis of gene expression provides a powerful tool for elucidation of 
pathogen-host interaction during an infection process. This approach had been applied to 
the Salmonella model system to describe both the host response to bacterial infection (44) 
and bacterial adaptation to the eukaryotic host (54). 
Salmonella typhimurium has two periplasmic superoxide dismutases, SodCI and 
SodCII. SodCI is known to contribute to bacterial survival during the systemic stage of 
infection, providing protection against the macrophage oxidative burst (56,118). However, 
the exact mechanism of how phagocytic superoxide damages the intracellular bacteria is 
not known (36). Knowledge of the Salmonella transcriptional profile during infection of 
macrophages and comparison between transcriptional responses of the wild type and 
sodCI sodCII  strains in vivo can shed light on the nature of damage by extracellular 
superoxide. Our goal is to study both bacterial and host gene expression in a RAW 264.7 
macrophage infection model.  
5.1 Salmonella Typhimurium lacking both periplasmic superoxide dismutases is 
sensitive to phagocytic superoxide 
  
It was previously reported that a sodCI mutant was attenuated in survival in INF-γ 
stimulated murine macrophages compared to the wild type strain (42). We compared the 
survival of the wild type and the sodCI mutant strain in mouse peritoneal and in RAW 
264.7 macrophages and did not observe any significant difference (data not shown). 
However, the strain of S. typhimurium that lacks both periplasmic superoxide dismutases 
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(sodCI sodCII) was 2.5- 5- fold attenuated in RAW 264.7 macrophage survival compared 
to the wild type strain at 2 hours after internalization of bacteria (Table 5.1). This result is 
in agreement with a study showing that the production of reactive oxygen species (ROS) 
by macrophages starts immediately after the phagocytosis of bacteria and continues for 
up to 6 hours. The authors showed that during the first 6 hours post-infection, 
macrophages exhibited significant bactericidal activity towards internalized Salmonella, 
resulting in a reduction in viable bacteria from the inoculum (223). Macrophages that 
were deficient in the NADPH-oxidase activity did not have this bactericidal effect.  
 
Table 5.1 Multiplicity of infection (MOI) of 10:1 (bacteria to macrophage); NS- not 
significant. These results are representative of a number of experiments with MOI 
ranging from 5:1 to 25:1. 
Addition of the SOD mimetic MnTPyP alleviated the survival defect suggesting 
that the attenuation of the sodCI sodCII mutant strain was caused by the host superoxide 
production (Table 5.1). Addition of the apocynin, which inhibits the NADPH-oxidase, 
did not show full restoration of the survival of the mutant strain. This is consistent with 
previously published experiments where full suppression of the phenotype was not 
observed (42). The action of the apocynin first stimulates ROS production by 
macrophages, which causes the conversion of the apocynin into an active form in the 
2h 
0.92 wt sodCI sodCII 
1.09 wt sodCI sodCII 
0.32 wt sodCI sodCII 
Strain B Strain A 
0.49 wt   sodCI sodCII   
Table 5.1 Competition assay in RAW 264.7 macrophages.  
CI 
NS 
NS 
<0.0005 
P 
<0.0005 
MnTMPyP 
concanamycin A 
- 
Treatment 
apocynin 
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presence of superoxide and hydrogen peroxide. The active form then acts as an inhibitor 
of ROS production by the NADPH-oxidase (225). Blocking phagosome acidification by 
incubating RAW 264.7 macrophages with concanamycin also restored the survival of the 
mutant to a wild type level.  
Having observed a virulence phenotype for the sodCI sodCII mutant strain in vivo 
allows for the study of the transcriptional response of intracellular bacteria to the 
oxidative challenge of the host. Isolation of Salmonella RNA requires the lysis of 
macrophages with concomitant preservation of bacterial RNA quality. Eriksson et al. (54) 
have published microarray analysis of S. typhimurium gene expression inside RAW 264.7 
macrophages at various time points during infection with the wild type strain. We have 
used their protocol for isolation of bacterial RNA from infected macrophages to obtain 
good quality RNA without the need for amplification steps (Fig 5.1). To note, the 23S 
RNA peak in Salmonella typhimurium total RNA preparation is not immediately evident, 
which is explained by the fact that fragmentation of the 23S rRNA during post-
transcriptional processing of the precursor is common among Salmonella strains. So, the 
observed peaks are not caused by rRNA degradation, but rRNA modification (92).  
5.2 Isolation of the Salmonella total RNA from infected macrophages 
Bacterial RNA isolation from infected RAW 264.7 macrophages following 2h of 
infection was based on the protocol described previously (54). RAW 264.7 macrophages 
(American Type Culture Collection) were maintained in DMEM medium supplemented 
with 10% fetal bovine serum and 1% L-glutamine (BioWhittaker). Macrophages were 
seeded into 6-well plates at 5x106 cells/well. Bacterial cells were washed with sterile 
phosphate buffered saline (PBS) and opsonized in 50% mouse serum for 20 min at 37oC. 
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Bacteria were then diluted in DMEM medium and used to infect macrophages at a 
Multiplicity of Infection (MOI) of 10.  After a 15 min incubation period, the wells were 
washed three times with PBS and then DMEM medium containing 25 μg/mL gentamycin 
to kill extracellular bacteria was added to the wells, and this was designated time zero. 
After 2 hours of incubation, macrophages were lysed for 30 minutes on ice with Lysis 
buffer (1% phenol, 19% ethanol and 1% SDS in RNAse-free water). The lysates were 
collected in 50 mL conical tubes and centrifuged for 20 minutes (40C) at 4000 rpm to 
pellet bacteria. The resulting pellet was washed twice with lysis buffer and stored at -
800C. Bacterial RNA isolation was performed using Ribopure Bacterial RNA Kit 
(Ambion Inc.). The resulting total RNA was treated with DNAseI (Ambion Inc.). A 
Nanodrop and Agilent Bioanalyser were used to determine the quantity and quality of 
RNA, respectively. The lysis buffer in this experiment serves to stabilize bacterial RNA, 
while separating the bacteria from the supernatant by centrifugation gets rid of the 
eukaryotic RNA.  
5.3 RNA isolation for the microarray analysis of host response  
A transcriptional profile of RAW 264.7 macrophages can also provide valuable 
information about Salmonella interaction with the host and the importance of particular 
virulence factors at different stages of infection. By comparing expression profiles of 
RAW 264.7 macrophages infected with the wild type or sodCI sodCII strain we can 
investigate whether scavenging of phagocytic superoxide by intracellular bacteria can 
alter the macrophage response to the pathogen.  
Bacteria require mechanical or enzymatic treatments in order to disrupt bacterial 
cells for RNA isolation. This property allows for isolation of only the eukaryotic RNA 
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from infected macrophages when bacterial disruption steps are omitted from the protocol. 
Uninfected or infected total RAW 264.7 macrophage RNA for microarray analysis was 
isolated using the Trizol reagent (Invitrogen Inc.), followed by on-column purification of 
the aqueous phase using Ribopure RNA Kit (Ambion Inc.). The resulting RNA was 
treated with DNAseI using the reagents included in the Ribopure RNA Kit (Ambion Inc.). 
A Nanodrop and Agilent Bioanalyser were used to determine the quantity and quality of 
RNA, respectively. Trizol isolation yields excellent quality total RNA which is suitable 
for gene expression analysis (Fig. 5.2). Note, that the RNA peaks in Figure 5.2 are 
labeled as 16S and 23S, because these RNA samples were run on the Bacterial RNA Chip 
(Agilent Inc.).   
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5.4 Figures  
 
 
Figure 5.1 Agilent Bioanalyser profile of the bacterial RNA isolated from in vitro liquid 
LB culture (A) and infected macrophages (B). 
 
 
 
 
Figure 5.2 Agilent Bioanalyser profile of eukaryotic RNA isolated from uninfected (A) 
and infected RAW 264.7 macrophages (B). The profile was obtained from the Bacterial 
Chip (note the RNA peaks labeling).   
B    RNA from infected RAW 264.7 
macrophages MOI 25:1 
A    RNA from RAW 264.7 
macrophages 
A    Salmonella RNA B    Salmonella RNA from RAW 264.7 macrophages 
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Chapter 6: Global regulatory input into the Salmonella 
Pathogenicity Island 1 Type III secretion system 
 
Salmonella Typhimurium uses the Salmonella Pathogenicity Island 1 (SPI1) Type 
III secretion system to induce bacterial uptake by intestinal epithelia. Expression of hilA, 
encoding the SPI1 master regulator, is directly controlled by three AraC-like regulators: 
HilD, HilC and RtsA, each of which can activate the hilD, hilC, rtsA, and hilA genes 
forming a complex feed-forward regulatory loop. A large number of regulatory signals 
affect SPI1 regulation. We have developed a series of genetic tests that allow us to 
determine where these regulators of SPI1 feed into the regulatory circuit. By testing 
various regulators and environmental signals in this experimental system, we can group 
the known SPI1 regulators into distinct classes based on the observed regulation patterns. 
Many of these regulatory factors are shown to work at the level of HilD. The flagellar 
protein FliZ activates expression of hilA by controlling HilD activity. Thus, FliZ serves 
as an important link between SPI1 and the flagellar regulon. We define a subset of the 
SPI1 regulatory network that works through FliZ, thus integrating the regulation of 
Salmonella invasion and motility in response to a complex environment within the host. 
6.1 Introduction 
During infection, Salmonella Typhimurium is capable of inducing inflammatory 
diarrhea and invading non-phagocytic epithelial cells using the Type III Secretion System 
(T3SS) encoded by Salmonella Pathogenicity Island 1 (SPI1) (71,218,228,232). The SPI1 
T3SS forms a needle-like structure capable of injecting bacterial effector proteins into the 
host cell cytosol. A subset of these proteins is required to promote actin cytoskeletal 
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rearrangements leading to the engulfment of the bacteria. The SPI1 locus encodes 
proteins for the assembly of the functional T3SS apparatus, a number of secreted 
effectors, and several regulators. Structural genes and several effector proteins are 
encoded in prg/org, inv/spa, and sic/sip operons, while other effectors are encoded 
elsewhere on the chromosome. HilA, a master regulator of SPI1, directly activates 
expression of the prg/org and the inv/spa operons, the latter encoding the AraC-like 
regulator InvF (8,37,45,136). InvF, in complex with SicA, then activates expression of 
number of genes encoding secreted effectors including the sic/sip operon, sopE, and sigD 
(39,40).  
Three AraC-like regulators HilD, HilC, and RtsA induce expression of HilA 
leading to the full induction of the SPI1system. While HilD and HilC are encoded in SPI1 
locus (156), RtsA is encoded on a 15 kb island inserted in Salmonella chromosome at 
tRNAPheU (50). Each of these regulators is capable of inducing expression of hilD, hilC, 
and rtsA genes forming a complex feed-forward regulatory loop to control SPI1 
expression (see Fig. 6.1) (48). Studies by Olekhnovich and Kadner (171-173) showed 
that HilD, HilC and RtsA bind to similar sites within the hilD, hilC, rtsA and hilA 
promoter regions, and counteract Hns/Hha silencing. HilD is a dominant regulator of the 
system, while HilC and RtsA work as amplifiers of the signal (48). The whole system 
works as a switch to turn SPI1 on. The switch is controlled primarily by affecting the 
threshold of HilD required for autoactivation (191).  
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The regulatory circuit is tightly controlled, and numerous regulators as well as 
many environmental conditions have been implicated in the regulation of hilA (Table 6.1). 
These external regulatory inputs presumably ensure that SPI1 is only expressed in the 
appropriate conditions within the host.  
Table 6.1 A List of regulatory factors controlling expression of SPI1 with references 
supporting the proposed mechanism. 
Regulator Mechanism of action/comments References 
HilA 
Direct activation of prg/org and 
inv/spa operons (8,37,45,135,136) 
HilD 
Direct activation of hilA, hilD, hilC, 
and rtsA (48,195) 
HilC 
Direct activation of hilA, hilD, hilC, 
and rtsA (47,48,103,195) 
RtsA 
Direct activation of hilA, hilD, hilC, 
and rtsA (48,50) 
HilE 
Repression of hilA by binding to and 
preventing HilD function 
(14);Ellermeier JR (unpublished) 
FliZ 
Activation of hilA via post-
translational regulation of HilD 
(29,100,132,139,221) 
EnvZ/OmpR Activation of hilA via HilD (48,138);Ellermeier JR 
(unpublished) 
FadD 
Activation of hilA via an unknown 
mechanism 
(139);Ellermeier JR (unpublished) 
SirA 
Activation of hilA via activation of 
csrBC to block CsrA repression of 
hilD 
(2,48,103,125,215,221);Ellermeier 
JR (unpublished) 
Dam 
Activation of hilA via post-
transcriptional regulation of hilD (134)  
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Table 6.1 (cont.) 
Regulator Mechanism of action/comments References 
Ack Pta 
Activation of hilA via an unknown 
mechanism by formate 
(93) 
YfgL 
Activation of hilA via an unknown 
mechanism 
(3,58) 
Fnr 
Repression of hilA via an unknown 
mechanism 
(221);Ellermeier JR (unpublished) 
PhoPQ 
(PhoQ24) 
Direct repression of hilA (9,13,17,175,250);Ellermeier JR 
(unpublished) 
Hns 
Direct repression of hilA, hilC, hilD 
and rtsA (172,173,197) 
Hha 
Direct repression of hilA, hilC, hilD 
and rtsA (55,172,173,221) 
Fis 
Activation of hilA; exact mechanism 
unclear 
(110,196,236) 
HU Activation of hilA (196) 
RfaH 
Activation of hilA via unknown 
mechanism 
(159) 
Fur 
Activation of hilA via unknown 
regulation of HilD 
(53) 
TdcA Activation of hilA through FliZ (113) 
FlhDC 
Activation of hilA via activation of 
fliZ 
(29,132) 
DsbA 
Activation of hilA via activation of 
FliZ, and repression of RcsCDB 
(51,132) 
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Table 6.1 (cont.) 
Regulator Mechanism of action/comments References 
RcsCDB 
Repression of hilA via repression of 
FliZ and an unknown regulation of 
HilD 
(132) 
Lon 
Repression of hilA via degradation of 
HilD, HilC, and FliZ 
(20,29,213,214) 
ClpXP Repression via FliZ (107) 
FimZY 
Repression of hilA via activation of 
hilE (15) 
Mlc 
Repression of hilA via activation of 
hilE 
(131) 
CpxA 
Activation of hilA via unknown 
mechanism, apparently independent 
of CpxR 
(160) 
Lrp 
Overproduction of Lrp represses hilA 
via unknown mechanism 
(7) 
PmrM 
Activation of hilA via unknown 
mechanism 
(143,158,221) 
ApaH/YgdP 
Repression of invasion via unknown 
mechanism 
(99) 
PhoBR Repression of hilA via PhoBR (139) 
Dimethyl 
sulfide/ 
DMSO 
Repression of hilA via unknown 
mechanism 
(4) 
Temperature 
Activation of hilA when shifted from 
25-37C 
(174) 
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Table 6.1 (cont.) 
Regulator Mechanism of action/comments References 
Butyrate 
Repression of hilA via unknown 
mechanism 
(73) 
ppGpp 
Activation of hilA via an unknown 
mechanism 
(177,204,217);Ellermeier JR 
(unpublished) 
Bile Repression of hilA via SirA (180,181) 
Formate Activation of hilA ( see Ack Pta) (93) 
Propanediol 
Repression of hilA via unknown 
mechanism 
(162) 
 
Salmonella Typhimurium produces peritrichous flagella required for motility, 
which are secreted and assembled via a distinct T3SS. The flagellar regulon contains 
more than 60 genes grouped into classes according to their transcriptional hierarchy (67). 
Class I consists of the flhDC master regulon, which encodes the FlhD4C2 transcriptional 
activator. The FlhD4C2 activates class II genes that encode proteins required for the 
assembly of the flagellar hook-basal body, and also the alternative sigma factor FliA, and 
the anti-sigma factor FlgM. FlgM binds to FliA and prevents its activity. Upon 
completion of the hook-basal body, FlgM is secreted freeing FliA, which activates class 
III operons that encode flagellin subunits and motor proteins (170). FliZ, encoded in an 
operon with fliA, is an enhancer of the class II flagellar genes expression, which in 
Salmonella was suggested to regulate FlhD4C2 post-translationally (95,190). FliZ 
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positively regulates hilA expression (46,100,139) thus serving as a connection between 
the flagellar and SPI1 systems. 
As a result of this study, we have grouped the known regulators of SPI1 into 
distinct classes based on their point of integration into the regulatory circuit. Our data 
provides supporting evidence for the feed-forward loop model of SPI1 regulation, and 
gives insights into the mechanism of action of individual regulators. The majority of SPI1 
regulators control HilD post-transcriptionally (Class I, II, V), consistent with the idea that 
HilD acts as a point of integration of regulatory signals. Class III and Class IV regulators 
control the system at the level of hilA or affect promoters of all genes in the feed-forward 
loop, respectively. We also define a subset of the known SPI1 regulators that regulates 
the system via FliZ. 
 6.2 Results 
Recent studies of the mechanism of SPI1 regulation suggest that the majority of 
SPI1 regulators integrate into the regulatory circuit via HilD. To test this hypothesis, we 
utilized a series of genetic tests that allowed us to determine whether the regulatory 
mutations or environmental conditions affecting hilA expression do so via HilD, as well 
as group these regulatory factors into distinct classes based on their point of integration 
into the SPI1 regulatory circuit. The features of the genetic constructs used in this study 
are discussed below.  
First, we tested whether each regulatory factor affected hilA expression under the 
indicated growth conditions. The details of the growth conditions used for each regulator 
can be found in Table 6.3. A hilA-lac (pDX1) transcriptional single copy chromosomal 
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fusion was used to monitor hilA transcription. The effect of each regulator on hilA 
expression in a wild type and in a hilD null background was determined. 
 A caveat of studying the effects of different regulatory mutations/conditions in a 
hilD null background is that hilA expression is greatly reduced in the absence of HilD 
(Fig. 6.2A), with SPI1 being effectively shut off. Thus, the effects of various regulatory 
mutations on hilA expression in hilD null background cannot be accurately determined. 
Therefore, we employed a different construct to determine whether the regulatory factors 
acted via HilD, or independently of HilD to regulate hilA. To overcome the problem of 
the low hilA expression in the absence of HilD, we control rtsA expression by 
tetracycline in a tetRA-rtsA strain, which allows us to induce rtsA, with concomitant 
induction of hilA (and hilC) expression, independently of HilD. In a hilD null background, 
addition of the 1 µg/mL tetracycline results in a level of hilA-lac expression comparable 
to that of the wild type strain. Under these conditions we can clearly see if a mutation of 
interest has an effect on hilA expression in the absence of HilD.  
Third, the effect of the regulatory mutation/condition on hilD transcription and 
translation was studied using a hilD-lac transcriptional and hilD’-‘lac translational 
fusions, respectively.  Both hilD fusions were constructed in the hilD locus in Salmonella 
chromosome, and thus these strains are hilD null. This property of the hilD fusion 
constructs allows us to monitor transcription and translation of hilD without the 
complication of autoinduction.  
For the experiments described in this chapter we routinely grew bacterial cultures 
in standard SPI1 inducing conditions. Bacteria were initially inoculated into LB (0.5% 
97 
 
NaCl), grown for 8-12 hours, then subcultured 1/100 and grown statically for 18-22 hours 
in 3 ml of LB with 1% NaCl (high salt LB, HSLB) in a 13 x 100 mm tubes. Where 
indicated, LB or NSLB (LB without NaCl) were used. 
The effects of various regulatory mutations and environmental conditions on SPI1, 
studied using the fusion constructs outlined above, are discussed in detail in the Results 
section and summarized in Table 6.2. Based on the patterns of regulation observed in 
each case we have assigned these regulators to different classes (also, see Table 6.2). 
Described below are the examples of each class of regulators; the remaining data are 
available in the Supplementary material section. 
Class I: Regulation at the level of HilD protein 
Class I includes regulators that apparently function through HilD protein to affect 
hilA expression. HilE is a negative regulator of SPI1 that has been shown to directly 
interact with the HilD protein ((14);Chubiz (unpublished). Thus, it serves as a positive 
control in the following experiments.  
Deletion of hilE resulted in a 4-fold activation of the transcriptional hilA-lac 
fusion (Fig. 6.2A), while it had no effect in a hilD null background, suggesting that HilE 
regulates hilA via HilD. However, the absence of HilD resulted in a very low level of hilA 
expression. Therefore, it remained possible that HilE functions downstream of HilD, for 
example at the hilA promoter, but that this regulation is not evident in the hilD null 
background. To distinguish whether HilE regulates hilA via HilD or independently of 
HilD, we induced hilA (and hilC) transcription in the absence of HilD by the addition of 
increasing concentrations of tetracycline in a tetRA-rtsA background. If HilE controls 
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hilA expression via HilD, we should not see the effect of a hilE deletion in a hilD null 
background. In the hilD+ strain in the absence of tetracycline, we observed a slight 
decrease in hilA-lac transcription in the tetRA-rtsA strain, which corresponds to loss of 
RtsA. Loss of HilE caused a 7.5-fold increase in hilA transcription under these hilD+ 
conditions. Moreover, at higher Tet concentrations HilE-dependent regulation was 
evident when HilD was present (Fig. 6.2B), although regulation became less dramatic. 
This is consistent with the proposed interaction of the HilE and HilD proteins, when not 
enough HilE is available to bind the overproduced HilD. In the absence of HilD, at 
1µg/mL tetracycline, hilA-lac expression reached the level observed in the wild type 
strain (compare with Fig. 6.2A). But under these conditions, deletion of hilE had no 
effect on tetRA-rtsA driven hilA expression in the absence of HilD. This result confirms 
that HilE works through HilD, which is consistent with the published data (14).  
In theory, HilE could regulate hilA expression by controlling transcription or 
translation of hilD. If this was true, we would expect the loss of HilE to have an effect on 
the hilD-lac transcriptional and/or hilD’-‘lac translational fusion (both are located at the 
hilD locus, and are hilD nulls). However, the absence of HilE had no effect on the hilD-
lac transcriptional and hilD’-‘lac translational fusions, showing that the presence of the 
functional HilD protein is required for regulation (Fig. 6.2C). These results are consistent 
with the known mechanism of HilE acting at the level of HilD protein. This set of 
experiments was performed for all of the regulatory factors tested, and the resulting data 
are summarized in Table 6.4.  
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The flagellar protein FliZ have been shown to positively regulate hilA expression. 
Deletion of FliZ causes a 4-fold decrease in hilA expression (Fig. 6.3A) with no apparent 
effect observed in the hilD null background.  
As expected, deletion of HilD in the tetRA-rtsA strain results in drastic reduction 
of hilA-lac transcription without tetracycline (Fig. 6.3B). Increasing concentrations of 
tetracycline allowed for an approximately wild type level of hilA induction in the absence 
of HilD. Deletion of FliZ in this background at 1 µg/mL tetracycline concentration had 
no effect on hilA-lac expression (Fig 6.3B). This result is consistent with the hypothesis 
that FliZ regulates hilA via HilD. Absence of FliZ-dependent regulation of hilD 
transcriptional and translational locus fusions also showed that FliZ controls hilA 
expression at the level of HilD protein (Fig. 6.3C). Other regulators belonging to this 
group include EnvZ and FadD with the supporting data available in the Supplementary 
Material section (Fig. S6.1. and Fig. S6.2., respectively). Possibility exists that FliZ, 
EnvZ, and FadD affect hilA expression via HilE, but published and unpublished data 
show that these regulators act independently of HilE ((29); Ellermeier (unpublished 
data)). 
Class II: Control of HilD mRNA stability/degradation or translation initiation 
Class II regulators function through HilD to control hilA expression, but do so by 
controlling hilD message stability or translation. SirA is a known positive regulator of 
SPI1 that functions through the csrABC system to control the stability of the HilD mRNA 
transcript ((2,48,103,125,215,221); Ellermeier (unpublished)). Deletion of sirA resulted 
in a 3-fold decrease of hilA transcription (Fig. 6.4A). Fig. 6.4B shows that while the sirA 
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deletion decreased hilA expression in the presence of HilD, it had no effect on the hilA 
expression when HilD was absent, when hilA was being activated by the tetRA-rtsA 
construct at 1µg/mL tetracycline concentration. This result showed that SirA controls 
hilA via HilD. In striking contrast to Class I, both the hilD-lac transcriptional and the 
hilD’-‘lac translational fusions were regulated by SirA in the absence of HilD protein 
(Fig. 6.4C). While the transcriptional hilD fusion was also regulated, we know that SirA 
indirectly prevents activity of the CsrA, which binds to hilD mRNA, Thus, SirA 
functions through HilD, and acts at the level of hilD mRNA. Other regulators belonging 
to Class II include Dam, YfgL, and Ack Pta (see Figures S6.3, S6.4, S6.5). 
Class III: Regulation at the level of hilA promoter 
The two-component regulatory system PhoPQ belongs to the Class III regulators, 
which do not require the presence of the functional HilD protein and work at the level of 
the hilA promoter. Deletion of phoP does not have a significant effect on hilA expression 
in HSLB medium. In these experiments, we are using the phoQ24 constitutive mutation 
which results in a hyperphosphorylation of the PhoP response regulator (111,154,226), 
and a decrease of the hilA-lac expression in HSLB. Introduction of the phoQ24 
constitutive allele caused a 10-fold reduction of hilA transcription (Fig. 6.5A). In the 
tetRA-rtsA strain, the phoQ24 mutation caused a decrease in hilA expression regardless of 
the presence or absence of HilD (Fig. 6.5B). Thus, the phoQ24 effect on hilA expression 
is independent of HilD. Results in Figure 6.5C showed that the hilD-lac transcriptional 
and the hilD’-‘lac translational fusions were not regulated in phoQ24 background 
indicating that the PhoPQ system does not affect hilD transcription of translation.  
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Dimethyl sulfide (DMS) had recently been shown to inhibit hilA expression, and 
we saw a 2.5-fold decrease in hilA expression in the presence of the 1.5 % DMS (Fig. 
6.6A). At 1 µg/mL tetracycline concentration, the addition of DMS also inhibited hilA 
transcription in hilD null background (Fig. 6.6B). This result showed that DMS inhibits 
hilA independently of HilD. Similarly to our phoQ24 result, the addition of DMS had no 
effect on the hilD-lac transcriptional and the hilD’-‘lac translational fusions indicating 
that DMS does not regulate HilD. We have also tested whether DMS works through HilC 
or RtsA, and the resulting data showed that DMS acts independently of HilC or RtsA 
(data not shown). This result confirmed that DMS acts at the level of hilA. 
Class IV: Regulation independent of HilD 
This class is comprised of a number of regulators and environmental conditions 
that control hilA expression independently of HilD. For example, the small nucleoid 
proteins Hns and Hha have been shown to directly bind to the promoter regions and 
silence transcription of SPI1 genes including hilD, hilC, rtsA, and hilA. Deletion of hha 
caused a 3.5-fold increase in hilA transcription as expected (Fig. 6.7A). This increase was 
also evident in the hilD null strain, also the absolute level of expression was decreased. 
With hilA expression driven by increasing concentrations of tetracycline in tetRA-rtsA 
strain, loss of Hha still resulted in hilA induction (Fig. 6.7B). Deleting hilD in this strain 
did not abolish the Hha regulation showing that Hha acts independently of HilD. Not 
surprisingly, the hilD-lac transcriptional and translational fusions were also regulated by 
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Hha (Fig. 6.7C). Thus, we conclude that Hha does not require HilD protein, but rather 
regulates both hilA and hilD (as well as hilC and rtsA) transcription.  
  In Figures S 6.6 and S 6.7 we showed that nucleoid proteins Fis and HU also 
work independently of HilD. In addition to nucleoid proteins, the RfaH and RelA SpoT 
deletion mutations, as well as the presence of butyrate, resulted in similar expression 
profiles (Fig. S 6.8, S 6.9, S 6.10). Changes in temperature likely affect hilA 
independently of HilD, with Hns implicated in this regulation (174). Whether some of 
these factors and conditions function through Hns/Hha remains to be determined. 
Class V: Regulation by Fur 
  Global transcriptional regulator Fur has been placed in a separate class V (for data 
see Fig. S 6.11) due to the fact that Fur requires both the HilD protein and hilD promoter 
to regulate hilA  (53), while it also affects Hns levels. Thus, Fur regulates hilA expression 
by affecting HilD ability to activate its own transcription.  
  We are not presenting results for the some of the regulators listed in Table 6.1 due 
to the fact that the phenotypes of these mutations/conditions (fimZY, mlc, lrp, pmrM, 
cpxA, ygdP, mitomycin, hydrogen peroxide) were not robust enough to be tested in the 
conditions and setup we used.  
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Table 6.2 Integration of regulators and conditions that affect hilA expression into 
SPI1 regulatory circuit. 
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I HilE HSLB - 4x ↑  yes no no 
 FliZ HSLB + 4x ↓     
 EnvZ HSLB + 3.5x ↓    
 FadD HSLB + 3x ↓    
        
IIa SirA HSLB + 3x ↓ yes yes yes 
 Dam HSLB + 5x ↓    
IIb 
Ack Pta 
(formate) 
HSLB 
pH6.0 
(MOPS), 
+ 2x ↓ yes no yes 
 YfgL HSLB + 5x ↓    
        
III 
PhoPQ 
(phoQ24) 
HSLB - 10x ↓ no no no 
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Table 6.2 (cont.) 
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III 
Dimethyl 
sulfide 
HSLB 
DMS 
- 2.5x ↓ no no no 
        
IV H-NS NSLB - ↑    
 Hha HSLB - 3.5x ↑ no yes yes 
 Fis HSLB + 15x ↓    
 HU HSLB + 4.7x ↓    
 RfaH HSLB + 4x ↓    
 Temperature 
HSLB , 
RT/37oC 
+ 2.5x ↑    
 
 
Butyrate 
 
 
HSLB, 
10mM 
butyrate 
- 3x ↓    
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Table 6.2 (cont.) 
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IV 
ppGpp 
(relA spoT) 
HSLB + 22x ↓ no yes yes 
        
V Fur HSLB + 5x ↓ yes no yes 
 
Regulation via FliZ 
Some of the environmental cues that regulate SPI1 also affect the flagellar 
regulon in Salmonella. Analysis of the published transcriptomic datasets revealed that 
SPI1 and flagellar genes are co-regulated in response to a number of regulatory signals 
(Table 6.3). 
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Table 6.3 Transcriptomic datasets that reveal co-regulation of SPI 1 and flagellar genes 
in Salmonella Typhimurium.  
Global response to a 
regulatory system or specific 
environmental stimuli 
References 
 
via FliZ 
Class of SPI1 
regulators 
Macrophage (54) (NA)  
CsrA (124) no II 
Antimicrobial peptides (5) (NA)  
Bile (180) no  
Swarming (230) (NA)  
Fis (110) no IV 
RfaH (159) no  
YfgL (58) no II 
Fnr (64) no  
Hydrogen peroxide (68) (NA)  
 
 
 The flagellar protein FliZ, controlled by FlhDC, activates expression of hilA 
suggesting that FliZ serves as an important link between SPI1 and the flagellar regulon. 
We utilized the genetic approach to determine what subset of the known SPI1 regulators 
works through FliZ, with FliZ entering the SPI1 regulatory circuit at the level of HilD. 
The hilA-lac transcriptional fusion was used to monitor hilA expression in various mutant 
backgrounds. We have characterized the effect of loss of the known SPI1 regulators (see 
Table 6.1) on hilA expression in otherwise wild type, hilD null and fliZ null backgrounds. 
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If the regulator of interest controls hilA via FliZ, loss of this regulator would no longer 
affect hilA expression in the absence of FliZ. We also tested the effect of the regulatory 
mutations/conditions in the strain where FliZ is expressed independently of FlhDC. 
FlhDC activates fliZ, and deletion of flhDC would behave as a fliZ deletion. Placing fliZ 
under the control of the tetRA promoter allowed us to induce fliZ by adding tetracycline 
to the medium. At 0.1 µg/mL tetracycline concentration the observed level of hilA 
expression in the flhDC null background approximately corresponds to that in a wild type 
background (Fig. 6.8). In these conditions, we would expect the FliZ-dependent 
regulators to have no effect on hilA expression.  
Several regulators that include FlhDC and RcsCDB have been shown to regulate 
hilA via FliZ (29,132). In addition, proteases ClpXP and Lon were shown to affect hilA 
expression via FliZ (29,107). We have tested the effect of loss of FlhDC on hilA 
expression in the fliZ null and wild type background. Since FlhDC is required for FliZ 
production, we would expect the deletion of flhDC to have no effect on hilA transcription 
in the absence of FliZ. Results in Figure 6.8 showed that hilA expression was decreased 
5-fold in the absence of FliZ. Deletion of flhDC had no effect on hilA expression in this 
background, confirming that FlhDC acts via FliZ to affect hilA expression, and serving as 
a positive control in these experiments. TdcA has been suggested to regulate SPI1 via 
FliZ (113). The authors reported that the deletion of tdcA, which resulted in less than a 2-
fold decrease of fliZ expression, also negatively affected expression of hilA. We saw a 
similar decrease of fliZ expression when the tdcA mutation was introduced (Fig. S6.15). 
However, loss of TdcA still caused a decrease in hilA transcription in the absence of FliZ. 
Deletion of tdcA also had an effect on hilA expression when fliZ production was 
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controlled by tetracycline. These results suggested that while TdcA regulated fliZ 
transcription, its effect on hilA expression was independent of FliZ. 
HilE is a known negative regulator of hilA, which works at the level of HilD 
protein independently of FliZ (29).  Deletion of hilE induced hilA transcription 4.5-fold. 
The effect of the hilE deletion was independent of FliZ, since loss of HilE induced hilA 
expression in the fliZ null background, as expected (Fig. 6.8). Very low level of hilA 
expression was observed in the hilD null background. Loss of HilE still had an effect on 
hilA expression when fliZ production was controlled by tetracycline, which confirmed 
that HilE functions independently of FliZ to control hilA expression. These results are 
consistent with the previously published data (29) and serve as a control for this set of 
experiments.  Based on our classification of SPI1 regulators we would expect that only 
the rest of Class I regulators can possibly function via FliZ. We wanted to determine 
whether the rest of Class I regulators (EnvZ, FadD) controlled hilA expression via FliZ. 
The resulting data (Fig. S6.16, S6.17) showed that EnvZ and FadD regulate hilA 
independently of FliZ. The regulators in other classes were tested in the same set of 
experiments (Fig. S6.18- S6.30), and Table 6.3 contains some of the results obtained in 
this experimental setup in the via FliZ column. The Class II-V regulators regulated hilA 
independently of FliZ, as expected. 
6.3 Discussion 
Previously published data from our lab led to the development of the feed-forward 
model of SPI1 regulation where HilD, HilC and RtsA activate the hilD, hilC and rtsA 
genes, and also activate the master regulator HilA (Fig. 6.1). HilD is the predominant 
regulator of the system while HilC and RtsA act as amplifiers of the regulatory signals 
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(48). For years, numerous regulatory systems and conditions have been added to the 
growing list of factors that affect SPI1 expression. In this study we characterize a 
hierarchy of regulatory effects that are involved in control of SPI1 expression. In 
agreement with the feed-forward loop model, we show that the majority of the known 
SPI1 regulators feed into the regulatory circuit via HilD, with the exception of the Class 
III and the Class IV regulators. Based on previously published (14,48,53,132)  and 
unpublished (Ellermeier JE) data we hypothesized that the majority of regulators would 
require a functional HilD protein to affect the SPI1system. However, our study shows 
that the regulation of SPI1 is more complex, where control is exerted at multiple levels.  
 First, Class I regulators work at the level of HilD protein, presumably controlling 
some aspect of HilD protein activity and/or stability. One of these, HilE, is a negative 
regulator of SPI1 that was shown to bind HilD protein ((14); Chubiz (unpublished 
results)). We have recently reported on the function of a positive regulator FliZ that acts 
by controlling HilD protein activity (29). Although the exact mechanism of action of 
EnvZ and FadD has not been elucidated, they also work at the level of HilD protein and 
likely affect some aspect of HilD protein function.  
 Class II regulators include those that affect hilD mRNA stability/degradation or 
translation. The mechanism of regulation by SirA involves activation of csrB and csrC 
RNAs that antagonize the action of CsrA. CsrA protein binding to hilD mRNA affecs 
stability, or prevent translation of the hilD message. Thus, SirA activates activates hilD 
expression post-transcriptionally. Our data on SirA regulation are in agreement with the 
published mechanism. A recent publication studying the effect of Dam on invasion gene 
expression showed that hilD mRNA levels were affected by the absence of Dam. Again, 
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our results correlate well with the published data. The deletion mutations of the YfgL, 
and Ack Pta have resulted in similar patterns of expression in our fusion strains, 
suggesting that these regulators control hilD post-transcriptionally. The details of this 
regulation remain to be elucidated. 
 PhoPQ, the two-component regulatory system shown to negatively affect SPI1, 
and classified as Class III, was the only global regulator to act directly at the hilA 
promoter. A putative PhoP binding site in hilA promoter region was predicted 
computationally by Zwir et al. (250). However, the direct repression by PhoP still awaits 
experimental confirmation. The activation of the SPI1 system is very complex to ensure 
that the system is fully turned on in the precise location in the small intestine to optimize 
invasion. The PhoPQ system is activated when Salmonella adapts to the intracellular 
environment of the macrophage (76), and SPI1 is no longer needed. Negative control by 
the PhoPQ system could allow for the fast turn off of SPI1 expression directly at the level 
of hilA in the systemic stage of infection.  
 The presence of DMSO-reductases in intestinal bacteria, and the fact that 
dimethyl sulfide (the product of DMSO reduction) occurs in the intestine of mammals, 
suggest that this compound can serve as environmental cue for Salmonella (4). However, 
a role for DMS during Salmonella infection has not been demonstrated. Antunes et al. (4) 
reported that DMS decreased expression of hilA, as well as of a number of downstream 
SPI1 genes. But the point of integration of this signal in the SPI1 regulatory circuit was 
not characterized. Our data suggest that dimethyl sulfide inhibits SPI1 expression at the 
level of hilA, perhaps providing a mechanism for the shut-off of the SPI1 system in 
conditions inappropriate for invasion.  
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 Nucleoid proteins Hns and Hha repress transcription by binding to the promoter 
regions of all SPI1 genes in feed-forward loop. Likewise, we show that nucleoid proteins 
Fis and HU fall into the same class with Hns and Hha, acting independently of HilD by 
presumably affecting all promoters in the system. Interestingly, other than nucleoid 
proteins, few other regulators and environmental conditions have been shown to belong 
to Class IV, including RfaH, temperature, butyrate, and ppGpp. The effect of these 
regulatory mutations on SPI1 is possibly indirect, and further studies are warranted to 
determine whether they function through Hns/Hha or Fis/HU. 
 A subset of regulators enters the circuit via FliZ, which in turn acts at the level of 
HilD protein. These regulators include previously published FlhDC that is required for 
activation of FliZ, and RcsCDB (29,132). TdcA has also been suggested to regulate SPI1 
via FliZ (113). However, our results suggested that while TdcA regulated fliZ 
transcription, its effect on hilA expression was independent of FliZ.  We also recently 
published a study showing that Lon protease affects SPI1 expression primarily via FliZ 
(29). Co-regulation of the SPI1 and flagellar genes that has been reported in a number of 
conditions (see Table 6.4), suggesting an overlap in the two regulatory systems.  
 We have tested whether any of the other SPI1 regulators worked through FliZ. 
Based on our classification of SPI1 regulators we would expect that the rest of Class I can 
possibly function via FliZ. However, we showed that HilE, EnvZ, and FadD regulate 
SPI1 independently of FliZ. The Class II-V regulators also work independently of FliZ, 
as expected. These results suggest that only a limited fraction of the overall regulatory 
input into SPI1 is FliZ-dependent. The reason for coordination of expression of the 
flagellar genes and the SPI1 genes during infection in the host is not completely 
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understood. FliZ has been shown to play a role in Salmonella virulence, and the observed 
virulence phenotype is partially dependent on SPI1 (29). Induction of the flagellar 
regulon might help Salmonella to colonize the intestine of the host (208). Flagellin 
related inflammation was also shown to be beneficial for Salmonella during infection 
(209).  
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6.4 Figures 
 
HilC
HilD
RtsA
HilA
HilE
FlhDC FliZRcsCDB
BarA/SirA
CsrA
CsrBC
VARIOUS REGULATORS
Effectors InvF/SicA
SPI1 TTS 
Apparatus
inv/spa 
prg /org
sic/sip 
?
 
Direct Regulation
Unknown Mechanism
Transcriptional
Post-translational
Post-transcriptional
Activation Repression  
Figure 6.1 A working model for SPI1 Regulation. Blue lines indicate transcriptional 
regulation.  Red lines indicate post-transcriptional regulation.  Green lines represent post-
translational regulation.  Activation is noted by lines with arrows at the ends.  Repression 
is noted as lines with blunt ends.  Solid lines represent direct regulation.  Short-dashed 
lines represent regulation that is not known to be direct or indirect.  For clarity, the genes 
encoding SPI1 regulators are not shown.   
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Figure 6.2 Example of the Class I regulator that works at the level of HilD protein:  HilE 
represses hilA expression via HilD.  
A. β-galactosidase activity in strains containing a hilA-lac transcriptional fusion and the 
indicated mutations after growth under SPI1 inducing conditions.  B. β-galactosidase 
activity of strains containing a hilA-lac transcriptional fusion and indicated mutations 
with rtsA under the control of a tetracycline regulated promoter.  Strains were grown 
under SPI1-inducing conditions with the indicated tetracycline concentrations.  C. β-
galactosidase activity in strains containing a hilD-lac transcriptional or a hilD’-’lac 
translational fusion and the indicated mutations after growth under SPI1 inducing 
conditions. β-galactosidase activity units are defined as (μmol of ONP formed min-1) x 
103/(OD600 x ml of cell suspension) and are reported as mean ± standard deviation 
where n=4. 
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Figure 6.3 Example of the Class I regulator that works at the level of HilD protein:  FliZ 
activates hilA-lac expression via HilD. 
A. β-galactosidase activity in strains containing a hilA-lac transcriptional fusion and the 
indicated mutations after growth under SPI1 inducing conditions.  B. β-galactosidase 
activity of strains containing a hilA-lac transcriptional fusion and indicated mutations 
with rtsA under the control of a tetracycline regulated promoter.  Strains were grown 
under SPI1-inducing conditions with the indicated tetracycline concentrations.  C. β-
galactosidase activity in strains containing a hilD-lac transcriptional or a hilD’-’lac 
translational fusion and the indicated mutations after growth under SPI1 inducing 
conditions. β-galactosidase activity units are defined as (μmol of ONP formed min-1) x 
103/(OD600 x ml of cell suspension) and are reported as mean ± standard deviation 
where n=4. Data in panels 6.3A. and 6.3B were recently published in (29). 
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Figure 6.4 Example of the Class II regulator that affects hilD post-transcriptionally:  
SirA activates hilA expression via HilD. 
A. β-galactosidase activity in strains containing a hilA-lac transcriptional fusion and the 
indicated mutations after growth under SPI1 inducing conditions.  B. β-galactosidase 
activity of strains containing a hilA-lac transcriptional fusion and indicated mutations 
with rtsA under the control of a tetracycline regulated promoter.  Strains were grown 
under SPI1-inducing conditions with the indicated tetracycline concentrations.  C. β-
galactosidase activity in strains containing a hilD-lac transcriptional or a hilD’-’lac 
translational fusion and the indicated mutations after growth under SPI1 inducing 
conditions. β-galactosidase activity units are defined as (μmol of ONP formed min-1) x 
103/(OD600 x ml of cell suspension) and are reported as mean ± standard deviation 
where n=4. 
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Figure 6.5 Example of the Class III regulator that functions independently of HilD at the 
level of HilA: PhoQ24 represses hilA expression. 
A. β-galactosidase activity in strains containing a hilA-lac transcriptional fusion and the 
indicated mutations after growth under SPI1 inducing conditions.  B. β-galactosidase 
activity of strains containing a hilA-lac transcriptional fusion and indicated mutations 
with rtsA under the control of a tetracycline regulated promoter.  Strains were grown 
under SPI1-inducing conditions with the indicated tetracycline concentrations.  C. β-
galactosidase activity in strains containing a hilD-lac transcriptional or a hilD’-’lac 
translational fusion and the indicated mutations after growth under SPI1 inducing 
conditions. β-galactosidase activity units are defined as (μmol of ONP formed min-1) x 
103/(OD600 x ml of cell suspension) and are reported as mean ± standard deviation 
where n=4. 
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Figure 6.6 Example of the Class III regulator that functions independently of HilD at the 
level of HilA: DMS represses hilA expression. 
A. β-galactosidase activity in strains containing a hilA-lac transcriptional fusion and the 
indicated mutations after growth under SPI1 inducing conditions.  B. β-galactosidase 
activity of strains containing a hilA-lac transcriptional fusion and indicated mutations 
with rtsA under the control of a tetracycline regulated promoter.  Strains were grown 
under SPI1-inducing conditions with the indicated tetracycline concentrations.  C. β-
galactosidase activity in strains containing a hilD-lac transcriptional or a hilD’-’lac 
translational fusion and the indicated mutations after growth under SPI1 inducing 
conditions. β-galactosidase activity units are defined as (μmol of ONP formed min-1) x 
103/(OD600 x ml of cell suspension) and are reported as mean ± standard deviation 
where n=4. 
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Figure 6.7 Example of class IV regulator that affects SPI1 expression independently of 
HilD (affects all regulators in the feed-forward loop):  Hha represses hilA expression.   
A. β-galactosidase activity in strains containing a hilA-lac transcriptional fusion and the 
indicated mutations after growth under SPI1 inducing conditions.  B. β-galactosidase 
activity of strains containing a hilA-lac transcriptional fusion and indicated mutations 
with rtsA under the control of a tetracycline regulated promoter.  Strains were grown 
under SPI1-inducing conditions with the indicated tetracycline concentrations.  C. β-
galactosidase activity in strains containing a hilD-lac transcriptional or a hilD’-’lac 
translational fusion and the indicated mutations after growth under SPI1 inducing 
conditions. β-galactosidase activity units are defined as (μmol of ONP formed min-1) x 
103/(OD600 x ml of cell suspension) and are reported as mean ± standard deviation 
where n=4. 
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Figure 6.8 FlhDC controls hilA expression via FliZ; HilE and FliZ affect hilA expression 
independently of each other. β-galactosidase activity in strains containing a hilA-lac 
transcriptional fusion and the indicated mutations after growth under SPI1 inducing 
conditions. β-galactosidase activity units are defined as (μmol of ONP formed min-1) x 
103/(OD600 x ml of cell suspension) and are reported as mean ± standard deviation 
where n=4. 
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6.5 Supplementary figures 
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Figure S6.1 Example of the Class I regulator that works at the level of HilD protein:  
EnvZ activates hilA expression via HilD. 
A. β-galactosidase activity in strains containing a hilA-lac transcriptional fusion and the 
indicated mutations after growth under SPI1 inducing conditions.  B. β-galactosidase 
activity of strains containing a hilA-lac transcriptional fusion and indicated mutations 
with rtsA under the control of a tetracycline regulated promoter.  Strains were grown 
under SPI1-inducing conditions with the indicated tetracycline concentrations.  C. β-
galactosidase activity in strains containing a hilD-lac transcriptional or a hilD’-’lac 
translational fusion and the indicated mutations after growth under SPI1 inducing 
conditions. β-galactosidase activity units are defined as (μmol of ONP formed min-1) x 
103/(OD600 x ml of cell suspension) and are reported as mean ± standard deviation 
where n=4. 
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Figure S6.2 Example of the Class I regulator that works at the level of HilD protein:  
FadD activates hilA expression via HilD. 
A. β-galactosidase activity in strains containing a hilA-lac transcriptional fusion and the 
indicated mutations after growth under SPI1 inducing conditions.  B. β-galactosidase 
activity of strains containing a hilA-lac transcriptional fusion and indicated mutations 
with rtsA under the control of a tetracycline regulated promoter.  Strains were grown 
under SPI1-inducing conditions with the indicated tetracycline concentrations.  C. β-
galactosidase activity in strains containing a hilD-lac transcriptional or a hilD’-’lac 
translational fusion and the indicated mutations after growth under SPI1 inducing 
conditions. β-galactosidase activity units are defined as (μmol of ONP formed min-1) x 
103/(OD600 x ml of cell suspension) and are reported as mean ± standard deviation 
where n=4.  
 
 
 
123 
 
β-
ga
la
ct
os
id
as
e 
ac
tiv
ity
A B C
[Tet] µg/mL
hilA-lac hilD-lac hilD'-'lactetRA-rtsA hilA-lac
0
20
40
60
80
100
120
0 0.01 0.1 1
0
200
400
600
800
1000
1200
wt
dam
hilD
dam hilD
0
20
40
60
80
100
120
140
 
Figure S6.3 Example of the Class II regulator that affects hilD post-transcriptionally:  
Dam activates hilA expression via HilD. 
A. β-galactosidase activity in strains containing a hilA-lac transcriptional fusion and the 
indicated mutations after growth under SPI1 inducing conditions.  B. β-galactosidase 
activity of strains containing a hilA-lac transcriptional fusion and indicated mutations 
with rtsA under the control of a tetracycline regulated promoter.  Strains were grown 
under SPI1-inducing conditions with the indicated tetracycline concentrations.  C. β-
galactosidase activity in strains containing a hilD-lac transcriptional or a hilD’-’lac 
translational fusion and the indicated mutations after growth under SPI1 inducing 
conditions. β-galactosidase activity units are defined as (μmol of ONP formed min-1) x 
103/(OD600 x ml of cell suspension) and are reported as mean ± standard deviation 
where n=4. 
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Figure S6.4 Example of the Class II regulator that affects hilD post-transcriptionally:  
YfgL activates hilA expression via HilD. 
A. β-galactosidase activity in strains containing a hilA-lac transcriptional fusion and the 
indicated mutations after growth under SPI1 inducing conditions.  B. β-galactosidase 
activity of strains containing a hilA-lac transcriptional fusion and indicated mutations 
with rtsA under the control of a tetracycline regulated promoter.  Strains were grown 
under SPI1-inducing conditions with the indicated tetracycline concentrations.  C. β-
galactosidase activity in strains containing a hilD-lac transcriptional or a hilD’-’lac 
translational fusion and the indicated mutations after growth under SPI1 inducing 
conditions. β-galactosidase activity units are defined as (μmol of ONP formed min-1) x 
103/(OD600 x ml of cell suspension) and are reported as mean ± standard deviation 
where n=4. 
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Figure S6.5 Example of the Class II regulator that affects hilD post-transcriptionally:  
Ack Pta activates hilA expression via HilD. 
A. β-galactosidase activity in strains containing a hilA-lac transcriptional fusion and the 
indicated mutations after growth under SPI1 inducing conditions.  B. β-galactosidase 
activity of strains containing a hilA-lac transcriptional fusion and indicated mutations 
with rtsA under the control of a tetracycline regulated promoter.  Strains were grown 
under SPI1-inducing conditions with the indicated tetracycline concentrations.  C. β-
galactosidase activity in strains containing a hilD-lac transcriptional or a hilD’-’lac 
translational fusion and the indicated mutations after growth under SPI1 inducing 
conditions. β-galactosidase activity units are defined as (μmol of ONP formed min-1) x 
103/(OD600 x ml of cell suspension) and are reported as mean ± standard deviation 
where n=4. 
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Figure S6.6 Example of the Class III regulator that functions independently of HilD at 
the level of HilA: Fnr represses hilA expression.   
A. β-galactosidase activity in strains containing a hilA-lac transcriptional fusion and the 
indicated mutations after growth under SPI1 inducing conditions.  B. β-galactosidase 
activity of strains containing a hilA-lac transcriptional fusion and indicated mutations 
with rtsA under the control of a tetracycline regulated promoter.  Strains were grown 
under SPI1-inducing conditions with the indicated tetracycline concentrations.  C. β-
galactosidase activity in strains containing a hilD-lac transcriptional or a hilD’-’lac 
translational fusion and the indicated mutations after growth under SPI1 inducing 
conditions. β-galactosidase activity units are defined as (μmol of ONP formed min-1) x 
103/(OD600 x ml of cell suspension) and are reported as mean ± standard deviation 
where n=4. 
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Figure S6.7 Dimethyl sulfide represses hilA expression independently of HilC and RtsA. 
β-galactosidase activity in strains containing a hilA-lac transcriptional fusion and the 
indicated mutations after growth under SPI1 inducing conditions in the presence or 
absence of the 1.5% dimethyl sulfide. β-galactosidase activity units are defined as (μmol 
of ONP formed min-1) x 103/(OD600 x ml of cell suspension) and are reported as mean ± 
standard deviation where n=4. 
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Figure S6.8 Example of Class IV regulator that affects SPI1 expression independently of 
HilD (affects all regulators in the feed-forward loop):  Fis activates hilA expression.   
A. β-galactosidase activity in strains containing a hilA-lac transcriptional fusion and the 
indicated mutations after growth under SPI1 inducing conditions.  B. β-galactosidase 
activity of strains containing a hilA-lac transcriptional fusion and indicated mutations 
with rtsA under the control of a tetracycline regulated promoter.  Strains were grown 
under SPI1-inducing conditions with the indicated tetracycline concentrations.  C. β-
galactosidase activity in strains containing a hilD-lac transcriptional or a hilD’-’lac 
translational fusion and the indicated mutations after growth under SPI1 inducing 
conditions. β-galactosidase activity units are defined as (μmol of ONP formed min-1) x 
103/(OD600 x ml of cell suspension) and are reported as mean ± standard deviation 
where n=4. 
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Figure S6.9 Example of Class IV regulator that affects SPI1 expression independently of 
HilD (affects all regulators in the feed-forward loop):  HU (encoded by hupA hupB) 
activates hilA expression.   
A. β-galactosidase activity in strains containing a hilA-lac transcriptional fusion and the 
indicated mutations after growth under SPI1 inducing conditions.  B. β-galactosidase 
activity of strains containing a hilA-lac transcriptional fusion and indicated mutations 
with rtsA under the control of a tetracycline regulated promoter.  Strains were grown 
under SPI1-inducing conditions with the indicated tetracycline concentrations.  C. β-
galactosidase activity in strains containing a hilD-lac transcriptional or a hilD’-’lac 
translational fusion and the indicated mutations after growth under SPI1 inducing 
conditions. β-galactosidase activity units are defined as (μmol of ONP formed min-1) x 
103/(OD600 x ml of cell suspension) and are reported as mean ± standard deviation 
where n=4. 
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Figure S6.10 Example of Class IV regulator that affects SPI1 expression independently 
of HilD (affects all regulators in the feed-forward loop):  RfaH activates hilA expression.   
A. β-galactosidase activity in strains containing a hilA-lac transcriptional fusion and the 
indicated mutations after growth under SPI1 inducing conditions.  B. β-galactosidase 
activity of strains containing a hilA-lac transcriptional fusion and indicated mutations 
with rtsA under the control of a tetracycline regulated promoter.  Strains were grown 
under SPI1-inducing conditions with the indicated tetracycline concentrations.  C. β-
galactosidase activity in strains containing a hilD-lac transcriptional or a hilD’-’lac 
translational fusion and the indicated mutations after growth under SPI1 inducing 
conditions. β-galactosidase activity units are defined as (μmol of ONP formed min-1) x 
103/(OD600 x ml of cell suspension) and are reported as mean ± standard deviation 
where n=4. 
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Figure S6.11 Example of Class IV regulator that affects SPI1 expression independently 
of HilD (affects all regulators in the feed-forward loop):  RelA SpoT (ppGpp) activates 
hilA expression.   
A. β-galactosidase activity in strains containing a hilA-lac transcriptional fusion and the 
indicated mutations after growth under SPI1 inducing conditions.  B. β-galactosidase 
activity of strains containing a hilA-lac transcriptional fusion and indicated mutations 
with rtsA under the control of a tetracycline regulated promoter.  Strains were grown 
under SPI1-inducing conditions with the indicated tetracycline concentrations.  C. β-
galactosidase activity in strains containing a hilD-lac transcriptional or a hilD’-’lac 
translational fusion and the indicated mutations after growth under SPI1 inducing 
conditions. β-galactosidase activity units are defined as (μmol of ONP formed min-1) x 
103/(OD600 x ml of cell suspension) and are reported as mean ± standard deviation 
where n=4. 
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Figure S6.12 Example of Class IV regulator that affects SPI1 expression independently 
of HilD (affects all regulators in the feed-forward loop):  Butyrate represses hilA 
expression.   
A. β-galactosidase activity in strains containing a hilA-lac transcriptional fusion and the 
indicated mutations after growth under SPI1 inducing conditions.  B. β-galactosidase 
activity of strains containing a hilA-lac transcriptional fusion and indicated mutations 
with rtsA under the control of a tetracycline regulated promoter.  Strains were grown 
under SPI1-inducing conditions with the indicated tetracycline concentrations.  C. β-
galactosidase activity in strains containing a hilD-lac transcriptional or a hilD’-’lac 
translational fusion and the indicated mutations after growth under SPI1 inducing 
conditions. β-galactosidase activity units are defined as (μmol of ONP formed min-1) x 
103/(OD600 x ml of cell suspension) and are reported as mean ± standard deviation 
where n=4. 
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Figure S6.13 Example of Class V regulator that affects SPI1 expression via HilD:  Fur 
activates hilA expression.   
A. β-galactosidase activity in strains containing a hilA-lac transcriptional fusion and the 
indicated mutations after growth under SPI1 inducing conditions.  B. β-galactosidase 
activity of strains containing a hilA-lac transcriptional fusion and indicated mutations 
with rtsA under the control of a tetracycline regulated promoter.  Strains were grown 
under SPI1-inducing conditions with the indicated tetracycline concentrations.  C. β-
galactosidase activity in strains containing a hilD-lac transcriptional or a hilD’-’lac 
translational fusion and the indicated mutations after growth under SPI1 inducing 
conditions. β-galactosidase activity units are defined as (μmol of ONP formed min-1) x 
103/(OD600 x ml of cell suspension) and are reported as mean ± standard deviation 
where n=4. 
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Figure S6.14 TdcA affects hilA expression independently of FliZ. β-galactosidase 
activity in strains containing a hilA-lac transcriptional fusion and the indicated mutations 
after growth under SPI1 inducing conditions. β-galactosidase activity units are defined as 
(μmol of ONP formed min-1) x 103/(OD600 x ml of cell suspension) and are reported as 
mean ± standard deviation where n=4. 
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Figure S6.15 EnvZ affects hilA expression independently of FliZ. β-galactosidase 
activity in strains containing a hilA-lac transcriptional fusion and the indicated mutations 
after growth under SPI1 inducing conditions. β-galactosidase activity units are defined as 
(μmol of ONP formed min-1) x 103/(OD600 x ml of cell suspension) and are reported as 
mean ± standard deviation where n=4. 
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Figure S6.16 FadD affects hilA expression independently of FliZ. β-galactosidase 
activity in strains containing a hilA-lac transcriptional fusion and the indicated mutations 
after growth under SPI1 inducing conditions. β-galactosidase activity units are defined as 
(μmol of ONP formed min-1) x 103/(OD600 x ml of cell suspension) and are reported as 
mean ± standard deviation where n=4. 
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Figure S6.17 SirA affects hilA expression independently of FliZ. β-galactosidase activity 
in strains containing a hilA-lac transcriptional fusion and the indicated mutations after 
growth under SPI1 inducing conditions. β-galactosidase activity units are defined as 
(μmol of ONP formed min-1) x 103/(OD600 x ml of cell suspension) and are reported as 
mean ± standard deviation where n=4. 
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Figure S6.18 Dam affects hilA expression independently of FliZ. β-galactosidase activity 
in strains containing a hilA-lac transcriptional fusion and the indicated mutations after 
growth under SPI1 inducing conditions. β-galactosidase activity units are defined as 
(μmol of ONP formed min-1) x 103/(OD600 x ml of cell suspension) and are reported as 
mean ± standard deviation where n=4. 
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Figure S6.19 YfgL affects hilA expression independently of FliZ. β-galactosidase 
activity in strains containing a hilA-lac transcriptional fusion and the indicated mutations 
after growth under SPI1 inducing conditions. β-galactosidase activity units are defined as 
(μmol of ONP formed min-1) x 103/(OD600 x ml of cell suspension) and are reported as 
mean ± standard deviation where n=4. 
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Figure S6.20 Presence of dimethyl sulfide affects hilA expression independently of FliZ. 
β-galactosidase activity in strains containing a hilA-lac transcriptional fusion and the 
indicated mutations after growth under SPI1 inducing conditions. β-galactosidase activity 
units are defined as (μmol of ONP formed min-1) x 103/(OD600 x ml of cell suspension) 
and are reported as mean ± standard deviation where n=4. 
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Figure S6.21 Fnr affects hilA expression independently of FliZ. β-galactosidase activity 
in strains containing a hilA-lac transcriptional fusion and the indicated mutations after 
growth under SPI1 inducing conditions. β-galactosidase activity units are defined as 
(μmol of ONP formed min-1) x 103/(OD600 x ml of cell suspension) and are reported as 
mean ± standard deviation where n=4. 
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Figure S6.22 Hha affects hilA expression independently of FliZ. β-galactosidase activity 
in strains containing a hilA-lac transcriptional fusion and the indicated mutations after 
growth under SPI1 inducing conditions. β-galactosidase activity units are defined as 
(μmol of ONP formed min-1) x 103/(OD600 x ml of cell suspension) and are reported as 
mean ± standard deviation where n=4. 
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Figure S6.23 Fis affects hilA expression independently of FliZ. β-galactosidase activity 
in strains containing a hilA-lac transcriptional fusion and the indicated mutations after 
growth under SPI1 inducing conditions. β-galactosidase activity units are defined as 
(μmol of ONP formed min-1) x 103/(OD600 x ml of cell suspension) and are reported as 
mean ± standard deviation where n=4. 
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Figure S6.24 HU (encoded by hupA and hupB) affects hilA expression independently of 
FliZ. β-galactosidase activity in strains containing a hilA-lac transcriptional fusion and 
the indicated mutations after growth under SPI1 inducing conditions. β-galactosidase 
activity units are defined as (μmol of ONP formed min-1) x 103/(OD600 x ml of cell 
suspension) and are reported as mean ± standard deviation where n=4. 
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Figure S6.25 RfaH affects hilA expression independently of FliZ. β-galactosidase 
activity in strains containing a hilA-lac transcriptional fusion and the indicated mutations 
after growth under SPI1 inducing conditions. β-galactosidase activity units are defined as 
(μmol of ONP formed min-1) x 103/(OD600 x ml of cell suspension) and are reported as 
mean ± standard deviation where n=4. 
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Figure S6.26 ppGpp (produced by RelA and SpoT) affects hilA expression independently 
of FliZ. β-galactosidase activity in strains containing a hilA-lac transcriptional fusion and 
the indicated mutations after growth under SPI1 inducing conditions. β-galactosidase 
activity units are defined as (μmol of ONP formed min-1) x 103/(OD600 x ml of cell 
suspension) and are reported as mean ± standard deviation where n=4. 
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Figure S6.27 Changes in temperature affect hilA expression independently of FliZ. β-
galactosidase activity in strains containing a hilA-lac transcriptional fusion and the 
indicated mutations after growth under SPI1 inducing conditions. β-galactosidase activity 
units are defined as (μmol of ONP formed min-1) x 103/(OD600 x ml of cell suspension) 
and are reported as mean ± standard deviation where n=4. 
 
 
 
 
 
 
 
148 
 
hilA-lac hilA-lac
fliZ
hilA-lac 
hilD
hilA-lac 
flhDC
tetRA-fliZ
hilA-lac
flhDC
tetRA-fliZ
[Tet] µg/mL
0.10
β-
ga
la
ct
os
id
as
e
ac
tiv
ity
0
20
40
60
80
100
120
wt
10 mM butyrate
 
Figure S6.28 Presence of butyrate affects hilA expression independently of FliZ. β-
galactosidase activity in strains containing a hilA-lac transcriptional fusion and the 
indicated mutations after growth under SPI1 inducing conditions. β-galactosidase activity 
units are defined as (μmol of ONP formed min-1) x 103/(OD600 x ml of cell suspension) 
and are reported as mean ± standard deviation where n=4. 
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Figure S6.29 Fur affects hilA expression independently of FliZ. β-galactosidase activity 
in strains containing a hilA-lac transcriptional fusion and the indicated mutations after 
growth under SPI1 inducing conditions. β-galactosidase activity units are defined as 
(μmol of ONP formed min-1) x 103/(OD600 x ml of cell suspension) and are reported as 
mean ± standard deviation where n=4. 
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Figure S6.30 Presence of bile affects hilA expression independently of FliZ. β-
galactosidase activity in strains containing a hilA-lac transcriptional fusion and the 
indicated mutations after growth under SPI1 inducing conditions. β-galactosidase activity 
units are defined as (μmol of ONP formed min-1) x 103/(OD600 x ml of cell suspension) 
and are reported as mean ± standard deviation where n=4. 
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Chapter 7: Phosphate regulation of the SPI1 T3SS in 
Salmonella enterica serovar Typhimurium 
7.1 Introduction 
Phosphate is an essential nutrient for cellular processes, and is found in sugars, 
nucleic acids, proteins, and lipids in the cell. Environmental inorganic phosphate (Pi) 
serves as a preferred P source. Therefore, active assimilation of Pi in phosphate limiting 
environments is a requirement for survival. The phosphate regulon (Pho) includes a large 
number of genes that respond to environmental Pi under the control of the PhoR/PhoB 
two-component regulatory system. The majority of genes in the Pho regulon have a role 
in assimilation of either Pi or alternative phosphate sources. Estimates of the number of 
Pho regulated genes vary, but proteomic studies suggested that up to 10% of E. coli genes 
could be involved in phosphate response (231).  
PhoR, an inner membrane histidine kinase sensor protein, lacks a Pi sensor 
domain but rather responds to the periplasmic Pi concentrations via an interaction with 
the high affinity phosphate-specific transport system (Pst), encoded in the pstSCAB-phoU 
operon. Pst is the predominant system for Pi uptake in low Pi conditions, although it was 
recently suggested be a primary transporter in conditions of both the excess and 
limitation of Pi (91). When Pi is limited, the PhoR sensor kinase phosphorylates the 
response regulator PhoB, which then binds to the promoter regions of genes in the Pho 
regulon, resulting in activation or repression.  
Signal transduction from PhoR to PhoB is accomplished in a complex with the 
four proteins comprising the ABC Pst transporter (PstS, PstC, PstA, and PstB), and an 
inhibitory chaperone-like protein PhoU (231). PstS is a periplasmic Pi binding protein. 
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PstA and PstC are inner membrane proteins that form a channel to transport Pi from the 
periplasm, and PstB is an ATP-binding protein that provides energy for transport. The 
PhoR/PhoB signaling includes the following 3 states: inhibition, activation, and 
deactivation. The inhibition state is caused by excess Pi, while Pi limitation leads to 
autophosphorylation of PhoR and subsequent phosphorylation of PhoB, resulting in 
activation. Deactivation returns the system to the inhibition state. PhoU plays an 
important role in both the inhibition and the deactivation of the system, probably by 
acting as a chaperone to promote dephosphorylation of phospho-PhoB by PhoR.  
The Pho regulon has been implicated in virulence of a number of microorganisms 
(122,178).   In Salmonella, the PhoBR system has been previously suggested to 
negatively affect expression of the SPI1 T3SS (139), suggesting that phosphate might 
serve as an environmental cue during colonization of the host. Invasion of the intestinal 
epithelial cells is a critical step for Salmonella to establish disease in the host. Invasion is 
mediated by a Type Three Secretion System (T3SS) that forms a needdle-like structure 
for the direct injection of the bacterial secreted effectors into the host cell cytosol 
(71,218,228,232). This T3SS is encoded on a 40 kb Salmonella Pathogenicity Island 1 
(SPI1), which carries all genes for the functional T3SS apparatus, a number of secreted 
effectors, and several regulators. The regulators HilA, HilD, and HilC are encoded in 
SPI1 locus, while RtsA is encoded elsewhere in the chromosome (50). HilA is the master 
SPI1 regulator that directly binds to the promoters and activates expression of the prg/org 
and inv/spa operons, encoding the components of the apparatus (8,37,43,45,136).  The 
expression of hilA is controlled by a complex feed-forward regulatory loop consisting of 
HilD, HilC, and RtsA, where each of them can independently activate expression of hilD, 
153 
 
hilC, rtsA, and hilA (48) (Figure 1.2 in the Introduction Chapter).  Of these three, HilD 
has a predominant role, but apparently cannot act alone in vivo to sufficiently activate 
SPI1 (48).  HilC and RtsA act as amplifiers of the inducing signals. Multiple regulators 
encoded outside of SPI1, as well as a number of environmental conditions have been 
shown to affect SPI1 expression (see Table 1.1 in the Introduction chapter). This chapter 
provides details of the regulation of SPI1 by environmental phosphate availability. 
7.2 Results 
A study by Lucas et al. (139) had suggested that hilA was controlled by the 
PhoBR two-component regulatory system. The authors had isolated a transposon 
insertion in the pstS gene, the first gene in the pstSCAB-phoU operon. This transposon 
insertion resulted in a 2-fold decrease in hilA expression when grown in LB medium, 
where Pi is not limited. Mutations in pst genes cause an activation of the PhoBR system, 
and thus the Pho regulon (Wanner, 1996) even when Pi is abundant in rich medium (LB). 
Introduction of a PhoB mutation relieved the effect of the pstS mutation and resulted in a 
wild type level of hilA expression. Based on the observed results, the authors concluded 
that hilA expression was negatively controlled by PhoBR. Salmonella needs the SPI 1 
T3SS to be produced at the site of invasion, so hilA is presumed to be induced in the 
distal ileum of the host. Based on that hypothesis, the authors suggested that Pi was 
abundant in the small intestine. However, the availability of inorganic phosphate in a 
mouse intestine is not known, and the authors did not present any data on the 
concentration of inorganic phosphate in the distal ileum. 
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Low phosphate conditions induce hilA expression; the PhoBR system does not play 
a major role in this induction 
We have decided to study phosphate-dependant regulation of SPI1 in MOPS 
defined medium where the Pi concentration can be precisely controlled. We knew from 
previous studies that hilA is expressed at low levels in standard minimal medium (high Pi) 
compared to classic SPI1 inducing conditions (LB, 10 mM NaCl, standing culture). This 
is indeed what we observed when me measured hilA transcription after growth in MOPS 
defined medium at 2 mM Pi. To our surprise, hilA expression was increased 50-fold in Pi 
limiting conditions (0.04 mM Pi) compared to the high Pi medium (2 mM Pi), contrary to 
the hypothesis that hilA is repressed in low phosphate (Fig. 7.1). Deletion of HilD 
resulted in significant decrease in hilA expression in both high and low Pi conditions, as 
expected. 
As a positive control, we have tested the effect of the low Pi conditions on 
expression of an apeE-lac fusion. ApeE, a Salmonella outer membrane esterase, was 
previously shown to be a member of the Pho regulon and to be induced in low Pi 
conditions, with PhoB binding sites located in the promoter region of apeE (25,32). As 
seen in Figure 7.1, the expression of apeE in 0.04 mM Pi medium was drastically 
increased, as expected. These experiments showed that hilA is induced in low phosphate 
conditions similarly to a known PhoBR regulated gene. To further examine this 
regulation, we determined the effect of the phoBR, phoU, or pst-phoU deletion mutations 
on apeE and hilA expression.  Deletion of phoBR completely abolished the apeE 
induction in low phosphate medium while the deletions of phoU or pst-phoU caused a 
constitutive activation of apeE in both low and high phosphate conditions (Fig. 7.2). 
These results confirmed that apeE is activated by the PhoBR system (33).  
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  If hilA expression is indeed under negative control by PhoBR, we would expect to 
see the increase in hilA expression in the phoBR null background. On the contrary, the 
deletion of phoBR in low Pi conditions led to a 2-fold decrease in hilA transcription while 
having no effect in high Pi medium. This result suggested that while PhoBR might have 
some role in activating hilA during Pi deprivation, hilA expression was primarily 
controlled by some other mechanism under these conditions. As seen in Figure 7.2., hilA 
transcription was still induced 25-fold in low Pi (Fig. 7.2 B) compared to the high Pi 
medium (Fig. 7.2 A) even when the phoBR deletion was introduced. Deletion of phoU or 
pst-phoU resulted in a decrease in hilA expression independently of Pi concentration. 
Taken together these results suggest that while hilA is induced by low Pi concentrations, 
the mechanism of this regulation is different from the known PhoBR-dependent 
activation. 
HilD has a role in low Pi induction of hilA  
 To test whether HilD had a role in regulation of hilA by low phosphate 
concentrations, we compared hilA transcription in the wild type and hilD null background. 
Figure 7.3A shows that hilA transcription was induced drasticly in low Pi compared to the 
high Pi medium. Introduction of the hilD deletion resulted in a very low level of hilA 
expression, such that the effect of low Pi could not be examined conclusively. To 
overcome that, we induced rtsA by addition of tetracycline in the tetRA-rtsA strain, which 
allowed us to induce hilA (and hilC) expression independently of HilD (Fig. 7.3B). In the 
absence of HilD, at 1µg/mL tetracycline, a significant increase in hilA expression was 
observed in high Pi. If the effect of low Pi is independent of HilD, we would expect low 
Pi conditions to still induce hilA in the hilD null background. However, hilA transcription 
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was actually decreased in low Pi in the absence of HilD compared to the high Pi (Fig. 7.3). 
This result suggested that HilD plays a role in phosphate regulation of hilA, although 
more than one mechanism could be involved in this regulation. Limitation of Pi affected 
both the hilD-lac transcriptional and hilD’-‘lac translational fusions, showing that effect 
of phosphate could potentially affect hilD at the post-transcriptional level (Fig. 6.2C).  
SPI1 gene expression is affected by a multitude of regulatory signals, so it is 
possible that the Pi signaling acts at the level of one of the known SPI1 regulators. We 
have tested an effect of a few regulatory mutations, potentially involved in post-
transcriptional regulation of hilD or affecting all genes in the feed-forward loop, on hilA 
expression in high and low Pi conditions. Loss of  Hns, Hha, Fis, RelA SpoT, Hfq, or 
SirA affected hilA expression in both low and high Pi concentrations (data not shown). As 
seen in Figure 7.4, hilA expression was induced more than 60-fold in low Pi medium 
compared to high Pi. When the sirA deletion was introduced, we observed a decrease in 
hilA transcription in both high and low Pi conditions, showing that SirA regulation of hilA 
is independent of the effect of phosphate. In contrast, deletion of the ack pta had no effect 
on hilA expression in the high Pi conditions, while it had significantly decreased hilA 
expression in low Pi (Fig. 7.4). Further work will be required to understand the effect of 
Ack Pta on the Pi signaling.  
 
The presence of amino acids is required for hilA induction in low Pi conditions 
As stated above, we had never observed significant hilA expression in defined 
minimal medium. However, we could induce hilA by adding > 1/50 volume LB to any of 
157 
 
several minimal media (Chubiz JE, unpublished), suggesting that the minimal media 
lacked some factor required for expression. Given this results, we were surprised that 
such a high induction of hilA was achived in the MOPS defined medium at low Pi. 
Therefore, we decided to analyze the effect of the presence/absence of the individual 
components of MOPS defined medium on hilA expression. The defined MOPS medium 
contains several components: MOPS base, glucose, potassium phosphate, and growth 
supplements “ACGU” and “EZ” (Teknova Inc.). The ACGU supplement is a mix of the 4 
nucleotides, while the EZ supplement provides the mix of 20 amino acids and certain 
vitamins. Both supplements serve to allow for an increased yield of bacterial biomass in 
otherwise minimal medium, effectively making it a rich defined MOPS medium.  We 
omitted the ACGU and/or EZ supplements from the medium and analyzed the hilA and 
apeE expression in these conditions. 
The apeE-lac fusion strain showed an increase in transcription in low Pi 
conditions regardless of whether the ACGU and/or EZ supplements were added to the 
medium (Fig. 7.5), albeit the absolute level of expression was decreased slightly. The 
Pho-dependent regulation of apeE was also evident in these conditions as deletion of 
phoBR resulted in a sharp decrease of the apeE transcription, while phoU deletion 
resulted in a high level of activity. In contrast, hilA induction in low Pi medium was 
completely abolished when supplement EZ was omitted, while the supplement ACGU 
was dispensable.  
To dissect which amino acids or vitamins in the EZ supplement were required for 
hilA induction in low phosphate, we tested the effect of the different combinations of 
amino acids on hilA expression in inducing conditions. First, lack of the supplement EZ 
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had abolished hilA induction in low Pi (Fig. 7.6). The omission of the vitamin solution 
from the MOPS medium had no effect on hilA induction in low Pi, since there was no 
difference in hilA expression in the complete medium (missing only the vitamin solution 
out of defined MOPS formulation) compared to the regular defined MOPS (Low Pi bar in 
Fig. 7.6). The omission of each amino acid individually did not abolish hilA induction in 
low Pi, suggesting that some combination of amino acids was required (Fig. 7.6). This 
experiment suggested that the absence of the Arg, Gly, or Ile affected hilA activation the 
most, but individually lack of none of them abolished the effect of phosphate limitation.  
To determine the minimal pool of amino acids that is sufficient to restore hilA 
induction in low Pi, multiple variations were tested. Further analysis of multiple 
combinations of amino acids allowed us to narrow it down to 7 amino acids (Arg, Asp, 
Cys, Glu, Ile, Met, Ser), which addition to the medium significantly restored the low Pi 
activation of hilA (Fig. 7.7). 
 The reason why these amino acids are important for phosphate regulation of hilA 
is not clear. One possibility would be that they can be required as a nitrogen or carbon 
source for bacterial growth in the conditions of phosphate limitation. This does not seem 
likely as the presence of the ammonium chloride and glucose in the MOPS modified 
medium would ensure a sufficient nitrogen and carbon source for the bacteria even when 
the ACGU/ EZ supplements are omitted. We have performed a number of the growth 
curve experiments with/without the supplements ACGU/ EZ or with the pool of the 7 
amino acids in both low and high Pi medium, and simultaneously monitored the 
expression of hilA to ensure that hilA was induced as expected during the growth in 96-
well plates. We did not observe any significant difference in Salmonella growth patterns 
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in the absence of the supplements ACGU/ EZ, as well as with the addition of the 7 amino 
acid pool (data not shown). Salmonella Typhimurium is a facultative intracellular 
pathogen where bacteria can live outside the host. The observed phenomenon of the 
amino acid requirement for SPI1 induction in low Pi raises a question whether phosphate 
regulation of invasion genes requires additional signals from the host environment. For 
example, the limitation of phosphate can be encountered in aqueous environment, as well 
as in soil where Salmonella does not need to produce the SPI1 T3SS. Possibly, the 
presence of amino acids can be a signal of intestinal localization within the host.  
Approaches to understand the small intestine environment of the mouse 
Despite the fact that the murine model has been an established system for 
studying host-pathogen interactions for decades, certain aspects of the host physiology 
have not been fully elucidated. Multiple studies have addressed the mechanism of 
intestinal Pi transport. However, data on the phosphate concentration in different parts of 
the mouse small intestine have not been extensively described in the literature. Phosphate 
constitutes a necessary nutrient in all mammals, and limitations in dietary phosphate lead 
to pathophysiological conditions. Therefore, dietary phosphate uptake and maintenance 
of the phosphate homeostasis are crucial for the normal physiological functions of the 
body. The small intestine, which is comprised of three parts, duodenum, jejunum, and 
ileum, serves as a site for phosphate uptake in the gastrointestinal tract of mammals 
(22,105). Both passive (diffusion) and active (sodium phosphate transporters) transport 
are presumed to play a role in intestinal Pi absorption, with diffusion being important 
when the concentration of Pi is high (22,234). Several families of sodium-dependent 
phosphate transporters (NaPi) are known. The NaPi-IIb type transporters are found in 
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apical membranes of epithelial cells, and are responsible for the transcellular Pi 
absorbtion in the small intestine (227). A number of studies have addressed the 
distribution and expression of the phosphate transporters in the small intestine, with some 
differences found between mice, rats, and humans. In rats and humans, these transporters 
are abundant in parts of duodenum and jejunum (144). In mice, the majority of the Pi 
transporters in small intestine are expressed in the ileum (182).  
By the time the digesta reach the distal small intestine, the majority of available 
inorganic phosphate has been taken up and transported across the intestinal wall. 
However, while free inorganic phosphate is bioavailable, a fraction of organic phosphate 
cannot be readily absorbed. Part of the phosphate dietary intake is comprised of phytate-
bound phosphate (inositol hexaphosphate), which is unavailable for the absorption in the 
small intestine of non-ruminant mammals (193,238). Phosphate can be released from 
phytate by the resident bacteria in the mammalian large intestine (238), but   the studies 
of phosphate absorption in pigs have shown that no absorption happens in the large 
intestine (21). Importantly, the concentration of phosphate in the diet does not influence 
the absorption of phosphate in the small intestine as a percentage of Pi intake. Increase in 
dietary phosphate increases both the Pi absorption and the Pi excretion in urine (210). 
The distal ileum serves as the site where Salmonella invades the intestinal 
epithelia of the host. It is possible that the majority of free inorganic phosphate in the 
digesta is taken up by the host, such that Salmonella could experience conditions of Pi 
limitation in the ileum, and this could lead to strong induction of SPI1. No specific 
studies on the ability of Salmonella to use phytate as a phosphate source have been 
reported. E. coli Agp is an acid phosphatase that was shown to possess the phytase 
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activity in vitro (35). There is an ortholog of an E. coli agp gene in Salmonella. Thus, 
Salmonella can be potentially able to utilize phytate as a phosphate source at the site of 
invasion. Determining the Pi concentration in the distal ileum of mice, and studying 
whether Salmonella can use phytate as a phosphate source in the small intestine would 
help us to better understand the conditions at the site of the bacterial invasion of the 
intestinal epithelia, and the signals that bacteria respond to in the host intestine.   
One of the approaches to study the availability of Pi in the distal ileum is to 
analyze the transcriptional responses of the known Pi-regulated genes in Salmonella as 
the bacteria colonize the host. Use of the Resolvase-In Vivo Expression Technology 
(RIVET) system will allow us to address the activation status of the Pi-activated 
promoters in the mouse intestine during infection (149). This system utilizes a 
promoterless tnpR gene that encodes the Tn1000 resolvase, and a tetracycline reporter 
that consists of the tetracycline antibiotic marker flanked by the two tandem res sites. The 
Tet reporter is integrated into the Salmonella chromosome near the purA gene. The 
promoterless tnpR gene is part of a tnpR-lacZY fusion plasmid, which is used for 
construction of the single copy chromosomal lac fusions to the genes of interest (49). 
When TnpR is produced in sufficient amounts, recombination between the two res sites 
results in a loss of the Tet marker. Thus, the in vivo promoter activation of the gene of 
interest leads to the resolution of the Tet marker, resulting in a heritable loss of the Tet 
resistance rendering the resulting colonies Tet sensitive. The ratio of the TetR/TetS 
bacteria in the inoculum is compared to the ratio of the TetR/TetS bacteria recovered 
from the animal tissues. The comparison of the percent of Tet sensitivity in bacteria 
recovered from animal tissues compared to the initial inoculum determines whether the 
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gene of interest was induced during infection. This system was successfully implemented 
in studying the patterns of expression of  the PhoPQ and PmrAB regulated genes during 
Salmonella infection in mice (149). It provides us with a potentially powerful tool for the 
elucidation of the details of SPI1 gene regulation in a mouse small intestine. 
We have constructed an apeE tnpR-lac chromosomal transcriptional fusions using 
the pCE70 fusion plasmid. Upon activation of the apeE promoter in low phosphate 
conditions we would expect to see an increase in the resolution of the Tet antibiotic 
marker in this construct, which would result in increase in the percent of the Tet sensitive 
colonies. Indeed, growth in Pi limiting conditions resulted in the approximately 80-85 % 
of Tet sensitive colonies, while the observed Tet sensitivity in the inoculum was less than 
10% (Fig. 7.8). The experiment was repeated a few times to ensure the reproducibility of 
the outcome. Our results confirmed that the construct was working correctly, and that 
there was a direct correlation between the percent of Tet sensitive bacteria and the Pi 
concentration in the culture medium. The next step would be to orally infect mice with 
the apeE tnpR-lac fusion strain, recover bacteria from the small intestine of infected mice, 
and analyse the ratio of the TetR/TetS bacteria recovered from the animal compared to 
the ratio of the TetR/TetS bacteria in the inoculum. 
Approaches to study the induction of hilA and fliZ in the small intestine of mice 
To successfully invade the intestinal epithelia of the host, Salmonella has to 
produce the SPI1 T3SS upon reaching the distal ileum of the mouse. This presumably 
requires a timely activation of the SPI1 genes, where hilA would become induced when 
bacteria reach the site of invasion. However, the question of when and where hilA 
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induction occurs has not been extensively addressed in vivo. The flagellar gene fliZ was 
shown to be an important regulator of SPI1 genes both in vitro and in vivo (29), so the 
study of fliZ expression in mice would also enhance our understanding of the regulation 
of Salmonella invasion. We would like to study the details of SPI1 and flagellar gene 
regulation during the passage of bacteria through different regions of the small intestine. 
Use of the pCE70 hilA-lac or fliZ-lac transcriptional fusion constructs (RIVET) should 
allow us to measure the level of hilA (or fliZ) induction in various sections of the mouse 
small intestine. The have constructed the pCE70 fusions at the end of the hilA or fliZ 
open reading frame so the resulting strains would not be attenuated in virulence. Use of 
the pCE70 hilA-lac or fliZ-lac transcriptional fusion constructs (RIVET) should allow us 
to measure the level of hilA (or fliZ) induction in various sections of the mouse small 
intestine. The resolution of the Tet marker in these fusion strains will be tested in vitro in 
the SPI1 inducing and repressing conditions to ensure that they respond correctly, and 
that the basal resolution in the inoculums is not too high. Then we will orally infect mice 
with each of these fusion strains, recover bacteria from the small intestine of infected 
mice, and analyse the ratio of the TetR/TetS bacteria recovered from the animal 
compared to the ratio of the TetR/TetS bacteria in the inoculum. 
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7.3 Figures 
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Figure 7.1 The β-galactosidase activity of the hilA-lac and the apaE-lac transcriptional 
fusion strains grown in high or low Pi conditions. β-galactosidase activity units are 
defined as (μmol of ONP formed min-1) x 103/(OD600 x ml of cell suspension) and are 
reported as mean ± standard deviation where n=4. 
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Figure 7.2 The β-galactosidase activity of the hilA and the apaE transcriptional lac 
fusion strains grown in (A) high  or (B) low  Pi conditions in wt, phoBR, phoU, and 
pstSCAB-phoU null background.  
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Figure 7.2 (cont.) The β-galactosidase activity of the hilA and the apaE transcriptional 
lac fusion strains grown in (A) high  or (B) low  Pi conditions in wt, phoBR, phoU, and 
pstSCAB-phoU null background. The MOPS modified rich medium supplemented with 
the 2 mM Pi or with the 0.04 mM Pi represents high Pi and low Pi conditions, respectively. 
β-galactosidase activity units are defined as (μmol of ONP formed min-1) x 103/(OD600 x 
ml of cell suspension) and are reported as mean ± standard deviation where n=4. 
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Figure 7.3 Phosphate signaling (A) β-galactosidase activity in strains containing a hilA-
lac transcriptional fusion and the indicated mutations after growth under high or low Pi 
conditions. (B) β-galactosidase activity of strains containing a hilA-lac transcriptional 
fusion and indicated mutations with rtsA under the control of a tetracycline regulated 
promoter.  Strains were grown under high or low Pi conditions with the indicated 
tetracycline concentrations. (C) β-galactosidase activity in strains containing a hilD-lac 
transcriptional or a hilD’-’lac translational fusion and the indicated mutations after 
growth under high or low Pi conditions. β-galactosidase activity units are defined as 
(μmol of ONP formed min-1) x 103/(OD600 x ml of cell suspension) and are reported as 
mean ± standard deviation where n=4. 
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Figure 7.4 The β-galactosidase activity of the hilA-lac transcriptional fusion strain in 
high or low Pi conditions in the wt, hilD, sirA, and ack pta null background. The MOPS 
modified rich medium supplemented with the 2 mM Pi or with the 0.04 mM Pi represents 
high Pi and low Pi conditions, respectively. β-galactosidase activity units are defined as 
(μmol of ONP formed min-1) x 103/(OD600 x ml of cell suspension) and are reported as 
mean ± standard deviation where n=4. 
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Figure 7.5 Effect of the supplements ACGU and/or EZ on the β-galactosidase activity of 
the hilA-lac and the apaE-lac transcriptional fusion strains grown in low Pi conditions.  
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Figure 7.5 (cont.) Effect of the supplements ACGU and/or EZ on the β-galactosidase 
activity of the hilA-lac and the apaE-lac transcriptional fusion strains grown in low Pi 
conditions. Bacteria were grown in the MOPS modified rich medium with (A) the 
supplements ACGU and EZ added to the medium, (B) the ACGU was omitted, (C) the 
EZ was omitted, and (D) both the ACGU and EZ were omitted. Expression of hilA and 
apeE was studied in the wt, phoBR, and phoU null background. β-galactosidase activity 
units are defined as (μmol of ONP formed min-1) x 103/(OD600 x ml of cell suspension) 
and are reported as mean ± standard deviation where n=4. 
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Figure 7.6 Effect of the individual amino acids omission on the β-galactosidase activity 
of the hilA-lac transcriptional fusion strains grown in low Pi conditions. Bacteria were 
grown in the MOPS modified rich medium with or without the supplement EZ, or 
supplemented with different pools of amino acids instead of the supplement EZ, as 
indicated. The high Pi and low Pi medium contain all of the supplements (ACGU and EZ). 
The complete medium contains the pool of all 20 amino acids (in identical concentrations 
to the supplement EZ), only missing the vitamin solution. β-galactosidase activity units 
are defined as (μmol of ONP formed min-1) x 103/(OD600 x ml of cell suspension) and 
are reported as mean ± standard deviation where n=4. 
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Figure 7.7 The determination of the amino acid pool that was sufficient to restore hilA 
induction in low Pi conditions. Bacteria were grown in the MOPS modified rich medium 
with or without the supplement EZ, or supplemented with different pools of amino acids 
instead of the supplement EZ, as indicated. The high Pi and low Pi medium contain all of 
the supplements (ACGU and EZ). The complete medium contains the pool of all 20 
amino acids (in identical concentrations to the supplement EZ), only missing the vitamin 
solution.  β-galactosidase activity units are defined as (μmol of ONP formed min-1) x 
103/(OD600 x ml of cell suspension) and are reported as mean ± standard deviation 
where n=4. 
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Figure 7.8 The resolution of the Tet marker in the apaE tnpR-lac pCE70 fusion strain in 
different concentrations of Pi. The % of Tet sensitive colonies for the apeE-lac fusion 
strain was determined after growth in the MOPS rich modified medium at the indicated Pi 
concentrations. At 20 h after inoculation bacteria were diluted and plated on LB agar, and 
replica plated on LB-Tet. Then the proportion of the Tet sensitive colonies was calculated. 
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